Sentence Id: DrugDDI.d201.s5
Drugs/NNS that/WDT Inhibit/VBP or/CC Induce/VBP Cytochrome/NN P450/NN 3A4/NN Enzymes/NNS Lapatinib/NN undergoes/VBZ extensive/JJ metabolism/NN by/IN CYP3A4/NN ,/, and/CC concomitant/JJ administration/NN of/IN strong/JJ inhibitors/NNS or/CC inducers/NNS of/IN CYP3A4/NN alter/VB lapatinib/NN concentrations/NNS significantly/RB ./.

root(ROOT-0, Drugs-1)
nsubj(Inhibit-3, Drugs-1)
rcmod(Drugs-1, Inhibit-3)
conj_or(Inhibit-3, Induce-5)
nn(3A4-8, Cytochrome-6)
nn(3A4-8, P450-7)
nn(Enzymes-9, 3A4-8)
dobj(Induce-5, Enzymes-9)
nsubj(undergoes-11, Lapatinib-10)
dep(Enzymes-9, undergoes-11)
amod(metabolism-13, extensive-12)
dobj(undergoes-11, metabolism-13)
prep_by(undergoes-11, CYP3A4-15)
amod(administration-19, concomitant-18)
nsubj(alter-27, administration-19)
amod(inhibitors-22, strong-21)
prep_of(administration-19, inhibitors-22)
conj_or(inhibitors-22, inducers-24)
prep_of(inducers-24, CYP3A4-26)
conj_and(undergoes-11, alter-27)
nn(concentrations-29, lapatinib-28)
dobj(alter-27, concentrations-29)
advmod(alter-27, significantly-30)

Sentence Id: DrugDDI.d201.s6
Dose/NN adjustment/NN of/IN lapatinib/NN should/MD be/VB considered/VBN for/IN patients/NNS who/WP must/MD receive/VBP concomitant/JJ strong/JJ inhibitors/NNS or/CC concomitant/JJ strong/JJ inducers/NNS of/IN CYP3A4/JJ enzymes/NNS ./.

nn(adjustment-2, Dose-1)
nsubjpass(considered-7, adjustment-2)
prep_of(adjustment-2, lapatinib-4)
aux(considered-7, should-5)
auxpass(considered-7, be-6)
root(ROOT-0, considered-7)
prep_for(considered-7, patients-9)
nsubj(receive-12, patients-9)
aux(receive-12, must-11)
rcmod(patients-9, receive-12)
amod(inhibitors-15, concomitant-13)
amod(inhibitors-15, strong-14)
dobj(receive-12, inhibitors-15)
amod(inducers-19, concomitant-17)
amod(inducers-19, strong-18)
conj_or(inhibitors-15, inducers-19)
amod(enzymes-22, CYP3A4-21)
prep_of(inhibitors-15, enzymes-22)

Sentence Id: DrugDDI.d201.s7
Ketoconazole/NN :/: In/IN healthy/JJ subjects/NNS receiving/VBG ketoconazole/NN ,/, a/DT CYP3A4/NN inhibitor/NN ,/, at/IN 200/CD mg/NN twice/RB daily/RB for/IN 7/CD days/NNS ,/, systemic/JJ exposure/NN (/-LRB- AUC/NN )/-RRB- to/TO lapatinib/NN was/VBD increased/VBN to/TO approximately/RB 3.6-fold/NN of/IN control/NN and/CC half-life/NN increased/VBD to/TO 1.7-fold/NN of/IN control/NN ./.

root(ROOT-0, Ketoconazole-1)
amod(subjects-5, healthy-4)
prep_in(increased-30, subjects-5)
partmod(subjects-5, receiving-6)
dobj(receiving-6, ketoconazole-7)
det(inhibitor-11, a-9)
nn(inhibitor-11, CYP3A4-10)
appos(ketoconazole-7, inhibitor-11)
num(mg-15, 200-14)
prep_at(receiving-6, mg-15)
advmod(daily-17, twice-16)
advmod(mg-15, daily-17)
num(days-20, 7-19)
prep_for(daily-17, days-20)
amod(exposure-23, systemic-22)
nsubjpass(increased-30, exposure-23)
abbrev(exposure-23, AUC-25)
prep_to(exposure-23, lapatinib-28)
auxpass(increased-30, was-29)
dep(Ketoconazole-1, increased-30)
advmod(3.6-fold-33, approximately-32)
prep_to(increased-30, 3.6-fold-33)
prep_of(3.6-fold-33, control-35)
conj_and(control-35, half-life-37)
partmod(3.6-fold-33, increased-38)
prep_to(increased-38, 1.7-fold-40)
prep_of(1.7-fold-40, control-42)

Sentence Id: DrugDDI.d201.s8
Carbamazepine/NN :/: In/IN healthy/JJ subjects/NNS receiving/VBG the/DT CYP3A4/NN inducer/NN ,/, carbamazepine/NN ,/, at/IN 100/CD mg/NN twice/RB daily/JJ for/IN 3/CD days/NNS and/CC 200/CD mg/NN twice/RB daily/JJ for/IN 17/CD days/NNS ,/, systemic/JJ exposure/NN (/-LRB- AUC/NN )/-RRB- to/TO lapatinib/NN was/VBD decreased/VBN approximately/RB 72/CD %./NN

root(ROOT-0, Carbamazepine-1)
amod(subjects-5, healthy-4)
prep_in(decreased-38, subjects-5)
partmod(subjects-5, receiving-6)
det(inducer-9, the-7)
nn(inducer-9, CYP3A4-8)
dobj(receiving-6, inducer-9)
appos(inducer-9, carbamazepine-11)
num(mg-15, 100-14)
prep_at(receiving-6, mg-15)
advmod(daily-17, twice-16)
amod(mg-15, daily-17)
num(days-20, 3-19)
prep_for(daily-17, days-20)
num(mg-23, 200-22)
conj_and(mg-15, mg-23)
advmod(daily-25, twice-24)
amod(mg-23, daily-25)
num(days-28, 17-27)
prep_for(daily-25, days-28)
amod(exposure-31, systemic-30)
nsubjpass(decreased-38, exposure-31)
abbrev(exposure-31, AUC-33)
prep_to(exposure-31, lapatinib-36)
auxpass(decreased-38, was-37)
dep(Carbamazepine-1, decreased-38)
quantmod(72-40, approximately-39)
num(%.-41, 72-40)
dobj(decreased-38, %.-41)

Sentence Id: DrugDDI.d201.s9
Drugs/NNS that/WDT Inhibit/VBP Drug/NN Transport/NN Systems/NNS Lapatinib/NN is/VBZ a/DT substrate/NN of/IN the/DT efflux/NN transporter/NN P-glycoprotein/NN (/-LRB- Pgp/NN ,/, ABCB1/NN )/-RRB- ./.

nsubj(Inhibit-3, Drugs-1)
nsubj(substrate-10, Drugs-1)
rcmod(Drugs-1, Inhibit-3)
nn(Systems-6, Drug-4)
nn(Systems-6, Transport-5)
nn(Lapatinib-7, Systems-6)
dobj(Inhibit-3, Lapatinib-7)
cop(substrate-10, is-8)
det(substrate-10, a-9)
root(ROOT-0, substrate-10)
det(P-glycoprotein-15, the-12)
nn(P-glycoprotein-15, efflux-13)
nn(P-glycoprotein-15, transporter-14)
prep_of(substrate-10, P-glycoprotein-15)
dep(P-glycoprotein-15, Pgp-17)
appos(Pgp-17, ABCB1-19)

Sentence Id: DrugDDI.d201.s10
If/IN TYKERB/NN is/VBZ administered/VBN with/IN drugs/NNS that/WDT inhibit/VBP Pgp/NN ,/, increased/VBN concentrations/NNS of/IN lapatinib/NN are/VBP likely/JJ ,/, and/CC caution/NN should/MD be/VB exercised/VBN ./.

mark(administered-4, If-1)
nsubjpass(administered-4, TYKERB-2)
auxpass(administered-4, is-3)
advcl(likely-16, administered-4)
prep_with(administered-4, drugs-6)
nsubj(inhibit-8, drugs-6)
rcmod(drugs-6, inhibit-8)
dobj(inhibit-8, Pgp-9)
amod(concentrations-12, increased-11)
nsubj(likely-16, concentrations-12)
prep_of(concentrations-12, lapatinib-14)
cop(likely-16, are-15)
root(ROOT-0, likely-16)
nsubjpass(exercised-22, caution-19)
aux(exercised-22, should-20)
auxpass(exercised-22, be-21)
conj_and(likely-16, exercised-22)

Sentence Id: DrugDDI.d201.s11
Other/JJ Chemotherapy/NN Agents/NNS :/: In/IN a/DT separate/JJ study/NN ,/, concomitant/JJ administration/NN of/IN lapatinib/NN with/IN capecitabine/NN did/VBD not/RB meaningfully/RB alter/VB the/DT pharmacokinetics/NNS of/IN either/DT agent/NN (/-LRB- or/CC the/DT metabolites/NNS of/IN capecitabine/NN )/-RRB- ./.

amod(Agents-3, Other-1)
nn(Agents-3, Chemotherapy-2)
root(ROOT-0, Agents-3)
det(study-8, a-6)
amod(study-8, separate-7)
prep_in(alter-19, study-8)
amod(administration-11, concomitant-10)
nsubj(alter-19, administration-11)
prep_of(administration-11, lapatinib-13)
prep_with(administration-11, capecitabine-15)
aux(alter-19, did-16)
neg(alter-19, not-17)
advmod(alter-19, meaningfully-18)
dep(Agents-3, alter-19)
det(pharmacokinetics-21, the-20)
dobj(alter-19, pharmacokinetics-21)
det(agent-24, either-23)
prep_of(pharmacokinetics-21, agent-24)
dep(metabolites-28, or-26)
det(metabolites-28, the-27)
dep(alter-19, metabolites-28)
prep_of(metabolites-28, capecitabine-30)

Sentence Id: DrugDDI.d581.s0
Cholestyramine/NN and/CC Charcoal/NN Administration/NN of/IN cholestyramine/NN or/CC activated/VBN charcoal/NN in/IN patients/NNS (/-LRB- n=13/NN )/-RRB- and/CC volunteers/NNS (/-LRB- n=96/CD )/-RRB- resulted/VBD in/IN a/DT rapid/JJ and/CC significant/JJ decrease/NN in/IN plasma/NN M1/NN (/-LRB- the/DT active/JJ metabolite/NN of/IN leflunomide/NN )/-RRB- concentration/NN ./.

nsubj(resulted-20, Cholestyramine-1)
nn(Administration-4, Charcoal-3)
conj_and(Cholestyramine-1, Administration-4)
prep_of(Cholestyramine-1, cholestyramine-6)
amod(charcoal-9, activated-8)
conj_or(cholestyramine-6, charcoal-9)
prep_in(Cholestyramine-1, patients-11)
appos(patients-11, n=13-13)
conj_and(patients-11, volunteers-16)
appos(volunteers-16, n=96-18)
root(ROOT-0, resulted-20)
det(decrease-26, a-22)
amod(decrease-26, rapid-23)
conj_and(rapid-23, significant-25)
prep_in(resulted-20, decrease-26)
nn(concentration-37, plasma-28)
nn(concentration-37, M1-29)
det(metabolite-33, the-31)
amod(metabolite-33, active-32)
dep(M1-29, metabolite-33)
prep_of(metabolite-33, leflunomide-35)
prep_in(decrease-26, concentration-37)

Sentence Id: DrugDDI.d581.s1
Hepatotoxic/JJ Drugs/NNS Increased/VBN side/NN effects/NNS may/MD occur/VB when/WRB leflunomide/NN is/VBZ given/VBN concomitantly/RB with/IN hepatotoxic/JJ substances/NNS ./.

amod(Drugs-2, Hepatotoxic-1)
nn(effects-5, Drugs-2)
amod(effects-5, Increased-3)
nn(effects-5, side-4)
nsubj(occur-7, effects-5)
aux(occur-7, may-6)
root(ROOT-0, occur-7)
advmod(given-11, when-8)
nsubjpass(given-11, leflunomide-9)
auxpass(given-11, is-10)
advcl(occur-7, given-11)
advmod(given-11, concomitantly-12)
amod(substances-15, hepatotoxic-14)
prep_with(given-11, substances-15)

Sentence Id: DrugDDI.d581.s2
This/DT is/VBZ also/RB to/TO be/VB considered/VBN when/WRB leflunomide/NN treatment/NN is/VBZ followed/VBN by/IN such/JJ drugs/NNS without/IN a/DT drug/NN elimination/NN procedure/NN ./.

nsubj(is-2, This-1)
xsubj(considered-6, This-1)
root(ROOT-0, is-2)
advmod(is-2, also-3)
aux(considered-6, to-4)
auxpass(considered-6, be-5)
xcomp(is-2, considered-6)
advmod(followed-11, when-7)
nn(treatment-9, leflunomide-8)
nsubjpass(followed-11, treatment-9)
auxpass(followed-11, is-10)
advcl(considered-6, followed-11)
amod(drugs-14, such-13)
agent(followed-11, drugs-14)
det(procedure-19, a-16)
nn(procedure-19, drug-17)
nn(procedure-19, elimination-18)
prep_without(followed-11, procedure-19)

Sentence Id: DrugDDI.d581.s3
In/IN a/DT small/JJ (/-LRB- n=30/NN )/-RRB- combination/NN study/NN of/IN ARAVA/NN with/IN methotrexate/NN ,/, a/DT 2-/CD to/TO 3-fold/JJ elevation/NN in/IN liver/NN enzymes/NNS was/VBD seen/VBN in/IN 5/CD of/IN 30/CD patients/NNS ./.

det(study-8, a-2)
amod(study-8, small-3)
dep(small-3, n=30-5)
nn(study-8, combination-7)
prep_in(seen-23, study-8)
prep_of(study-8, ARAVA-10)
prep_with(study-8, methotrexate-12)
det(elevation-18, a-14)
number(3-fold-17, 2--15)
dep(3-fold-17, to-16)
amod(elevation-18, 3-fold-17)
nsubjpass(seen-23, elevation-18)
nn(enzymes-21, liver-20)
prep_in(elevation-18, enzymes-21)
auxpass(seen-23, was-22)
root(ROOT-0, seen-23)
prep_in(seen-23, 5-25)
num(patients-28, 30-27)
prep_of(5-25, patients-28)

Sentence Id: DrugDDI.d581.s4
All/DT elevations/NNS resolved/VBN ,/, 2/CD with/IN continuation/NN of/IN both/DT drugs/NNS and/CC 3/CD after/IN discontinuation/NN of/IN leflunomide/NN ./.

det(elevations-2, All-1)
nsubj(resolved-3, elevations-2)
root(ROOT-0, resolved-3)
dobj(resolved-3, 2-5)
prep_with(2-5, continuation-7)
det(drugs-10, both-9)
prep_of(continuation-7, drugs-10)
conj_and(2-5, 3-12)
prep_after(3-12, discontinuation-14)
prep_of(discontinuation-14, leflunomide-16)

Sentence Id: DrugDDI.d581.s6
All/DT of/IN these/DT also/RB resolved/VBN ,/, 2/CD with/IN continuation/NN of/IN both/DT drugs/NNS and/CC 3/CD after/IN discontinuation/NN of/IN leflunomide/NN ./.

nsubj(resolved-5, All-1)
prep_of(All-1, these-3)
advmod(resolved-5, also-4)
root(ROOT-0, resolved-5)
dobj(resolved-5, 2-7)
prep_with(2-7, continuation-9)
det(drugs-12, both-11)
prep_of(continuation-9, drugs-12)
conj_and(2-7, 3-14)
prep_after(3-14, discontinuation-16)
prep_of(discontinuation-16, leflunomide-18)

Sentence Id: DrugDDI.d581.s7
Three/CD patients/NNS met/NN ACR/NN criteria/NNS for/IN liver/NN biopsy/NN (/-LRB- 1/CD :/: Roegnik/NNP Grade/NN I/CD ,/, 2/CD :/: Roegnik/NNP Grade/NN IIIa/NN )./NN

num(criteria-5, Three-1)
nn(criteria-5, patients-2)
nn(criteria-5, met-3)
nn(criteria-5, ACR-4)
root(ROOT-0, criteria-5)
nn(biopsy-8, liver-7)
prep_for(criteria-5, biopsy-8)
num(Roegnik-12, 1-10)
dep(criteria-5, Roegnik-12)
dep(Roegnik-12, Grade-13)
num(Grade-13, I-14)
num(Grade-13, 2-16)
dep(Roegnik-12, Roegnik-18)
nn(-RRB-.-21, Grade-19)
nn(-RRB-.-21, IIIa-20)
dep(Roegnik-18, -RRB-.-21)

Sentence Id: DrugDDI.d581.s9
NSAIDs/NNS :/: In/IN in/FW vitro/FW studies/NNS ,/, M1/NN was/VBD shown/VBN to/TO cause/VB increases/NNS ranging/VBG from/IN 13/CD -/CC 50/CD %/NN in/IN the/DT free/JJ fraction/NN of/IN diclofenac/NN and/CC ibuprofen/NN at/IN concentrations/NNS in/IN the/DT clinical/JJ range/NN ./.

root(ROOT-0, NSAIDs-1)
nn(vitro-5, in-4)
amod(studies-6, vitro-5)
prep_in(shown-10, studies-6)
nsubjpass(shown-10, M1-8)
xsubj(cause-12, M1-8)
auxpass(shown-10, was-9)
dep(NSAIDs-1, shown-10)
aux(cause-12, to-11)
xcomp(shown-10, cause-12)
dobj(cause-12, increases-13)
partmod(increases-13, ranging-14)
num(%-19, 13-16)
conj(13-16, 50-18)
prep_from(ranging-14, %-19)
det(fraction-23, the-21)
amod(fraction-23, free-22)
prep_in(ranging-14, fraction-23)
prep_of(fraction-23, diclofenac-25)
conj_and(diclofenac-25, ibuprofen-27)
prep_at(diclofenac-25, concentrations-29)
det(range-33, the-31)
amod(range-33, clinical-32)
prep_in(concentrations-29, range-33)

Sentence Id: DrugDDI.d581.s11
however/RB ,/, there/EX was/VBD extensive/JJ concomitant/JJ use/NN of/IN NSAIDs/NN in/IN clinical/JJ studies/NNS and/CC no/DT differential/JJ effect/NN was/VBD observed/VBN ./.

advmod(was-4, however-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
amod(use-7, extensive-5)
amod(use-7, concomitant-6)
nsubj(was-4, use-7)
prep_of(use-7, NSAIDs-9)
amod(studies-12, clinical-11)
prep_in(use-7, studies-12)
det(effect-16, no-14)
amod(effect-16, differential-15)
nsubjpass(observed-18, effect-16)
auxpass(observed-18, was-17)
conj_and(was-4, observed-18)

Sentence Id: DrugDDI.d581.s12
Tolbutamide/NN :/: In/IN in/FW vitro/FW studies/NNS ,/, M1/NN was/VBD shown/VBN to/TO cause/VB increases/NNS ranging/VBG from/IN 13/CD -/CC 50/CD %/NN in/IN the/DT free/JJ fraction/NN of/IN tolbutamide/NN at/IN concentrations/NNS in/IN the/DT clinical/JJ range/NN ./.

root(ROOT-0, Tolbutamide-1)
nn(vitro-5, in-4)
amod(studies-6, vitro-5)
prep_in(shown-10, studies-6)
nsubjpass(shown-10, M1-8)
xsubj(cause-12, M1-8)
auxpass(shown-10, was-9)
dep(Tolbutamide-1, shown-10)
aux(cause-12, to-11)
xcomp(shown-10, cause-12)
dobj(cause-12, increases-13)
partmod(increases-13, ranging-14)
num(%-19, 13-16)
conj(13-16, 50-18)
prep_from(ranging-14, %-19)
det(fraction-23, the-21)
amod(fraction-23, free-22)
prep_in(ranging-14, fraction-23)
prep_of(fraction-23, tolbutamide-25)
prep_at(ranging-14, concentrations-27)
det(range-31, the-29)
amod(range-31, clinical-30)
prep_in(concentrations-27, range-31)

Sentence Id: DrugDDI.d581.s14
Rifampin/NN Following/VBG concomitant/JJ administration/NN of/IN a/DT single/JJ dose/NN of/IN ARAVA/NN to/TO subjects/NNS receiving/VBG multiple/JJ doses/NNS of/IN rifampin/NN ,/, M1/NN peak/NN levels/NNS were/VBD increased/VBN (/-LRB- ~40/CD %/NN )/-RRB- over/IN those/DT seen/VBN when/WRB ARAVA/NN was/VBD given/VBN alone/RB ./.

nsubj(Following-2, Rifampin-1)
root(ROOT-0, Following-2)
amod(administration-4, concomitant-3)
dobj(Following-2, administration-4)
det(dose-8, a-6)
amod(dose-8, single-7)
prep_of(administration-4, dose-8)
prep_of(dose-8, ARAVA-10)
prep_to(Following-2, subjects-12)
partmod(subjects-12, receiving-13)
amod(doses-15, multiple-14)
dobj(receiving-13, doses-15)
prep_of(doses-15, rifampin-17)
nn(levels-21, M1-19)
nn(levels-21, peak-20)
nsubjpass(increased-23, levels-21)
auxpass(increased-23, were-22)
dep(Following-2, increased-23)
num(%-26, ~40-25)
dep(increased-23, %-26)
prep_over(increased-23, those-29)
partmod(those-29, seen-30)
advmod(given-34, when-31)
nsubjpass(given-34, ARAVA-32)
auxpass(given-34, was-33)
advcl(seen-30, given-34)
advmod(given-34, alone-35)

Sentence Id: DrugDDI.d581.s15
Because/IN of/IN the/DT potential/NN for/IN ARAVA/NN levels/NNS to/TO continue/VBP to/TO increase/VB with/IN multiple/JJ dosing/NN ,/, caution/NN should/MD be/VB used/VBN if/IN patients/NNS are/VBP to/TO be/VB receiving/VBG both/CC ARAVA/NN and/CC rifampin/NN ./.

prepc_because_of(used-19, of-2)
det(potential-4, the-3)
pobj(used-19, potential-4)
nn(levels-7, ARAVA-6)
prep_for(potential-4, levels-7)
aux(continue-9, to-8)
infmod(potential-4, continue-9)
aux(increase-11, to-10)
xcomp(continue-9, increase-11)
amod(dosing-14, multiple-13)
prep_with(increase-11, dosing-14)
nsubjpass(used-19, caution-16)
aux(used-19, should-17)
auxpass(used-19, be-18)
root(ROOT-0, used-19)
mark(are-22, if-20)
nsubj(are-22, patients-21)
advcl(used-19, are-22)
aux(receiving-25, to-23)
aux(receiving-25, be-24)
xcomp(are-22, receiving-25)
preconj(ARAVA-27, both-26)
dobj(receiving-25, ARAVA-27)
conj_and(ARAVA-27, rifampin-29)

Sentence Id: DrugDDI.d581.s16
Warfarin/JJ Increased/VBN INR/NN (/-LRB- International/NNP Normalized/VBN Ratio/NN )/-RRB- when/WRB ARAVA/NN and/CC warfarin/NN were/VBD co-administered/VBN has/VBZ been/VBN rarely/RB reported/VBN ./.

amod(INR-3, Warfarin-1)
amod(INR-3, Increased-2)
tmod(co-administered-14, INR-3)
nsubjpass(reported-18, INR-3)
nn(Ratio-7, International-5)
amod(Ratio-7, Normalized-6)
appos(INR-3, Ratio-7)
advmod(co-administered-14, when-9)
nsubjpass(co-administered-14, ARAVA-10)
conj_and(ARAVA-10, warfarin-12)
auxpass(co-administered-14, were-13)
dep(INR-3, co-administered-14)
aux(reported-18, has-15)
auxpass(reported-18, been-16)
advmod(reported-18, rarely-17)
root(ROOT-0, reported-18)

Sentence Id: DrugDDI.d379.s0
Clinical/JJ interaction/NN studies/NNS with/IN cimetidine/NN and/CC warfarin/NN indicated/VBD that/IN the/DT coadministration/NN of/IN Femara/NN with/IN these/DT drugs/NNS does/VBZ not/RB result/VB in/IN clinically-/JJ significant/JJ drug/NN interactions/NNS ./.

amod(studies-3, Clinical-1)
nn(studies-3, interaction-2)
nsubj(indicated-8, studies-3)
prep_with(studies-3, cimetidine-5)
conj_and(cimetidine-5, warfarin-7)
root(ROOT-0, indicated-8)
complm(result-19, that-9)
det(coadministration-11, the-10)
nsubj(result-19, coadministration-11)
prep_of(coadministration-11, Femara-13)
det(drugs-16, these-15)
prep_with(coadministration-11, drugs-16)
aux(result-19, does-17)
neg(result-19, not-18)
ccomp(indicated-8, result-19)
amod(interactions-24, clinically--21)
amod(interactions-24, significant-22)
nn(interactions-24, drug-23)
prep_in(result-19, interactions-24)

Sentence Id: DrugDDI.d379.s1
(/-LRB- See/VB CLINICAL/JJ PHARMACOLOGY/NN )/-RRB- Coadministration/NN of/IN Femara/NN and/CC tamoxifen/NN 20/CD mg/NN daily/RB resulted/VBD in/IN a/DT reduction/NN of/IN letrozole/NN plasma/NN levels/NNS by/IN 38/CD %/NN on/IN average/NN ./.

dep(Coadministration-6, See-2)
amod(PHARMACOLOGY-4, CLINICAL-3)
dobj(See-2, PHARMACOLOGY-4)
nsubj(resulted-14, Coadministration-6)
prep_of(Coadministration-6, Femara-8)
nn(mg-12, tamoxifen-10)
num(mg-12, 20-11)
conj_and(Coadministration-6, mg-12)
advmod(mg-12, daily-13)
root(ROOT-0, resulted-14)
det(reduction-17, a-16)
prep_in(resulted-14, reduction-17)
nn(levels-21, letrozole-19)
nn(levels-21, plasma-20)
prep_of(reduction-17, levels-21)
num(%-24, 38-23)
prep_by(reduction-17, %-24)
prep_on(%-24, average-26)

Sentence Id: DrugDDI.d379.s2
There/EX is/VBZ no/DT clinical/JJ experience/VBP to/TO date/VB on/IN the/DT use/NN of/IN Femara/NN in/IN combination/NN with/IN other/JJ anticancer/JJ agents/NNS ./.

expl(is-2, There-1)
root(ROOT-0, is-2)
det(clinical-4, no-3)
nsubj(is-2, clinical-4)
dep(clinical-4, experience-5)
aux(date-7, to-6)
infmod(clinical-4, date-7)
det(use-10, the-9)
prep_on(date-7, use-10)
prep_of(use-10, Femara-12)
prep_in(use-10, combination-14)
amod(agents-18, other-16)
amod(agents-18, anticancer-17)
prep_with(combination-14, agents-18)

Sentence Id: DrugDDI.d379.s3
Drug/NN /Laboratory/NN Test-Interactions/NN None/NN observed/VBN ./.

nn(None-4, Drug-1)
nn(None-4, /Laboratory-2)
nn(None-4, Test-Interactions-3)
nsubj(observed-5, None-4)
root(ROOT-0, observed-5)

Sentence Id: DrugDDI.d341.s0
Folic/JJ acid/NN in/IN large/JJ amounts/NNS may/MD counteract/VB the/DT antiepileptic/JJ effect/NN of/IN phenobarbital/NN ,/, phenytoin/NN and/CC primidone/NN ,/, and/CC increase/VB the/DT frequency/NN of/IN seizures/NNS in/IN susceptible/JJ pediatric/JJ patients/NNS ./.

amod(acid-2, Folic-1)
nsubj(counteract-7, acid-2)
amod(amounts-5, large-4)
prep_in(acid-2, amounts-5)
aux(counteract-7, may-6)
root(ROOT-0, counteract-7)
det(effect-10, the-8)
amod(effect-10, antiepileptic-9)
dobj(counteract-7, effect-10)
prep_of(effect-10, phenobarbital-12)
conj_and(phenobarbital-12, phenytoin-14)
conj_and(phenobarbital-12, primidone-16)
conj_and(counteract-7, increase-19)
det(frequency-21, the-20)
dobj(increase-19, frequency-21)
prep_of(frequency-21, seizures-23)
amod(patients-27, susceptible-25)
amod(patients-27, pediatric-26)
prep_in(frequency-21, patients-27)

Sentence Id: DrugDDI.d341.s1
Preliminary/JJ animal/JJ and/CC human/JJ studies/NNS have/VBP shown/VBN that/IN small/JJ quantities/NNS of/IN systemically/RB administered/VBN leucovorin/NN enter/VBP the/DT CSF/NN primarily/RB as/IN 5-methyltetrahydro-folate/NN and/CC ,/, in/IN humans/NNS ,/, remain/VBP 1/CD to/TO 3/CD orders/NNS of/IN magnitude/NN lower/JJR than/IN the/DT usual/JJ methotrexate/NN concentrations/NNS following/VBG intrathecal/JJ administration/NN ./.

amod(studies-5, Preliminary-1)
amod(studies-5, animal-2)
conj_and(animal-2, human-4)
nsubj(shown-7, studies-5)
aux(shown-7, have-6)
root(ROOT-0, shown-7)
amod(quantities-10, small-9)
nsubj(enter-15, quantities-10)
advmod(administered-13, systemically-12)
amod(leucovorin-14, administered-13)
prep_of(quantities-10, leucovorin-14)
prepc_that(shown-7, enter-15)
det(CSF-17, the-16)
dobj(enter-15, CSF-17)
advmod(enter-15, primarily-18)
prep_as(enter-15, 5-methyltetrahydro-folate-20)
conj_and(enter-15, in-23)
prep_in(enter-15, humans-24)
cop(orders-30, remain-26)
number(3-29, 1-27)
dep(3-29, to-28)
num(orders-30, 3-29)
conj_and(enter-15, orders-30)
prep_of(orders-30, magnitude-32)
amod(orders-30, lower-33)
det(concentrations-38, the-35)
amod(concentrations-38, usual-36)
nn(concentrations-38, methotrexate-37)
prep_than(lower-33, concentrations-38)
partmod(concentrations-38, following-39)
amod(administration-41, intrathecal-40)
dobj(following-39, administration-41)

Sentence Id: DrugDDI.d341.s2
However/RB ,/, high/JJ doses/NNS of/IN leucovorin/NN may/MD reduce/VB the/DT efficacy/NN of/IN intrathecally/RB administered/VBN methotrexate/NN ./.

advmod(reduce-8, However-1)
amod(doses-4, high-3)
nsubj(reduce-8, doses-4)
prep_of(doses-4, leucovorin-6)
aux(reduce-8, may-7)
root(ROOT-0, reduce-8)
det(efficacy-10, the-9)
dobj(reduce-8, efficacy-10)
advmod(administered-13, intrathecally-12)
amod(methotrexate-14, administered-13)
prep_of(efficacy-10, methotrexate-14)

Sentence Id: DrugDDI.d341.s3
Leucovorin/NN may/MD enhance/VB the/DT toxicity/NN of/IN 5-/CD fluorouracil/NN ./.

nsubj(enhance-3, Leucovorin-1)
aux(enhance-3, may-2)
root(ROOT-0, enhance-3)
det(toxicity-5, the-4)
dobj(enhance-3, toxicity-5)
num(fluorouracil-8, 5--7)
prep_of(toxicity-5, fluorouracil-8)

Sentence Id: DrugDDI.d484.s0
Although/IN BETAGAN/NN used/VBN alone/RB has/VBZ little/JJ or/CC no/DT effect/NN on/IN pupil/NN size/NN ,/, mydriasis/NNS resulting/VBG from/IN concomitant/JJ therapy/NN with/IN BETAGAN/NN and/CC epinephrine/NN may/MD occur/VB ./.

mark(has-5, Although-1)
nsubj(has-5, BETAGAN-2)
partmod(BETAGAN-2, used-3)
advmod(used-3, alone-4)
advcl(occur-24, has-5)
dobj(has-5, little-6)
det(effect-9, no-8)
conj_or(little-6, effect-9)
nn(size-12, pupil-11)
prep_on(effect-9, size-12)
nsubj(occur-24, mydriasis-14)
partmod(mydriasis-14, resulting-15)
amod(therapy-18, concomitant-17)
prep_from(resulting-15, therapy-18)
prep_with(therapy-18, BETAGAN-20)
conj_and(BETAGAN-20, epinephrine-22)
aux(occur-24, may-23)
root(ROOT-0, occur-24)

Sentence Id: DrugDDI.d484.s1
Close/JJ observation/NN of/IN the/DT patient/NN is/VBZ recommended/VBN when/WRB a/DT beta-blocker/NN is/VBZ administered/VBN to/TO patients/NNS receiving/VBG catecholamine-depleting/JJ drugs/NNS such/JJ as/IN reserpine/NN ,/, because/IN of/IN possible/JJ additive/JJ effects/NNS and/CC the/DT production/NN of/IN hypotension/NN and/or/CC marked/JJ bradycardia/NN ,/, which/WDT may/MD produce/VB vertigo/NN ,/, syncope/NN or/CC postural/JJ hypotension/NN ./.

amod(observation-2, Close-1)
nsubjpass(recommended-7, observation-2)
det(patient-5, the-4)
prep_of(observation-2, patient-5)
auxpass(recommended-7, is-6)
root(ROOT-0, recommended-7)
advmod(administered-12, when-8)
det(beta-blocker-10, a-9)
nsubjpass(administered-12, beta-blocker-10)
auxpass(administered-12, is-11)
advcl(recommended-7, administered-12)
prep_to(administered-12, patients-14)
partmod(patients-14, receiving-15)
amod(drugs-17, catecholamine-depleting-16)
dobj(receiving-15, drugs-17)
prep_such_as(drugs-17, reserpine-20)
prepc_because_of(drugs-17, of-23)
amod(effects-26, possible-24)
amod(effects-26, additive-25)
pobj(drugs-17, effects-26)
det(production-29, the-28)
conj_and(effects-26, production-29)
prep_of(production-29, hypotension-31)
amod(bradycardia-34, marked-33)
conj_and/or(hypotension-31, bradycardia-34)
nsubj(produce-38, which-36)
aux(produce-38, may-37)
rcmod(drugs-17, produce-38)
dobj(produce-38, vertigo-39)
conj_or(vertigo-39, syncope-41)
amod(hypotension-44, postural-43)
conj_or(vertigo-39, hypotension-44)

Sentence Id: DrugDDI.d484.s2
Patients/NNS receiving/VBG beta-adrenergic/JJ blocking/NN agents/NNS along/IN with/IN either/CC oral/JJ or/CC intravenous/JJ calcium/NN antagonist/NN s/NN should/MD be/VB monitored/VBN for/IN possible/JJ atrioventricular/JJ conduction/NN disturbances/NNS ,/, left/JJ ventricular/NN failure/NN and/CC hypotension/NN ./.

nsubjpass(monitored-17, Patients-1)
partmod(Patients-1, receiving-2)
amod(agents-5, beta-adrenergic-3)
nn(agents-5, blocking-4)
dobj(receiving-2, agents-5)
prepc_along_with(receiving-2, with-7)
preconj(oral-9, either-8)
amod(s-14, oral-9)
conj_or(oral-9, intravenous-11)
nn(s-14, calcium-12)
nn(s-14, antagonist-13)
pobj(receiving-2, s-14)
aux(monitored-17, should-15)
auxpass(monitored-17, be-16)
root(ROOT-0, monitored-17)
amod(disturbances-22, possible-19)
amod(disturbances-22, atrioventricular-20)
nn(disturbances-22, conduction-21)
prep_for(monitored-17, disturbances-22)
amod(ventricular-25, left-24)
nn(failure-26, ventricular-25)
conj_and(disturbances-22, failure-26)
conj_and(disturbances-22, hypotension-28)

Sentence Id: DrugDDI.d484.s4
The/DT concomitant/JJ use/NN of/IN beta-adrenergic/JJ blocking/NN agents/NNS with/IN digitalis/NN and/CC calcium/NN antagonist/NN s/NN may/MD have/VB additive/JJ effects/NNS on/IN prolonging/VBG atrioventricular/JJ conduction/NN time/NN ./.

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubj(have-15, use-3)
amod(agents-7, beta-adrenergic-5)
nn(agents-7, blocking-6)
prep_of(use-3, agents-7)
prep_with(agents-7, digitalis-9)
nn(s-13, calcium-11)
nn(s-13, antagonist-12)
conj_and(digitalis-9, s-13)
aux(have-15, may-14)
root(ROOT-0, have-15)
amod(effects-17, additive-16)
dobj(have-15, effects-17)
prepc_on(have-15, prolonging-19)
amod(time-22, atrioventricular-20)
nn(time-22, conduction-21)
dobj(prolonging-19, time-22)

Sentence Id: DrugDDI.d484.s5
Phenothiazine/JJ -related/JJ compounds/NNS and/CC beta-adrenergic/JJ blocking/NN agents/NNS may/MD have/VB additive/JJ hypotensite/JJ effects/NNS due/JJ to/TO the/DT inhibition/NN of/IN each/DT other/JJ @/NN s/NN metabolism/NN ./.

amod(compounds-3, Phenothiazine-1)
amod(compounds-3, -related-2)
nsubj(have-9, compounds-3)
amod(agents-7, beta-adrenergic-5)
nn(agents-7, blocking-6)
conj_and(compounds-3, agents-7)
aux(have-9, may-8)
root(ROOT-0, have-9)
amod(effects-12, additive-10)
amod(effects-12, hypotensite-11)
dobj(have-9, effects-12)
det(inhibition-16, the-15)
prep_due_to(have-9, inhibition-16)
det(metabolism-22, each-18)
amod(metabolism-22, other-19)
nn(metabolism-22, @-20)
nn(metabolism-22, s-21)
prep_of(inhibition-16, metabolism-22)

Sentence Id: DrugDDI.d112.s0
No/DT significant/JJ drug-drug/JJ pharmacokinetic/JJ interactions/NNS have/VBP been/VBN found/VBN in/IN interaction/NN studies/NNS with/IN hydrochlorothiazide/NN ,/, digoxin/NN ,/, warfarin/NN ,/, cimetidine/NN and/CC phenobarbital/NN ./.

det(interactions-5, No-1)
amod(interactions-5, significant-2)
amod(interactions-5, drug-drug-3)
amod(interactions-5, pharmacokinetic-4)
nsubjpass(found-8, interactions-5)
aux(found-8, have-6)
auxpass(found-8, been-7)
root(ROOT-0, found-8)
nn(studies-11, interaction-10)
prep_in(found-8, studies-11)
prep_with(studies-11, hydrochlorothiazide-13)
conj_and(hydrochlorothiazide-13, digoxin-15)
conj_and(hydrochlorothiazide-13, warfarin-17)
conj_and(hydrochlorothiazide-13, cimetidine-19)
conj_and(hydrochlorothiazide-13, phenobarbital-21)

Sentence Id: DrugDDI.d112.s1
Rifampin/NN ,/, an/DT inducer/NN of/IN drug/NN metabolism/NN ,/, decreased/VBD the/DT concentrations/NNS of/IN losartan/NN and/CC its/PRP$ active/JJ metabolite/NN ./.

nsubj(decreased-9, Rifampin-1)
det(inducer-4, an-3)
appos(Rifampin-1, inducer-4)
nn(metabolism-7, drug-6)
prep_of(inducer-4, metabolism-7)
root(ROOT-0, decreased-9)
det(concentrations-11, the-10)
dobj(decreased-9, concentrations-11)
prep_of(concentrations-11, losartan-13)
poss(metabolite-17, its-15)
amod(metabolite-17, active-16)
conj_and(losartan-13, metabolite-17)

Sentence Id: DrugDDI.d112.s2
In/IN humans/NNS ,/, two/CD inhibitors/NNS of/IN P450/NN 3A4/NN have/VBP been/VBN studied/VBN ./.

prep_in(studied-11, humans-2)
num(inhibitors-5, two-4)
nsubjpass(studied-11, inhibitors-5)
nn(3A4-8, P450-7)
prep_of(inhibitors-5, 3A4-8)
aux(studied-11, have-9)
auxpass(studied-11, been-10)
root(ROOT-0, studied-11)

Sentence Id: DrugDDI.d112.s3
Ketoconazole/NN did/VBD not/RB affect/VB the/DT conversion/NN of/IN losartan/NN to/TO the/DT active/JJ metabolite/NN after/IN intravenous/JJ administration/NN of/IN losartan/NN ,/, and/CC erythromycin/NN had/VBD no/DT clinically/RB significant/JJ effect/NN after/IN oral/JJ administration/NN ./.

nsubj(affect-4, Ketoconazole-1)
aux(affect-4, did-2)
neg(affect-4, not-3)
root(ROOT-0, affect-4)
det(conversion-6, the-5)
dobj(affect-4, conversion-6)
prep_of(conversion-6, losartan-8)
det(metabolite-12, the-10)
amod(metabolite-12, active-11)
prep_to(conversion-6, metabolite-12)
amod(administration-15, intravenous-14)
prep_after(metabolite-12, administration-15)
prep_of(administration-15, losartan-17)
nsubj(had-21, erythromycin-20)
conj_and(affect-4, had-21)
det(effect-25, no-22)
advmod(significant-24, clinically-23)
amod(effect-25, significant-24)
dobj(had-21, effect-25)
amod(administration-28, oral-27)
prep_after(had-21, administration-28)

Sentence Id: DrugDDI.d112.s4
Fluconazole/NN ,/, an/DT inhibitor/NN of/IN P450/NN 2C9/NNS ,/, decreased/VBD active/JJ metabolite/NN concentration/NN and/CC increased/VBD losartan/NN concentration/NN ./.

nsubj(decreased-9, Fluconazole-1)
det(inhibitor-4, an-3)
appos(Fluconazole-1, inhibitor-4)
nn(2C9-7, P450-6)
prep_of(inhibitor-4, 2C9-7)
root(ROOT-0, decreased-9)
amod(concentration-12, active-10)
nn(concentration-12, metabolite-11)
dobj(decreased-9, concentration-12)
conj_and(decreased-9, increased-14)
nn(concentration-16, losartan-15)
dobj(increased-14, concentration-16)

Sentence Id: DrugDDI.d112.s5
The/DT pharmacodynamic/JJ consequences/NNS of/IN concomitant/JJ use/NN of/IN losartan/NN and/CC inhibitors/NNS of/IN P450/NN 2C9/NNS have/VBP not/RB been/VBN examined/VBN ./.

det(consequences-3, The-1)
amod(consequences-3, pharmacodynamic-2)
nsubjpass(examined-17, consequences-3)
amod(use-6, concomitant-5)
prep_of(consequences-3, use-6)
prep_of(use-6, losartan-8)
conj_and(losartan-8, inhibitors-10)
nn(2C9-13, P450-12)
prep_of(inhibitors-10, 2C9-13)
aux(examined-17, have-14)
neg(examined-17, not-15)
auxpass(examined-17, been-16)
root(ROOT-0, examined-17)

Sentence Id: DrugDDI.d112.s6
Subjects/NNS who/WP do/VBP not/RB metabolize/VB losartan/NN to/TO active/JJ metabolite/NN have/VBP been/VBN shown/VBN to/TO have/VB a/DT specific/JJ ,/, rare/JJ defect/NN in/IN cytochrome/NN P450/NN 2C9/NN ./.

nsubj(metabolize-5, Subjects-1)
nsubjpass(shown-12, Subjects-1)
xsubj(have-14, Subjects-1)
aux(metabolize-5, do-3)
neg(metabolize-5, not-4)
rcmod(Subjects-1, metabolize-5)
dobj(metabolize-5, losartan-6)
amod(metabolite-9, active-8)
prep_to(losartan-6, metabolite-9)
aux(shown-12, have-10)
auxpass(shown-12, been-11)
root(ROOT-0, shown-12)
aux(have-14, to-13)
xcomp(shown-12, have-14)
det(defect-19, a-15)
amod(defect-19, specific-16)
dep(specific-16, rare-18)
dobj(have-14, defect-19)
nn(2C9-23, cytochrome-21)
nn(2C9-23, P450-22)
prep_in(have-14, 2C9-23)

Sentence Id: DrugDDI.d112.s7
These/DT data/NNS suggest/VBP that/IN the/DT conversion/NN of/IN losartan/NN to/TO its/PRP$ active/JJ metabolite/NN is/VBZ mediated/VBN primarily/RB by/IN P450/NN 2C9/NN and/CC not/RB P450/NN 3A4/NN ./.

det(data-2, These-1)
nsubj(suggest-3, data-2)
root(ROOT-0, suggest-3)
complm(mediated-14, that-4)
det(conversion-6, the-5)
nsubjpass(mediated-14, conversion-6)
prep_of(conversion-6, losartan-8)
poss(metabolite-12, its-10)
amod(metabolite-12, active-11)
prep_to(conversion-6, metabolite-12)
auxpass(mediated-14, is-13)
ccomp(suggest-3, mediated-14)
advmod(mediated-14, primarily-15)
nn(2C9-18, P450-17)
agent(mediated-14, 2C9-18)
neg(3A4-22, not-20)
nn(3A4-22, P450-21)
conj_and(mediated-14, 3A4-22)

Sentence Id: DrugDDI.d112.s8
As/IN with/IN other/JJ drugs/NNS that/WDT block/VBP angiotensin/NN II/CD or/CC its/PRP$ effects/NNS ,/, concomitant/JJ use/NN of/IN potassium-sparing/JJ diuretics/NNS (/-LRB- e.g./FW ,/, spironolactone/NN ,/, triamterene/NN ,/, amiloride/NN )/-RRB- ,/, potassium/NN supplement/NN s/NNS ,/, or/CC salt/NN substitutes/VBZ containing/VBG potassium/NN may/MD lead/VB to/TO increases/NNS in/IN serum/NN potassium/NN ./.

prep(lead-38, As-1)
pcomp(As-1, with-2)
amod(drugs-4, other-3)
prep_with(As-1, drugs-4)
nsubj(block-6, drugs-4)
rcmod(drugs-4, block-6)
dobj(block-6, angiotensin-7)
num(angiotensin-7, II-8)
poss(effects-11, its-10)
conj_or(angiotensin-7, effects-11)
amod(use-14, concomitant-13)
nsubj(lead-38, use-14)
amod(diuretics-17, potassium-sparing-16)
prep_of(use-14, diuretics-17)
dep(diuretics-17, e.g.-19)
pobj(e.g.-19, spironolactone-21)
appos(spironolactone-21, triamterene-23)
appos(spironolactone-21, amiloride-25)
nn(s-30, potassium-28)
nn(s-30, supplement-29)
conj_or(diuretics-17, s-30)
conj_or(diuretics-17, salt-33)
dep(salt-33, substitutes-34)
partmod(salt-33, containing-35)
dobj(containing-35, potassium-36)
aux(lead-38, may-37)
root(ROOT-0, lead-38)
prep_to(lead-38, increases-40)
nn(potassium-43, serum-42)
prep_in(increases-40, potassium-43)

Sentence Id: DrugDDI.d112.s9
As/IN with/IN other/JJ antihypertensive/JJ agents/NNS ,/, the/DT antihypertensive/JJ effect/NN of/IN losartan/NN may/MD be/VB blunted/VBN by/IN the/DT non-steroidal/JJ anti-inflammatory/JJ drug/NN indomethacin/NN ./.

prep(blunted-14, As-1)
pcomp(As-1, with-2)
amod(agents-5, other-3)
amod(agents-5, antihypertensive-4)
prep_with(As-1, agents-5)
det(effect-9, the-7)
amod(effect-9, antihypertensive-8)
nsubjpass(blunted-14, effect-9)
prep_of(effect-9, losartan-11)
aux(blunted-14, may-12)
auxpass(blunted-14, be-13)
root(ROOT-0, blunted-14)
det(drug-19, the-16)
amod(drug-19, non-steroidal-17)
amod(drug-19, anti-inflammatory-18)
nn(indomethacin-20, drug-19)
agent(blunted-14, indomethacin-20)

Sentence Id: DrugDDI.d464.s0
When/WRB administered/VBN concurrently/RB ,/, the/DT following/VBG drugs/NNS may/MD interact/VB with/IN beta-adrenergic/JJ receptor/NN blocking/NN agents/NNS :/: Anesthetics/NN ,/, general/JJ :/: exaggeration/NN of/IN the/DT hypotension/NN induced/VBN by/IN general/JJ anesthetics/NNS ./.

advmod(administered-2, When-1)
advcl(interact-9, administered-2)
advmod(administered-2, concurrently-3)
det(drugs-7, the-5)
amod(drugs-7, following-6)
nsubj(interact-9, drugs-7)
aux(interact-9, may-8)
root(ROOT-0, interact-9)
amod(agents-14, beta-adrenergic-11)
nn(agents-14, receptor-12)
nn(agents-14, blocking-13)
prep_with(interact-9, agents-14)
dep(agents-14, Anesthetics-16)
appos(Anesthetics-16, general-18)
dep(Anesthetics-16, exaggeration-20)
det(hypotension-23, the-22)
prep_of(exaggeration-20, hypotension-23)
partmod(hypotension-23, induced-24)
amod(anesthetics-27, general-26)
agent(induced-24, anesthetics-27)

Sentence Id: DrugDDI.d464.s1
Antidiabetic/JJ drugs/NNS (/-LRB- oral/JJ agents/NNS and/CC insulin/NN )/-RRB- :/: hypoglycemia/NN or/CC hyperglycemia/NN ;/: ./.

amod(drugs-2, Antidiabetic-1)
root(ROOT-0, drugs-2)
amod(agents-5, oral-4)
dep(drugs-2, agents-5)
conj_and(agents-5, insulin-7)
dep(drugs-2, hypoglycemia-10)
conj_or(hypoglycemia-10, hyperglycemia-12)

Sentence Id: DrugDDI.d464.s2
adjust/VB dosage/NN of/IN antidiabetic/JJ drug/NN accordingly/RB ./.

root(ROOT-0, adjust-1)
dobj(adjust-1, dosage-2)
amod(drug-5, antidiabetic-4)
prep_of(dosage-2, drug-5)
advmod(adjust-1, accordingly-6)

Sentence Id: DrugDDI.d464.s3
Catecholamine-depleting/JJ drugs/NNS (/-LRB- e.g./FW ,/, reserpine/NN )/-RRB- :/: additive/JJ effect/NN ;/: ./.

amod(drugs-2, Catecholamine-depleting-1)
dep(effect-10, drugs-2)
dep(drugs-2, e.g.-4)
pobj(e.g.-4, reserpine-6)
amod(effect-10, additive-9)
root(ROOT-0, effect-10)

Sentence Id: DrugDDI.d464.s5
Response/NN to/TO Treatment/NN for/IN Anaphylactic/JJ Reaction/NN :/: While/IN taking/VBG beta-blockers/NN ,/, patients/NNS with/IN a/DT history/NN of/IN severe/JJ anaphylactic/JJ reaction/NN to/TO a/DT variety/NN of/IN allergens/NNS may/MD be/VB more/RBR reactive/JJ to/TO repeated/JJ challenge/NN ,/, either/CC accidental/JJ ,/, diagnostic/JJ ,/, or/CC therapeutic/JJ ./.

root(ROOT-0, Response-1)
prep_to(Response-1, Treatment-3)
amod(Reaction-6, Anaphylactic-5)
prep_for(Treatment-3, Reaction-6)
mark(taking-9, While-8)
advcl(reactive-28, taking-9)
dobj(taking-9, beta-blockers-10)
nsubj(reactive-28, patients-12)
det(history-15, a-14)
prep_with(patients-12, history-15)
amod(reaction-19, severe-17)
amod(reaction-19, anaphylactic-18)
prep_of(history-15, reaction-19)
det(variety-22, a-21)
prep_to(reaction-19, variety-22)
prep_of(variety-22, allergens-24)
aux(reactive-28, may-25)
cop(reactive-28, be-26)
advmod(reactive-28, more-27)
dep(Response-1, reactive-28)
amod(challenge-31, repeated-30)
prep_to(reactive-28, challenge-31)
preconj(reactive-28, either-33)
conj_or(reactive-28, accidental-34)
conj_or(reactive-28, diagnostic-36)
conj_or(reactive-28, therapeutic-39)

Sentence Id: DrugDDI.d464.s6
Such/JJ patients/NNS may/MD be/VB unresponsive/JJ to/TO the/DT usual/JJ doses/NNS of/IN epinephrine/NN used/VBN to/TO treat/VB allergic/JJ reaction/NN ./.

amod(patients-2, Such-1)
nsubj(unresponsive-5, patients-2)
aux(unresponsive-5, may-3)
cop(unresponsive-5, be-4)
root(ROOT-0, unresponsive-5)
det(doses-9, the-7)
amod(doses-9, usual-8)
prep_to(unresponsive-5, doses-9)
prep_of(doses-9, epinephrine-11)
partmod(doses-9, used-12)
aux(treat-14, to-13)
xcomp(used-12, treat-14)
amod(reaction-16, allergic-15)
dobj(treat-14, reaction-16)

Sentence Id: DrugDDI.d485.s0
Elevated/JJ plasma/NN levels/NNS of/IN theophylline/NN have/VBP been/VBN reported/VBN with/IN concomitant/JJ quinolone/NN use/NN ./.

amod(levels-3, Elevated-1)
nn(levels-3, plasma-2)
nsubjpass(reported-8, levels-3)
prep_of(levels-3, theophylline-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
amod(use-12, concomitant-10)
nn(use-12, quinolone-11)
prep_with(reported-8, use-12)

Sentence Id: DrugDDI.d485.s1
There/EX have/VBP been/VBN reports/NNS of/IN theophylline/NN -related/JJ side/JJ effects/NNS in/IN patients/NNS on/IN concomitant/JJ therapy/NN with/IN quinolones/NNS and/CC theophylline/NN ./.

expl(reports-4, There-1)
aux(reports-4, have-2)
cop(reports-4, been-3)
root(ROOT-0, reports-4)
dep(-related-7, theophylline-6)
amod(effects-9, -related-7)
amod(effects-9, side-8)
prep_of(reports-4, effects-9)
prep_in(effects-9, patients-11)
amod(therapy-14, concomitant-13)
prep_on(patients-11, therapy-14)
prep_with(therapy-14, quinolones-16)
conj_and(quinolones-16, theophylline-18)

Sentence Id: DrugDDI.d485.s2
Therefore/RB ,/, monitoring/NN of/IN theophylline/NN plasma/NN levels/NNS should/MD be/VB considered/VBN and/CC dosage/NN of/IN theophylline/NN adjusted/VBN ,/, as/IN required/VBN ./.

advmod(considered-10, Therefore-1)
nsubjpass(considered-10, monitoring-3)
nn(levels-7, theophylline-5)
nn(levels-7, plasma-6)
prep_of(monitoring-3, levels-7)
aux(considered-10, should-8)
auxpass(considered-10, be-9)
root(ROOT-0, considered-10)
conj_and(considered-10, dosage-12)
prep_of(dosage-12, theophylline-14)
partmod(theophylline-14, adjusted-15)
mark(required-18, as-17)
advcl(dosage-12, required-18)

Sentence Id: DrugDDI.d485.s3
Quinolones/NNS have/VBP been/VBN shown/VBN to/TO interfere/VB with/IN the/DT metabolism/NN of/IN caffeine/NN ./.

nsubjpass(shown-4, Quinolones-1)
xsubj(interfere-6, Quinolones-1)
aux(shown-4, have-2)
auxpass(shown-4, been-3)
root(ROOT-0, shown-4)
aux(interfere-6, to-5)
xcomp(shown-4, interfere-6)
det(metabolism-9, the-8)
prep_with(interfere-6, metabolism-9)
prep_of(metabolism-9, caffeine-11)

Sentence Id: DrugDDI.d485.s4
This/DT may/MD lead/VB to/TO reduced/VBN clearance/NN of/IN caffeine/NN and/CC the/DT prolongation/NN of/IN its/PRP$ plasma/NN half-life/NN ./.

nsubj(lead-3, This-1)
aux(lead-3, may-2)
root(ROOT-0, lead-3)
amod(clearance-6, reduced-5)
prep_to(lead-3, clearance-6)
prep_of(clearance-6, caffeine-8)
det(prolongation-11, the-10)
conj_and(clearance-6, prolongation-11)
poss(half-life-15, its-13)
nn(half-life-15, plasma-14)
prep_of(prolongation-11, half-life-15)

Sentence Id: DrugDDI.d485.s5
Quinolones/NNS ,/, including/VBG nalidixic/JJ acid/NN ,/, may/MD enhance/VB the/DT effects/NNS of/IN the/DT oral/JJ anticoagulant/NN warfarin/NN or/CC its/PRP$ derivatives/NNS ./.

nsubj(enhance-8, Quinolones-1)
amod(acid-5, nalidixic-4)
prep_including(Quinolones-1, acid-5)
aux(enhance-8, may-7)
root(ROOT-0, enhance-8)
det(effects-10, the-9)
dobj(enhance-8, effects-10)
det(warfarin-15, the-12)
amod(warfarin-15, oral-13)
nn(warfarin-15, anticoagulant-14)
prep_of(effects-10, warfarin-15)
poss(derivatives-18, its-17)
conj_or(warfarin-15, derivatives-18)

Sentence Id: DrugDDI.d485.s7
Nitrofurantoin/NN interferes/VBZ with/IN the/DT therapeutic/JJ action/NN of/IN nalidixic/JJ acid/NN ./.

nsubj(interferes-2, Nitrofurantoin-1)
root(ROOT-0, interferes-2)
det(action-6, the-4)
amod(action-6, therapeutic-5)
prep_with(interferes-2, action-6)
amod(acid-9, nalidixic-8)
prep_of(action-6, acid-9)

Sentence Id: DrugDDI.d485.s8
Antacids/NNS containing/VBG magnesium/NN ,/, aluminum/NN ,/, or/CC calcium/NN ;/: ./.

nsubj(containing-2, Antacids-1)
root(ROOT-0, containing-2)
dobj(containing-2, magnesium-3)
conj_or(magnesium-3, aluminum-5)
conj_or(magnesium-3, calcium-8)

Sentence Id: DrugDDI.d485.s9
sucralfate/VBP or/CC divalent/JJ or/CC trivalent/JJ cations/NNS such/JJ as/IN iron/NN ;/: ./.

root(ROOT-0, sucralfate-1)
amod(cations-6, divalent-3)
conj_or(divalent-3, trivalent-5)
dobj(sucralfate-1, cations-6)
prep_such_as(cations-6, iron-9)

Sentence Id: DrugDDI.d485.s10
multivitamins/NNS containing/VBG zinc/NN ;/: ./.

nsubj(containing-2, multivitamins-1)
root(ROOT-0, containing-2)
dobj(containing-2, zinc-3)

Sentence Id: DrugDDI.d485.s11
and/CC Videx/NN @/NN ,/, (/-LRB- Didanosine/NN )/-RRB- ,/, chewable//NN buffer/NN ed/NN tablets/NNS or/CC the/DT pediatric/JJ powder/NN for/IN oral/JJ solution/NN may/MD substantially/RB interfere/VB with/IN the/DT absorption/NN of/IN quinolones/NNS ,/, resulting/VBG in/IN systemic/JJ levels/NNS considerably/RB lower/JJR than/IN desired/VBN ./.

nn(@-3, Videx-2)
nsubj(interfere-22, @-3)
appos(@-3, Didanosine-6)
nn(tablets-12, chewable/-9)
nn(tablets-12, buffer-10)
nn(tablets-12, ed-11)
appos(@-3, tablets-12)
det(powder-16, the-14)
amod(powder-16, pediatric-15)
conj_or(@-3, powder-16)
amod(solution-19, oral-18)
prep_for(powder-16, solution-19)
aux(interfere-22, may-20)
advmod(interfere-22, substantially-21)
root(ROOT-0, interfere-22)
det(absorption-25, the-24)
prep_with(interfere-22, absorption-25)
prep_of(absorption-25, quinolones-27)
xcomp(interfere-22, resulting-29)
amod(levels-32, systemic-31)
prep_in(resulting-29, levels-32)
advmod(lower-34, considerably-33)
amod(levels-32, lower-34)
mark(desired-36, than-35)
dep(lower-34, desired-36)

Sentence Id: DrugDDI.d485.s12
These/DT agents/NNS should/MD not/RB be/VB taken/VBN within/IN the/DT two/CD hour/NN period/NN before/IN or/CC within/IN the/DT two-hour/JJ period/NN after/IN nalidixic/JJ acid/NN administration/NN ./.

det(agents-2, These-1)
nsubjpass(taken-6, agents-2)
aux(taken-6, should-3)
neg(taken-6, not-4)
auxpass(taken-6, be-5)
root(ROOT-0, taken-6)
det(period-11, the-8)
number(hour-10, two-9)
amod(period-11, hour-10)
prep_within(taken-6, period-11)
prep(taken-6, before-12)
conj_or(before-12, within-14)
det(period-17, the-15)
amod(period-17, two-hour-16)
pobj(within-14, period-17)
dep(before-12, after-18)
amod(acid-20, nalidixic-19)
nn(administration-21, acid-20)
pobj(after-18, administration-21)

Sentence Id: DrugDDI.d485.s13
Elevated/JJ serum/NN levels/NNS of/IN cyclosporine/NN have/VBP been/VBN reported/VBN with/IN the/DT concomitant/JJ use/NN of/IN some/DT quinolones/NN and/CC cyclosporine/NN ./.

amod(levels-3, Elevated-1)
nn(levels-3, serum-2)
nsubjpass(reported-8, levels-3)
prep_of(levels-3, cyclosporine-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
det(use-12, the-10)
amod(use-12, concomitant-11)
prep_with(reported-8, use-12)
det(quinolones-15, some-14)
prep_of(use-12, quinolones-15)
conj_and(quinolones-15, cyclosporine-17)

Sentence Id: DrugDDI.d485.s14
Therefore/RB ,/, cyclosporine/NN serum/NN levels/NNS should/MD be/VB monitored/VBN and/CC appropriate/JJ cyclosporine/NN dosage/NN adjustments/NNS made/VBD when/WRB these/DT drugs/NNS are/VBP used/VBN concomitantly/RB ./.

advmod(monitored-8, Therefore-1)
nn(levels-5, cyclosporine-3)
nn(levels-5, serum-4)
nsubjpass(monitored-8, levels-5)
aux(monitored-8, should-6)
auxpass(monitored-8, be-7)
root(ROOT-0, monitored-8)
amod(adjustments-13, appropriate-10)
nn(adjustments-13, cyclosporine-11)
nn(adjustments-13, dosage-12)
nsubj(made-14, adjustments-13)
conj_and(monitored-8, made-14)
advmod(used-19, when-15)
det(drugs-17, these-16)
nsubjpass(used-19, drugs-17)
auxpass(used-19, are-18)
advcl(made-14, used-19)
advmod(used-19, concomitantly-20)

Sentence Id: DrugDDI.d249.s0
In/FW vitro/FW drug/NN metabolism/NN studies/NNS indicate/VBP that/IN Starlix/NN is/VBZ predominantly/RB metabolized/VBN by/IN the/DT cytochrome/NN P450/NN isozyme/NN CYP2C9/NN (/-LRB- 70/CD %/NN )/-RRB- and/CC to/TO a/DT lesser/JJR extent/NN CYP3A4/NN (/-LRB- 30%)./NN

nn(vitro-2, In-1)
amod(studies-5, vitro-2)
nn(studies-5, drug-3)
nn(studies-5, metabolism-4)
nsubj(indicate-6, studies-5)
root(ROOT-0, indicate-6)
complm(metabolized-11, that-7)
nsubjpass(metabolized-11, Starlix-8)
auxpass(metabolized-11, is-9)
advmod(metabolized-11, predominantly-10)
ccomp(indicate-6, metabolized-11)
conj_and(metabolized-11, metabolized-11)
det(CYP2C9-17, the-13)
nn(CYP2C9-17, cytochrome-14)
nn(CYP2C9-17, P450-15)
nn(CYP2C9-17, isozyme-16)
agent(metabolized-11, CYP2C9-17)
num(%-20, 70-19)
appos(CYP2C9-17, %-20)
det(extent-26, a-24)
amod(extent-26, lesser-25)
prep_to(metabolized-11, extent-26)
dep(metabolized-11, CYP3A4-27)
dep(metabolized-11, 30%-RRB-.-29)

Sentence Id: DrugDDI.d249.s1
Starlix/NN is/VBZ a/DT potential/JJ inhibitor/NN of/IN the/DT CYP2C9/NN isoenzyme/NN in/FW vivo/FW as/IN indicated/VBN by/IN its/PRP$ ability/NN to/TO inhibit/VB the/DT in/FW vitro/FW metabolism/NN of/IN tolbutamide/NN ./.

nsubj(inhibitor-5, Starlix-1)
cop(inhibitor-5, is-2)
det(inhibitor-5, a-3)
amod(inhibitor-5, potential-4)
root(ROOT-0, inhibitor-5)
det(isoenzyme-9, the-7)
nn(isoenzyme-9, CYP2C9-8)
prep_of(inhibitor-5, isoenzyme-9)
nn(vivo-11, in-10)
advmod(inhibitor-5, vivo-11)
mark(indicated-13, as-12)
advcl(inhibitor-5, indicated-13)
poss(ability-16, its-15)
prep_by(indicated-13, ability-16)
aux(inhibit-18, to-17)
infmod(ability-16, inhibit-18)
det(metabolism-22, the-19)
nn(vitro-21, in-20)
amod(metabolism-22, vitro-21)
dobj(inhibit-18, metabolism-22)
prep_of(metabolism-22, tolbutamide-24)

Sentence Id: DrugDDI.d249.s2
Inhibition/NN of/IN CYP3A4/JJ metabolic/JJ reactions/NNS was/VBD not/RB detected/VBN in/IN in/FW vitro/FW experiments/NNS ./.

nsubjpass(detected-8, Inhibition-1)
amod(reactions-5, CYP3A4-3)
amod(reactions-5, metabolic-4)
prep_of(Inhibition-1, reactions-5)
auxpass(detected-8, was-6)
neg(detected-8, not-7)
root(ROOT-0, detected-8)
nn(vitro-11, in-10)
amod(experiments-12, vitro-11)
prep_in(detected-8, experiments-12)

Sentence Id: DrugDDI.d249.s3
Glyburide/NN :/: In/IN a/DT randomized/JJ ,/, multiple-dose/JJ crossover/NN study/NN ,/, patients/NNS with/IN Type/NN 2/CD diabetes/NNS were/VBD administered/VBN 120/CD mg/NN Starlix/NN three/CD times/NNS a/DT day/NN before/IN meals/NN for/IN 1/CD day/NN in/IN combination/NN with/IN glyburide/NN 10/CD mg/NN daily/RB ./.

root(ROOT-0, Glyburide-1)
det(study-9, a-4)
amod(study-9, randomized-5)
dep(randomized-5, multiple-dose-7)
nn(study-9, crossover-8)
prep_in(administered-17, study-9)
nsubjpass(administered-17, patients-11)
nn(diabetes-15, Type-13)
num(diabetes-15, 2-14)
prep_with(patients-11, diabetes-15)
auxpass(administered-17, were-16)
dep(Glyburide-1, administered-17)
num(times-22, 120-18)
nn(times-22, mg-19)
nn(times-22, Starlix-20)
num(times-22, three-21)
dobj(administered-17, times-22)
iobj(administered-17, times-22)
det(day-24, a-23)
dobj(administered-17, day-24)
dep(times-22, day-24)
prep_before(day-24, meals-26)
num(day-29, 1-28)
prep_for(day-24, day-29)
prep_in(administered-17, combination-31)
nn(mg-35, glyburide-33)
num(mg-35, 10-34)
prep_with(combination-31, mg-35)
advmod(mg-35, daily-36)

Sentence Id: DrugDDI.d249.s5
Metformin/NN :/: When/WRB Starlix/NN 120/CD mg/NN three/CD times/NNS daily/RB before/IN meals/NN was/VBD administered/VBN in/IN combination/NN with/IN metformin/NN 500/CD mg/NN three/CD times/NNS daily/JJ to/TO patients/NNS with/IN Type/NN 2/CD diabetes/NNS ,/, there/EX were/VBD no/DT clinically/RB relevant/JJ changes/NNS in/IN the/DT pharmacokinetics/NNS of/IN either/DT agent/NN ./.

root(ROOT-0, Metformin-1)
advmod(administered-13, When-3)
nn(mg-6, Starlix-4)
num(mg-6, 120-5)
nsubjpass(administered-13, mg-6)
num(times-8, three-7)
npadvmod(daily-9, times-8)
advmod(mg-6, daily-9)
prep_before(daily-9, meals-11)
auxpass(administered-13, was-12)
advcl(were-31, administered-13)
prep_in(administered-13, combination-15)
nn(times-21, metformin-17)
num(times-21, 500-18)
nn(times-21, mg-19)
num(times-21, three-20)
prep_with(combination-15, times-21)
amod(times-21, daily-22)
prep_to(daily-22, patients-24)
nn(diabetes-28, Type-26)
num(diabetes-28, 2-27)
prep_with(patients-24, diabetes-28)
expl(were-31, there-30)
dep(Metformin-1, were-31)
det(changes-35, no-32)
advmod(relevant-34, clinically-33)
amod(changes-35, relevant-34)
nsubj(were-31, changes-35)
det(pharmacokinetics-38, the-37)
prep_in(changes-35, pharmacokinetics-38)
det(agent-41, either-40)
prep_of(pharmacokinetics-38, agent-41)

Sentence Id: DrugDDI.d249.s6
Digoxin/NN :/: When/WRB Starlix/NN 120/CD mg/NN before/IN meals/NN was/VBD administered/VBN in/IN combination/NN with/IN a/DT single/JJ 1-mg/JJ dose/NN of/IN digoxin/NN to/TO healthy/JJ volunteers/NNS ,/, there/EX were/VBD no/DT clinically/RB relevant/JJ changes/NNS in/IN the/DT pharmacokinetics/NNS of/IN either/DT agent/NN ./.

root(ROOT-0, Digoxin-1)
advmod(administered-10, When-3)
nn(mg-6, Starlix-4)
num(mg-6, 120-5)
nsubjpass(administered-10, mg-6)
prep_before(mg-6, meals-8)
auxpass(administered-10, was-9)
advcl(were-25, administered-10)
prep_in(administered-10, combination-12)
det(dose-17, a-14)
amod(dose-17, single-15)
amod(dose-17, 1-mg-16)
prep_with(combination-12, dose-17)
prep_of(dose-17, digoxin-19)
amod(volunteers-22, healthy-21)
prep_to(dose-17, volunteers-22)
expl(were-25, there-24)
dep(Digoxin-1, were-25)
det(changes-29, no-26)
advmod(relevant-28, clinically-27)
amod(changes-29, relevant-28)
nsubj(were-25, changes-29)
det(pharmacokinetics-32, the-31)
prep_in(changes-29, pharmacokinetics-32)
det(agent-35, either-34)
prep_of(pharmacokinetics-32, agent-35)

Sentence Id: DrugDDI.d249.s7
Warfarin/NN :/: When/WRB healthy/JJ subjects/NNS were/VBD administered/VBN Starlix/NN 120/CD mg/NN three/CD times/NNS daily/RB before/IN meals/NN for/IN four/CD days/NNS in/IN combination/NN with/IN a/DT single/JJ dose/NN of/IN warfarin/NN 30/CD mg/NN on/IN day/NN 2/CD ,/, there/EX were/VBD no/DT alterations/NNS in/IN the/DT pharmacokinetics/NNS of/IN either/DT agent/NN ./.

root(ROOT-0, Warfarin-1)
advmod(administered-7, When-3)
amod(subjects-5, healthy-4)
nsubjpass(administered-7, subjects-5)
auxpass(administered-7, were-6)
advcl(were-34, administered-7)
nn(times-12, Starlix-8)
num(times-12, 120-9)
nn(times-12, mg-10)
num(times-12, three-11)
npadvmod(daily-13, times-12)
advmod(administered-7, daily-13)
prep_before(administered-7, meals-15)
num(days-18, four-17)
prep_for(administered-7, days-18)
prep_in(days-18, combination-20)
det(dose-24, a-22)
amod(dose-24, single-23)
prep_with(combination-20, dose-24)
nn(mg-28, warfarin-26)
num(mg-28, 30-27)
prep_of(dose-24, mg-28)
prep_on(mg-28, day-30)
num(day-30, 2-31)
expl(were-34, there-33)
dep(Warfarin-1, were-34)
det(alterations-36, no-35)
nsubj(were-34, alterations-36)
det(pharmacokinetics-39, the-38)
prep_in(were-34, pharmacokinetics-39)
det(agent-42, either-41)
prep_of(pharmacokinetics-39, agent-42)

Sentence Id: DrugDDI.d249.s9
Diclofenac/NN :/: Administration/NN of/IN morning/NN and/CC lunch/NN doses/NNS of/IN Starlix/NN 120/CD mg/NN in/IN combination/NN with/IN a/DT single/JJ 75-mg/NN dose/NN of/IN diclofenac/NN in/IN healthy/JJ volunteers/NNS resulted/VBD in/IN no/DT significant/JJ changes/NNS to/TO the/DT pharmacokinetics/NNS of/IN either/DT agent/NN ./.

root(ROOT-0, Diclofenac-1)
nsubj(resulted-25, Administration-3)
nn(doses-8, morning-5)
conj_and(morning-5, lunch-7)
prep_of(Administration-3, doses-8)
nn(mg-12, Starlix-10)
num(mg-12, 120-11)
prep_of(doses-8, mg-12)
prep_in(mg-12, combination-14)
det(dose-19, a-16)
amod(dose-19, single-17)
nn(dose-19, 75-mg-18)
prep_with(combination-14, dose-19)
prep_of(dose-19, diclofenac-21)
amod(volunteers-24, healthy-23)
prep_in(dose-19, volunteers-24)
dep(Diclofenac-1, resulted-25)
det(changes-29, no-27)
amod(changes-29, significant-28)
prep_in(resulted-25, changes-29)
det(pharmacokinetics-32, the-31)
prep_to(changes-29, pharmacokinetics-32)
det(agent-35, either-34)
prep_of(pharmacokinetics-32, agent-35)

Sentence Id: DrugDDI.d249.s10
Nateglinide/NN is/VBZ highly/RB bound/VBN to/TO plasma/NN proteins/NNS (/-LRB- 98/CD %/NN )/-RRB- ,/, mainly/RB albumin/NN ./.

nsubjpass(bound-4, Nateglinide-1)
auxpass(bound-4, is-2)
advmod(bound-4, highly-3)
root(ROOT-0, bound-4)
nn(proteins-7, plasma-6)
prep_to(bound-4, proteins-7)
num(%-10, 98-9)
appos(proteins-7, %-10)
advmod(albumin-14, mainly-13)
appos(proteins-7, albumin-14)

Sentence Id: DrugDDI.d249.s11
In/FW vitro/FW displacement/NN studies/NNS with/IN highly/RB protein/NN -bound/JJ drugs/NNS such/JJ as/IN furosemide/NN ,/, propranolol/NN ,/, captopril/NN ,/, nicardipine/NN ,/, pravastatin/NN ,/, glyburide/NN ,/, warfarin/NN ,/, phenytoin/NN ,/, acetylsalicylic/JJ acid/NN ,/, tolbutamide/NN ,/, and/CC metformin/NN showed/VBD no/DT influence/NN on/IN the/DT extent/NN of/IN nateglinide/JJ protein/NN binding/NN ./.

nn(vitro-2, In-1)
amod(studies-4, vitro-2)
nn(studies-4, displacement-3)
nsubj(showed-35, studies-4)
advmod(-bound-8, highly-6)
dep(-bound-8, protein-7)
amod(drugs-9, -bound-8)
prep_with(studies-4, drugs-9)
prep_such_as(drugs-9, furosemide-12)
conj_and(furosemide-12, propranolol-14)
conj_and(furosemide-12, captopril-16)
conj_and(furosemide-12, nicardipine-18)
conj_and(furosemide-12, pravastatin-20)
conj_and(furosemide-12, glyburide-22)
conj_and(furosemide-12, warfarin-24)
conj_and(furosemide-12, phenytoin-26)
amod(acid-29, acetylsalicylic-28)
conj_and(furosemide-12, acid-29)
conj_and(furosemide-12, tolbutamide-31)
conj_and(furosemide-12, metformin-34)
root(ROOT-0, showed-35)
det(influence-37, no-36)
dobj(showed-35, influence-37)
det(extent-40, the-39)
prep_on(influence-37, extent-40)
amod(binding-44, nateglinide-42)
nn(binding-44, protein-43)
prep_of(extent-40, binding-44)

Sentence Id: DrugDDI.d249.s12
Similarly/RB ,/, nateglinide/NN had/VBD no/DT influence/NN on/IN the/DT serum/NN protein/NN binding/NN of/IN propranolol/NN ,/, glyburide/NN ,/, nicardipine/NN ,/, warfarin/NN ,/, phenytoin/NN ,/, acetylsalicylic/JJ acid/NN ,/, and/CC tolbutamide/NN in/FW vitro/FW ./.

advmod(had-4, Similarly-1)
nsubj(had-4, nateglinide-3)
root(ROOT-0, had-4)
det(influence-6, no-5)
dobj(had-4, influence-6)
det(binding-11, the-8)
nn(binding-11, serum-9)
nn(binding-11, protein-10)
prep_on(had-4, binding-11)
prep_of(binding-11, propranolol-13)
conj_and(propranolol-13, glyburide-15)
conj_and(propranolol-13, nicardipine-17)
conj_and(propranolol-13, warfarin-19)
conj_and(propranolol-13, phenytoin-21)
amod(acid-24, acetylsalicylic-23)
conj_and(propranolol-13, acid-24)
conj_and(propranolol-13, tolbutamide-27)
nn(vitro-29, in-28)
advmod(had-4, vitro-29)

Sentence Id: DrugDDI.d249.s14
Certain/JJ drugs/NNS ,/, including/VBG nonsteroidal/JJ anti-inflammatory/JJ agents/NNS (/-LRB- NSAIDs/NNS )/-RRB- ,/, salicylates/NNS ,/, monoamine/NN oxidase/NN inhibitors/NNS ,/, and/CC non-selective/JJ beta-adrenergic-blocking/JJ agents/NNS may/MD potentiate/VB the/DT hypoglycemic/JJ action/NN of/IN Starlix/NN and/CC other/JJ oral/JJ antidiabetic/JJ drugs/NNS ./.

amod(drugs-2, Certain-1)
nsubj(potentiate-23, drugs-2)
amod(agents-7, nonsteroidal-5)
amod(agents-7, anti-inflammatory-6)
prep_including(drugs-2, agents-7)
appos(agents-7, NSAIDs-9)
conj_and(agents-7, salicylates-12)
nn(oxidase-15, monoamine-14)
nn(inhibitors-16, oxidase-15)
conj_and(agents-7, inhibitors-16)
amod(agents-21, non-selective-19)
amod(agents-21, beta-adrenergic-blocking-20)
conj_and(agents-7, agents-21)
aux(potentiate-23, may-22)
root(ROOT-0, potentiate-23)
det(action-26, the-24)
amod(action-26, hypoglycemic-25)
dobj(potentiate-23, action-26)
prep_of(action-26, Starlix-28)
amod(drugs-33, other-30)
amod(drugs-33, oral-31)
amod(drugs-33, antidiabetic-32)
conj_and(Starlix-28, drugs-33)

Sentence Id: DrugDDI.d249.s15
Certain/JJ drugs/NNS including/VBG thiazides/NNS ,/, corticosteroids/NNS ,/, thyroid/NN products/NNS ,/, and/CC sympathomimetics/NNS may/MD reduce/VB the/DT hypoglycemic/JJ action/NN of/IN Starlix/NN and/CC other/JJ oral/JJ antidiabetic/JJ drugs/NNS ./.

amod(drugs-2, Certain-1)
nsubj(reduce-14, drugs-2)
prep_including(drugs-2, thiazides-4)
conj_and(thiazides-4, corticosteroids-6)
nn(products-9, thyroid-8)
conj_and(thiazides-4, products-9)
conj_and(thiazides-4, sympathomimetics-12)
aux(reduce-14, may-13)
root(ROOT-0, reduce-14)
det(action-17, the-15)
amod(action-17, hypoglycemic-16)
dobj(reduce-14, action-17)
prep_of(action-17, Starlix-19)
amod(drugs-24, other-21)
amod(drugs-24, oral-22)
amod(drugs-24, antidiabetic-23)
conj_and(Starlix-19, drugs-24)

Sentence Id: DrugDDI.d249.s16
When/WRB these/DT drugs/NNS are/VBP administered/VBN to/TO or/CC withdrawn/VBN from/IN patients/NNS receiving/VBG Starlix/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN changes/NNS in/IN glycemic/JJ control/NN ./.

advmod(administered-5, When-1)
det(drugs-3, these-2)
nsubjpass(administered-5, drugs-3)
auxpass(administered-5, are-4)
advcl(observed-18, administered-5)
prep(administered-5, to-6)
conj_or(administered-5, withdrawn-8)
prep_from(withdrawn-8, patients-10)
partmod(patients-10, receiving-11)
dobj(receiving-11, Starlix-12)
det(patient-15, the-14)
nsubjpass(observed-18, patient-15)
aux(observed-18, should-16)
auxpass(observed-18, be-17)
root(ROOT-0, observed-18)
advmod(observed-18, closely-19)
prep_for(observed-18, changes-21)
amod(control-24, glycemic-23)
prep_in(changes-21, control-24)

Sentence Id: DrugDDI.d312.s0
In/IN clinical/JJ studies/NNS ,/, Tilade/NN has/VBZ been/VBN co-administered/VBN with/IN other/JJ anti-asthma/NN medications/NNS ,/, including/VBG inhaled/JJ and/CC oral/JJ bronchodilators/NNS ,/, and/CC inhaled/JJ corticosteroids/NNS ,/, with/IN no/DT evidence/NN of/IN increased/VBN frequency/NN of/IN adverse/JJ events/NNS or/CC laboratory/NN abnormalities/NNS ./.

amod(studies-3, clinical-2)
prep_in(co-administered-8, studies-3)
nsubjpass(co-administered-8, Tilade-5)
aux(co-administered-8, has-6)
auxpass(co-administered-8, been-7)
root(ROOT-0, co-administered-8)
amod(medications-12, other-10)
nn(medications-12, anti-asthma-11)
prep_with(co-administered-8, medications-12)
amod(bronchodilators-18, inhaled-15)
conj_and(inhaled-15, oral-17)
prep_including(medications-12, bronchodilators-18)
amod(corticosteroids-22, inhaled-21)
conj_and(medications-12, corticosteroids-22)
det(evidence-26, no-25)
prep_with(co-administered-8, evidence-26)
amod(frequency-29, increased-28)
prep_of(evidence-26, frequency-29)
amod(events-32, adverse-31)
prep_of(frequency-29, events-32)
nn(abnormalities-35, laboratory-34)
conj_or(events-32, abnormalities-35)

Sentence Id: DrugDDI.d336.s0
Caution/NN should/MD be/VB taken/VBN in/IN concurrent/JJ or/CC serial/JJ use/NN of/IN other/JJ neurotoxic/JJ and//NN or/CC nephrotoxic/JJ drugs/NNS because/IN of/IN possible/JJ enhancement/NN of/IN the/DT nephrotoxicity/NN and/or/CC ototoxicity/NN of/IN neomycin/NN ./.

nsubjpass(taken-4, Caution-1)
aux(taken-4, should-2)
auxpass(taken-4, be-3)
root(ROOT-0, taken-4)
amod(use-9, concurrent-6)
conj_or(concurrent-6, serial-8)
prep_in(taken-4, use-9)
amod(and/-13, other-11)
amod(and/-13, neurotoxic-12)
prep_of(use-9, and/-13)
amod(drugs-16, nephrotoxic-15)
conj_or(and/-13, drugs-16)
prepc_because_of(and/-13, of-18)
amod(enhancement-20, possible-19)
pobj(and/-13, enhancement-20)
dep(nephrotoxicity-23, the-22)
prep_of(enhancement-20, nephrotoxicity-23)
conj_and/or(nephrotoxicity-23, ototoxicity-25)
prep_of(nephrotoxicity-23, neomycin-27)

Sentence Id: DrugDDI.d336.s1
Caution/NN should/MD also/RB be/VB taken/VBN in/IN concurrent/JJ or/CC serial/JJ use/NN of/IN other/JJ aminoglycosides/NNS and/CC polymyxins/NNS because/IN they/PRP may/MD enhance/VB neomycin/NN @/NN s/NN nephrotoxicity/NN and/or/CC ototoxicity/NN and/CC potentiate/VB neomycin/NN sulfate/NN @/NN s/NN neuromuscular/JJ blocking/VBG effects/NNS ./.

nsubjpass(taken-5, Caution-1)
aux(taken-5, should-2)
advmod(taken-5, also-3)
auxpass(taken-5, be-4)
root(ROOT-0, taken-5)
amod(use-10, concurrent-7)
conj_or(concurrent-7, serial-9)
prep_in(taken-5, use-10)
amod(aminoglycosides-13, other-12)
prep_of(use-10, aminoglycosides-13)
conj_and(aminoglycosides-13, polymyxins-15)
mark(enhance-19, because-16)
nsubj(enhance-19, they-17)
aux(enhance-19, may-18)
advcl(taken-5, enhance-19)
nn(nephrotoxicity-23, neomycin-20)
nn(nephrotoxicity-23, @-21)
nn(nephrotoxicity-23, s-22)
dobj(enhance-19, nephrotoxicity-23)
conj_and/or(nephrotoxicity-23, ototoxicity-25)
conj_and(enhance-19, potentiate-27)
dep(neuromuscular-32, neomycin-28)
dep(neuromuscular-32, sulfate-29)
dep(neuromuscular-32, @-30)
dep(neuromuscular-32, s-31)
amod(effects-34, neuromuscular-32)
amod(effects-34, blocking-33)
dobj(potentiate-27, effects-34)

Sentence Id: DrugDDI.d336.s2
Oral/JJ neomycin/NN inhibits/VBZ the/DT gastrointestinal/JJ absorption/NN of/IN penicillin/NN V/NN ,/, oral/JJ vitamin/NN B-12/NN ,/, methotrexate/NN and/CC 5-fluorouracil/NN ./.

amod(neomycin-2, Oral-1)
nsubj(inhibits-3, neomycin-2)
root(ROOT-0, inhibits-3)
det(absorption-6, the-4)
amod(absorption-6, gastrointestinal-5)
dobj(inhibits-3, absorption-6)
nn(V-9, penicillin-8)
prep_of(absorption-6, V-9)
amod(B-12-13, oral-11)
nn(B-12-13, vitamin-12)
appos(absorption-6, B-12-13)
appos(absorption-6, methotrexate-15)
conj_and(methotrexate-15, 5-fluorouracil-17)

Sentence Id: DrugDDI.d336.s3
The/DT gastrointestinal/JJ absorption/NN of/IN digoxin/NN also/RB appears/VBZ to/TO be/VB inhibited/VBN ./.

det(absorption-3, The-1)
amod(absorption-3, gastrointestinal-2)
nsubj(appears-7, absorption-3)
xsubj(inhibited-10, absorption-3)
prep_of(absorption-3, digoxin-5)
advmod(appears-7, also-6)
root(ROOT-0, appears-7)
aux(inhibited-10, to-8)
auxpass(inhibited-10, be-9)
xcomp(appears-7, inhibited-10)

Sentence Id: DrugDDI.d336.s5
Oral/JJ neomycin/NN sulfate/NN may/MD enhance/VB the/DT effect/NN of/IN coumarin/NN in/IN anticoagulants/NNS by/IN decreasing/VBG vitamin/NN K/NN availability/NN ./.

amod(sulfate-3, Oral-1)
nn(sulfate-3, neomycin-2)
nsubj(enhance-5, sulfate-3)
aux(enhance-5, may-4)
root(ROOT-0, enhance-5)
det(effect-7, the-6)
dobj(enhance-5, effect-7)
prep_of(effect-7, coumarin-9)
prep_in(effect-7, anticoagulants-11)
prepc_by(enhance-5, decreasing-13)
nn(availability-16, vitamin-14)
nn(availability-16, K-15)
dobj(decreasing-13, availability-16)

Sentence Id: DrugDDI.d266.s0
Beta-adrenergic/JJ Blocking/NN Agents/NNS :/: Experience/VBP in/IN over/IN 1400/CD patients/NNS in/IN a/DT non-comparative/JJ clinical/JJ trial/NN has/VBZ shown/VBN that/IN concomitant/JJ administration/NN of/IN nifedipine/NN and/CC beta-blocking/JJ agent/NN s/NNS is/VBZ usually/RB well/RB tolerated/VBN ,/, but/CC there/EX have/VBP been/VBN occasional/JJ literature/NN reports/NNS suggesting/VBG that/IN the/DT combination/NN may/MD increase/VBP the/DT likelihood/NN of/IN congestive/JJ heart/NN failure/NN ,/, severe/JJ hypotension/NN or/CC exacerbation/NN of/IN angina/NN ./.

amod(Agents-3, Beta-adrenergic-1)
nn(Agents-3, Blocking-2)
root(ROOT-0, Agents-3)
dep(Agents-3, Experience-5)
quantmod(1400-8, over-7)
num(patients-9, 1400-8)
prep_in(Experience-5, patients-9)
mark(shown-16, in-10)
det(trial-14, a-11)
amod(trial-14, non-comparative-12)
amod(trial-14, clinical-13)
nsubj(shown-16, trial-14)
aux(shown-16, has-15)
advcl(Experience-5, shown-16)
complm(tolerated-29, that-17)
amod(administration-19, concomitant-18)
nsubjpass(tolerated-29, administration-19)
prep_of(administration-19, nifedipine-21)
amod(s-25, beta-blocking-23)
nn(s-25, agent-24)
conj_and(nifedipine-21, s-25)
auxpass(tolerated-29, is-26)
advmod(tolerated-29, usually-27)
advmod(tolerated-29, well-28)
ccomp(shown-16, tolerated-29)
expl(reports-37, there-32)
aux(reports-37, have-33)
cop(reports-37, been-34)
amod(reports-37, occasional-35)
nn(reports-37, literature-36)
conj_but(tolerated-29, reports-37)
partmod(reports-37, suggesting-38)
complm(increase-43, that-39)
det(combination-41, the-40)
nsubj(increase-43, combination-41)
aux(increase-43, may-42)
ccomp(suggesting-38, increase-43)
det(likelihood-45, the-44)
dobj(increase-43, likelihood-45)
amod(failure-49, congestive-47)
nn(failure-49, heart-48)
prep_of(likelihood-45, failure-49)
amod(hypotension-52, severe-51)
conj_or(failure-49, hypotension-52)
conj_or(failure-49, exacerbation-54)
prep_of(exacerbation-54, angina-56)

Sentence Id: DrugDDI.d266.s1
Long/JJ Acting/NN Nitrates/NNS :/: Nifedipine/NN may/MD be/VB safely/RB co-administered/VBN with/IN nitrates/NNS ,/, but/CC there/EX have/VBP been/VBN no/DT controlled/JJ studies/NNS to/TO evaluate/VB the/DT antianginal/JJ effectiveness/NN of/IN this/DT combination/NN ./.

amod(Nitrates-3, Long-1)
nn(Nitrates-3, Acting-2)
root(ROOT-0, Nitrates-3)
nsubjpass(co-administered-9, Nifedipine-5)
aux(co-administered-9, may-6)
auxpass(co-administered-9, be-7)
advmod(co-administered-9, safely-8)
dep(Nitrates-3, co-administered-9)
prep_with(co-administered-9, nitrates-11)
expl(studies-19, there-14)
aux(studies-19, have-15)
cop(studies-19, been-16)
det(studies-19, no-17)
amod(studies-19, controlled-18)
conj_but(co-administered-9, studies-19)
aux(evaluate-21, to-20)
xcomp(studies-19, evaluate-21)
det(effectiveness-24, the-22)
amod(effectiveness-24, antianginal-23)
dobj(evaluate-21, effectiveness-24)
det(combination-27, this-26)
prep_of(effectiveness-24, combination-27)

Sentence Id: DrugDDI.d266.s2
Digitalis/NN :/: Immediate/JJ Release/NN Capsules/NNS :/: Since/IN there/EX have/VBP been/VBN isolated/VBN reports/NNS of/IN patients/NNS with/IN elevated/JJ digoxin/NN levels/NNS ,/, and/CC there/EX is/VBZ a/DT possible/JJ interaction/NN between/IN digoxin/NN and/CC nifedipine/NN ,/, it/PRP is/VBZ recommended/VBN that/IN digoxin/NN levels/NNS be/VB monitored/VBN when/WRB initiating/VBG ,/, adjusting/VBG ,/, and/CC discontinuing/VBG nifedipine/NN to/TO avoid/VB possible/JJ over-/NN or/CC under-digitalization/NN ./.

root(ROOT-0, Digitalis-1)
amod(Capsules-5, Immediate-3)
nn(Capsules-5, Release-4)
dep(Digitalis-1, Capsules-5)
mark(reports-12, Since-7)
expl(reports-12, there-8)
aux(reports-12, have-9)
cop(reports-12, been-10)
amod(reports-12, isolated-11)
advcl(recommended-33, reports-12)
prep_of(reports-12, patients-14)
amod(levels-18, elevated-16)
nn(levels-18, digoxin-17)
prep_with(patients-14, levels-18)
expl(is-22, there-21)
conj_and(reports-12, is-22)
det(interaction-25, a-23)
amod(interaction-25, possible-24)
nsubj(is-22, interaction-25)
prep_between(interaction-25, digoxin-27)
conj_and(digoxin-27, nifedipine-29)
nsubjpass(recommended-33, it-31)
auxpass(recommended-33, is-32)
dep(Digitalis-1, recommended-33)
complm(monitored-38, that-34)
nn(levels-36, digoxin-35)
nsubjpass(monitored-38, levels-36)
auxpass(monitored-38, be-37)
ccomp(recommended-33, monitored-38)
advmod(initiating-40, when-39)
advcl(monitored-38, initiating-40)
conj_and(initiating-40, adjusting-42)
conj_and(initiating-40, discontinuing-45)
dobj(discontinuing-45, nifedipine-46)
aux(avoid-48, to-47)
xcomp(discontinuing-45, avoid-48)
amod(over--50, possible-49)
dobj(avoid-48, over--50)
conj_or(over--50, under-digitalization-52)

Sentence Id: DrugDDI.d266.s3
Extended/JJ Release/NN Tablets/NNS :/: Administration/NN of/IN nifedipine/NN with/IN digoxin/NN increased/VBD digoxin/NN levels/NNS in/IN 9/CD of/IN 12/CD normal/JJ volunteers/NNS ./.

amod(Tablets-3, Extended-1)
nn(Tablets-3, Release-2)
root(ROOT-0, Tablets-3)
nsubj(increased-10, Administration-5)
prep_of(Administration-5, nifedipine-7)
prep_with(Administration-5, digoxin-9)
dep(Tablets-3, increased-10)
nn(levels-12, digoxin-11)
dobj(increased-10, levels-12)
prep_in(increased-10, 9-14)
num(volunteers-18, 12-16)
amod(volunteers-18, normal-17)
prep_of(9-14, volunteers-18)

Sentence Id: DrugDDI.d266.s7
Since/IN there/EX have/VBP been/VBN isolated/VBN reports/NNS of/IN patients/NNS with/IN elevated/JJ digoxin/NN levels/NNS ,/, it/PRP is/VBZ recommended/VBN that/IN digoxin/NN levels/NNS be/VB monitored/VBN when/WRB initiating/VBG ,/, adjusting/VBG ,/, and/CC discontinuing/VBG nifedipine/NN to/TO avoid/VB possible/JJ over-/NN or/CC under-digitalization/NN ./.

mark(reports-6, Since-1)
expl(reports-6, there-2)
aux(reports-6, have-3)
cop(reports-6, been-4)
amod(reports-6, isolated-5)
advcl(recommended-16, reports-6)
prep_of(reports-6, patients-8)
amod(levels-12, elevated-10)
nn(levels-12, digoxin-11)
prep_with(patients-8, levels-12)
nsubjpass(recommended-16, it-14)
auxpass(recommended-16, is-15)
root(ROOT-0, recommended-16)
complm(monitored-21, that-17)
nn(levels-19, digoxin-18)
nsubjpass(monitored-21, levels-19)
auxpass(monitored-21, be-20)
ccomp(recommended-16, monitored-21)
advmod(initiating-23, when-22)
advcl(monitored-21, initiating-23)
conj_and(initiating-23, adjusting-25)
conj_and(initiating-23, discontinuing-28)
dobj(discontinuing-28, nifedipine-29)
aux(avoid-31, to-30)
xcomp(discontinuing-28, avoid-31)
amod(over--33, possible-32)
dobj(avoid-31, over--33)
conj_or(over--33, under-digitalization-35)

Sentence Id: DrugDDI.d266.s8
Quinidine/NN :/: Immediate/JJ Release/NN Capsules/NNS :/: There/EX have/VBP been/VBN rare/JJ reports/NNS of/IN an/DT interaction/NN between/IN quinidine/NN and/CC nifedipine/NN (/-LRB- with/IN a/DT decreased/VBN plasma/NN level/NN of/IN quinidine/NN )/-RRB- ./.

root(ROOT-0, Quinidine-1)
amod(Capsules-5, Immediate-3)
nn(Capsules-5, Release-4)
dep(Quinidine-1, Capsules-5)
expl(reports-11, There-7)
aux(reports-11, have-8)
cop(reports-11, been-9)
amod(reports-11, rare-10)
dep(Quinidine-1, reports-11)
det(interaction-14, an-13)
prep_of(reports-11, interaction-14)
prep_between(interaction-14, quinidine-16)
conj_and(quinidine-16, nifedipine-18)
det(level-24, a-21)
amod(level-24, decreased-22)
nn(level-24, plasma-23)
prep_with(interaction-14, level-24)
prep_of(level-24, quinidine-26)

Sentence Id: DrugDDI.d266.s9
Coumarin/NN Anticoagulant/NN s/NNS :/: There/EX have/VBP been/VBN rare/JJ reports/NNS of/IN increased/VBN prothrombin/NN time/NN in/IN patients/NNS taking/VBG coumarin/NN anticoagulant/NN s/NNS to/TO whom/WP nifedipine/NN was/VBD administered/VBN ./.

nn(s-3, Coumarin-1)
nn(s-3, Anticoagulant-2)
root(ROOT-0, s-3)
expl(reports-9, There-5)
aux(reports-9, have-6)
cop(reports-9, been-7)
amod(reports-9, rare-8)
dep(s-3, reports-9)
amod(time-13, increased-11)
nn(time-13, prothrombin-12)
prep_of(reports-9, time-13)
prep_in(reports-9, patients-15)
partmod(patients-15, taking-16)
nn(s-19, coumarin-17)
nn(s-19, anticoagulant-18)
dobj(taking-16, s-19)
rel(administered-24, whom-21)
nsubjpass(administered-24, nifedipine-22)
auxpass(administered-24, was-23)
rcmod(s-19, administered-24)

Sentence Id: DrugDDI.d266.s10
However/RB ,/, the/DT relationship/NN to/TO nifedipine/NN therapy/NN is/VBZ uncertain/JJ ./.

advmod(uncertain-9, However-1)
det(relationship-4, the-3)
nsubj(uncertain-9, relationship-4)
nn(therapy-7, nifedipine-6)
prep_to(relationship-4, therapy-7)
cop(uncertain-9, is-8)
root(ROOT-0, uncertain-9)

Sentence Id: DrugDDI.d266.s11
Cimetidine/NN :/: A/DT study/NN in/IN 6/CD healthy/JJ volunteers/NNS has/VBZ shown/VBN a/DT significant/JJ increase/NN in/IN peak/NN nifedipine/NN plasma/NN levels/NNS (/-LRB- 80/CD %/NN )/-RRB- and/CC area-under-the-curve/JJ (/-LRB- 74/CD %/NN )/-RRB- after/IN a/DT 1/CD week/NN course/NN of/IN cimetidine/NN at/IN 1000/CD mg/NN per/IN day/NN and/CC nifedipine/NN at/IN 40/CD mg/NN per/IN day/NN ./.

root(ROOT-0, Cimetidine-1)
det(study-4, A-3)
nsubj(shown-10, study-4)
num(volunteers-8, 6-6)
amod(volunteers-8, healthy-7)
prep_in(study-4, volunteers-8)
aux(shown-10, has-9)
dep(Cimetidine-1, shown-10)
det(increase-13, a-11)
amod(increase-13, significant-12)
dobj(shown-10, increase-13)
nn(levels-18, peak-15)
nn(levels-18, nifedipine-16)
nn(levels-18, plasma-17)
prep_in(increase-13, levels-18)
num(%-21, 80-20)
appos(levels-18, %-21)
conj_and(levels-18, area-under-the-curve-24)
num(%-27, 74-26)
appos(area-under-the-curve-24, %-27)
det(course-33, a-30)
num(course-33, 1-31)
nn(course-33, week-32)
prep_after(shown-10, course-33)
prep_of(course-33, cimetidine-35)
num(mg-38, 1000-37)
prep_at(cimetidine-35, mg-38)
prep_per(mg-38, day-40)
conj_and(day-40, nifedipine-42)
num(mg-45, 40-44)
prep_at(mg-38, mg-45)
prep_per(mg-45, day-47)

Sentence Id: DrugDDI.d266.s12
Ranitidine/NN produced/VBD smaller/JJR ,/, non-significant/JJ increases/NNS ./.

nsubj(produced-2, Ranitidine-1)
root(ROOT-0, produced-2)
amod(increases-6, smaller-3)
dep(smaller-3, non-significant-5)
dobj(produced-2, increases-6)

Sentence Id: DrugDDI.d266.s13
The/DT effect/NN may/MD be/VB mediated/VBN by/IN the/DT known/JJ inhibition/NN of/IN cimetidine/NN on/IN hepatic/JJ cytochrome/NN P-450/NN ,/, the/DT enzyme/NN system/NN probably/RB responsible/JJ for/IN the/DT first-pass/NN metabolism/NN of/IN nifedipine/NN ./.

det(effect-2, The-1)
nsubjpass(mediated-5, effect-2)
aux(mediated-5, may-3)
auxpass(mediated-5, be-4)
root(ROOT-0, mediated-5)
det(inhibition-9, the-7)
amod(inhibition-9, known-8)
agent(mediated-5, inhibition-9)
prep_of(inhibition-9, cimetidine-11)
amod(P-450-15, hepatic-13)
nn(P-450-15, cytochrome-14)
prep_on(inhibition-9, P-450-15)
det(system-19, the-17)
nn(system-19, enzyme-18)
appos(P-450-15, system-19)
advmod(responsible-21, probably-20)
amod(system-19, responsible-21)
det(metabolism-25, the-23)
nn(metabolism-25, first-pass-24)
prep_for(responsible-21, metabolism-25)
prep_of(metabolism-25, nifedipine-27)

Sentence Id: DrugDDI.d266.s14
If/IN nifedipine/NN therapy/NN is/VBZ initiated/VBN in/IN a/DT patient/NN currently/RB receiving/VBG cimetidine/NN ,/, cautious/JJ titration/NN is/VBZ advised/VBN ./.

mark(initiated-5, If-1)
nn(therapy-3, nifedipine-2)
nsubjpass(initiated-5, therapy-3)
auxpass(initiated-5, is-4)
advcl(advised-16, initiated-5)
det(patient-8, a-7)
prep_in(initiated-5, patient-8)
advmod(receiving-10, currently-9)
partmod(patient-8, receiving-10)
dobj(receiving-10, cimetidine-11)
amod(titration-14, cautious-13)
nsubjpass(advised-16, titration-14)
auxpass(advised-16, is-15)
root(ROOT-0, advised-16)

Sentence Id: DrugDDI.d234.s0
A/DT 30/CD to/TO 45/CD %/NN increase/NN in/IN AUC/NN and/CC Cmax/NN of/IN nisoldipine/NN was/VBD observed/VBN with/IN concomitant/JJ administration/NN of/IN cimetidine/NN 400/CD mg/NN twice/RB daily/RB ./.

det(increase-6, A-1)
num(increase-6, 30-2)
dep(increase-6, to-3)
num(increase-6, 45-4)
nn(increase-6, %-5)
nsubjpass(observed-14, increase-6)
prep_in(increase-6, AUC-8)
conj_and(AUC-8, Cmax-10)
prep_of(AUC-8, nisoldipine-12)
auxpass(observed-14, was-13)
root(ROOT-0, observed-14)
amod(administration-17, concomitant-16)
prep_with(observed-14, administration-17)
nn(mg-21, cimetidine-19)
num(mg-21, 400-20)
prep_of(administration-17, mg-21)
advmod(daily-23, twice-22)
advmod(mg-21, daily-23)

Sentence Id: DrugDDI.d234.s1
Ranitidine/NN 150/CD mg/NN twice/RB daily/RB did/VBD not/RB interact/VB significantly/RB with/IN nisoldipine/NN (/-LRB- AUC/NN was/VBD decreased/VBN by/IN 15-20/CD %/NN )./CD

nn(mg-3, Ranitidine-1)
num(mg-3, 150-2)
nsubj(interact-8, mg-3)
advmod(daily-5, twice-4)
advmod(mg-3, daily-5)
aux(interact-8, did-6)
neg(interact-8, not-7)
root(ROOT-0, interact-8)
advmod(interact-8, significantly-9)
prep_with(interact-8, nisoldipine-11)
nsubjpass(decreased-15, AUC-13)
auxpass(decreased-15, was-14)
dep(interact-8, decreased-15)
num(%-18, 15-20-17)
agent(decreased-15, %-18)
num(%-18, -RRB-.-19)

Sentence Id: DrugDDI.d234.s2
No/DT pharmacodynamic/JJ effects/NNS of/IN either/DT histamine/NN H2/NN receptor/NN antagonist/NN were/VBD observed/VBN ./.

det(effects-3, No-1)
amod(effects-3, pharmacodynamic-2)
nsubjpass(observed-11, effects-3)
det(antagonist-9, either-5)
nn(antagonist-9, histamine-6)
nn(antagonist-9, H2-7)
nn(antagonist-9, receptor-8)
prep_of(effects-3, antagonist-9)
auxpass(observed-11, were-10)
root(ROOT-0, observed-11)

Sentence Id: DrugDDI.d234.s3
Coadministration/NN of/IN phenytoin/NN with/IN 40/CD mg/NN SULAR/NN tablets/NNS in/IN epileptic/JJ patients/NNS lowered/VBD the/DT nisoldipine/NN plasma/NN concentrations/NNS to/TO undetectable/JJ levels/NNS ./.

nsubj(lowered-12, Coadministration-1)
prep_of(Coadministration-1, phenytoin-3)
num(tablets-8, 40-5)
nn(tablets-8, mg-6)
nn(tablets-8, SULAR-7)
prep_with(Coadministration-1, tablets-8)
amod(patients-11, epileptic-10)
prep_in(tablets-8, patients-11)
root(ROOT-0, lowered-12)
det(concentrations-16, the-13)
nn(concentrations-16, nisoldipine-14)
nn(concentrations-16, plasma-15)
dobj(lowered-12, concentrations-16)
amod(levels-19, undetectable-18)
prep_to(lowered-12, levels-19)

Sentence Id: DrugDDI.d234.s4
Coadministration/NN of/IN SULAR/NN with/IN phenytoin/NN or/CC any/DT known/JJ CYP3A4/NN inducer/NN should/MD be/VB avoided/VBN and/CC alternative/JJ antihypertensive/JJ therapy/NN should/MD be/VB considered/VBN ./.

nsubjpass(avoided-13, Coadministration-1)
prep_of(Coadministration-1, SULAR-3)
prep_with(Coadministration-1, phenytoin-5)
det(inducer-10, any-7)
amod(inducer-10, known-8)
nn(inducer-10, CYP3A4-9)
conj_or(phenytoin-5, inducer-10)
aux(avoided-13, should-11)
auxpass(avoided-13, be-12)
root(ROOT-0, avoided-13)
amod(therapy-17, alternative-15)
amod(therapy-17, antihypertensive-16)
nsubjpass(considered-20, therapy-17)
aux(considered-20, should-18)
auxpass(considered-20, be-19)
conj_and(avoided-13, considered-20)

Sentence Id: DrugDDI.d234.s5
Pharmacokinetic/JJ interactions/NNS between/IN nisoldipine/NN and/CC beta-blockers/NNS (/-LRB- atenolol/NN ,/, propranolol/NN )/-RRB- were/VBD variable/JJ and/CC not/RB significant/JJ ./.

amod(interactions-2, Pharmacokinetic-1)
nsubj(variable-13, interactions-2)
prep_between(interactions-2, nisoldipine-4)
conj_and(nisoldipine-4, beta-blockers-6)
dep(beta-blockers-6, atenolol-8)
appos(atenolol-8, propranolol-10)
cop(variable-13, were-12)
root(ROOT-0, variable-13)
neg(significant-16, not-15)
conj_and(variable-13, significant-16)

Sentence Id: DrugDDI.d234.s6
Propranolol/NN attenuated/VBD the/DT heart/NN rate/NN increase/NN following/VBG administration/NN of/IN immediate/JJ release/NN nisoldipine/NN ./.

nsubj(attenuated-2, Propranolol-1)
root(ROOT-0, attenuated-2)
det(increase-6, the-3)
nn(increase-6, heart-4)
nn(increase-6, rate-5)
dobj(attenuated-2, increase-6)
prep_following(attenuated-2, administration-8)
amod(nisoldipine-12, immediate-10)
nn(nisoldipine-12, release-11)
prep_of(administration-8, nisoldipine-12)

Sentence Id: DrugDDI.d234.s7
The/DT blood/NN pressure/NN effect/NN of/IN SULAR/NN tended/VBD to/TO be/VB greater/JJR in/IN patients/NNS on/IN atenolol/NN than/IN in/IN patients/NNS on/IN no/DT other/JJ antihypertensive/JJ therapy/NN ./.

det(effect-4, The-1)
nn(effect-4, blood-2)
nn(effect-4, pressure-3)
nsubj(tended-7, effect-4)
xsubj(greater-10, effect-4)
prep_of(effect-4, SULAR-6)
root(ROOT-0, tended-7)
aux(greater-10, to-8)
cop(greater-10, be-9)
xcomp(tended-7, greater-10)
prep_in(greater-10, patients-12)
prep_on(patients-12, atenolol-14)
prep(greater-10, than-15)
pcomp(than-15, in-16)
prep_in(than-15, patients-17)
det(therapy-22, no-19)
amod(therapy-22, other-20)
amod(therapy-22, antihypertensive-21)
prep_on(patients-17, therapy-22)

Sentence Id: DrugDDI.d234.s8
Quinidine/NN at/IN 648/CD mg/NN bid/NN decreased/VBD the/DT bioavailability/NN (/-LRB- AUC/NN )/-RRB- of/IN nisoldipine/NN by/IN 26/CD %/NN ,/, but/CC not/RB the/DT peak/JJ concentration/NN ./.

nsubj(decreased-6, Quinidine-1)
number(mg-4, 648-3)
amod(bid-5, mg-4)
prep_at(Quinidine-1, bid-5)
root(ROOT-0, decreased-6)
det(bioavailability-8, the-7)
dobj(decreased-6, bioavailability-8)
abbrev(bioavailability-8, AUC-10)
prep_of(bioavailability-8, nisoldipine-13)
num(%-16, 26-15)
prep_by(decreased-6, %-16)
det(concentration-22, the-20)
amod(concentration-22, peak-21)
conj_negcc(decreased-6, concentration-22)
dobj(decreased-6, concentration-22)

Sentence Id: DrugDDI.d234.s9
The/DT immediate/JJ release/NN ,/, but/CC not/RB the/DT coat-core/JJ formulation/NN of/IN nisoldipine/NN increased/VBD plasma/NN quinidine/NN concentrations/NNS by/IN about/RB 20/CD %./NN

det(release-3, The-1)
amod(release-3, immediate-2)
root(ROOT-0, release-3)
det(formulation-9, the-7)
amod(formulation-9, coat-core-8)
nsubj(increased-12, formulation-9)
prep_of(formulation-9, nisoldipine-11)
conj_negcc(release-3, increased-12)
nn(concentrations-15, plasma-13)
nn(concentrations-15, quinidine-14)
dobj(increased-12, concentrations-15)
quantmod(20-18, about-17)
num(%.-19, 20-18)
prep_by(increased-12, %.-19)

Sentence Id: DrugDDI.d234.s11
No/DT significant/JJ interactions/NNS were/VBD found/VBN between/IN nisoldipine/NN and/CC warfarin/NN or/CC digoxin/NN ./.

det(interactions-3, No-1)
amod(interactions-3, significant-2)
nsubjpass(found-5, interactions-3)
auxpass(found-5, were-4)
root(ROOT-0, found-5)
prep_between(found-5, nisoldipine-7)
conj_and(nisoldipine-7, warfarin-9)
conj_or(nisoldipine-7, digoxin-11)

Sentence Id: DrugDDI.d306.s0
Tizoxanide/NN is/VBZ highly/RB bound/VBN to/TO plasma/NN protein/NN (/-LRB- 99.9/CD %)./NN

nsubjpass(bound-4, Tizoxanide-1)
auxpass(bound-4, is-2)
advmod(bound-4, highly-3)
root(ROOT-0, bound-4)
nn(protein-7, plasma-6)
prep_to(bound-4, protein-7)
num(%-RRB-.-10, 99.9-9)
dep(bound-4, %-RRB-.-10)

Sentence Id: DrugDDI.d306.s1
Therefore/RB ,/, caution/NN should/MD be/VB used/VBN when/WRB administering/VBG nitazoxanide/NN concurrently/RB with/IN other/JJ highly/RB plasma/NN protein-bound/JJ drugs/NNS with/IN narrow/JJ therapeutic/JJ indices/NNS ,/, as/IN competition/NN for/IN binding/NN sites/NNS may/MD occur/VB (/-LRB- e.g./FW ,/, warfarin/NN )/-RRB- ./.

advmod(used-6, Therefore-1)
nsubjpass(used-6, caution-3)
aux(used-6, should-4)
auxpass(used-6, be-5)
root(ROOT-0, used-6)
advmod(administering-8, when-7)
advcl(used-6, administering-8)
dobj(administering-8, nitazoxanide-9)
advmod(nitazoxanide-9, concurrently-10)
amod(drugs-16, other-12)
advmod(protein-bound-15, highly-13)
dep(protein-bound-15, plasma-14)
amod(drugs-16, protein-bound-15)
prep_with(nitazoxanide-9, drugs-16)
amod(indices-20, narrow-18)
amod(indices-20, therapeutic-19)
prep_with(administering-8, indices-20)
mark(occur-28, as-22)
nsubj(occur-28, competition-23)
nn(sites-26, binding-25)
prep_for(competition-23, sites-26)
aux(occur-28, may-27)
advcl(used-6, occur-28)
dep(used-6, e.g.-30)
pobj(e.g.-30, warfarin-32)

Sentence Id: DrugDDI.d306.s2
In/FW vitro/FW metabolism/NN studies/NNS have/VBP demonstrated/VBN that/IN tizoxanide/NN has/VBZ no/DT significant/JJ inhibitory/JJ effect/NN on/IN cytochrome/NN P450/NN enzymes/NNS ./.

nn(vitro-2, In-1)
amod(studies-4, vitro-2)
nn(studies-4, metabolism-3)
nsubj(demonstrated-6, studies-4)
aux(demonstrated-6, have-5)
root(ROOT-0, demonstrated-6)
complm(has-9, that-7)
nsubj(has-9, tizoxanide-8)
ccomp(demonstrated-6, has-9)
det(effect-13, no-10)
amod(effect-13, significant-11)
amod(effect-13, inhibitory-12)
dobj(has-9, effect-13)
nn(enzymes-17, cytochrome-15)
nn(enzymes-17, P450-16)
prep_on(has-9, enzymes-17)

Sentence Id: DrugDDI.d306.s3
Although/IN no/DT drug-drug/JJ interaction/NN studies/NNS have/VBP been/VBN conducted/VBN in/FW vivo/FW ,/, it/PRP is/VBZ expected/VBN that/IN no/DT significant/JJ interaction/NN would/MD occur/VB when/WRB nitazoxanide/NN is/VBZ co-administered/VBN with/IN drugs/NNS that/WDT either/RB are/VBP metabolized/VBN by/IN or/CC inhibit/VB cytochrome/NN P450/NN enzymes/NNS ./.

mark(conducted-8, Although-1)
det(studies-5, no-2)
amod(studies-5, drug-drug-3)
nn(studies-5, interaction-4)
nsubjpass(conducted-8, studies-5)
aux(conducted-8, have-6)
auxpass(conducted-8, been-7)
advcl(expected-14, conducted-8)
nn(vivo-10, in-9)
advmod(conducted-8, vivo-10)
nsubjpass(expected-14, it-12)
auxpass(expected-14, is-13)
root(ROOT-0, expected-14)
complm(occur-20, that-15)
det(interaction-18, no-16)
amod(interaction-18, significant-17)
nsubj(occur-20, interaction-18)
aux(occur-20, would-19)
ccomp(expected-14, occur-20)
advmod(co-administered-24, when-21)
nsubjpass(co-administered-24, nitazoxanide-22)
auxpass(co-administered-24, is-23)
advcl(occur-20, co-administered-24)
prep_with(co-administered-24, drugs-26)
nsubjpass(metabolized-30, drugs-26)
advmod(metabolized-30, either-28)
auxpass(metabolized-30, are-29)
rcmod(drugs-26, metabolized-30)
prep(metabolized-30, by-31)
conj_or(metabolized-30, inhibit-33)
nn(enzymes-36, cytochrome-34)
nn(enzymes-36, P450-35)
dobj(inhibit-33, enzymes-36)

Sentence Id: DrugDDI.d20.s0
Oxcarbazepine/NN can/MD inhibit/VB CYP2C19/NN and/CC induce/VB CYP3A4/NN /5/NN with/IN potentially/RB important/JJ effects/NNS on/IN plasma/NN concentrations/NNS of/IN other/JJ drugs/NNS ./.

nsubj(inhibit-3, Oxcarbazepine-1)
aux(inhibit-3, can-2)
root(ROOT-0, inhibit-3)
dobj(inhibit-3, CYP2C19-4)
conj_and(inhibit-3, induce-6)
nn(/5-8, CYP3A4-7)
dobj(induce-6, /5-8)
advmod(important-11, potentially-10)
amod(effects-12, important-11)
prep_with(/5-8, effects-12)
nn(concentrations-15, plasma-14)
prep_on(effects-12, concentrations-15)
amod(drugs-18, other-17)
prep_of(concentrations-15, drugs-18)

Sentence Id: DrugDDI.d20.s1
In/IN addition/NN ,/, several/JJ AED/JJ @/NN s/NNS that/WDT are/VBP cytochrome/NN P450/NN inducers/NNS can/MD decrease/VB plasma/NN concentrations/NNS of/IN oxcarbazepine/NN and/CC MHD/NN ./.

prep_in(decrease-14, addition-2)
amod(s-7, several-4)
amod(s-7, AED-5)
nn(s-7, @-6)
nsubj(inducers-12, s-7)
nsubj(decrease-14, s-7)
cop(inducers-12, are-9)
nn(inducers-12, cytochrome-10)
nn(inducers-12, P450-11)
rcmod(s-7, inducers-12)
aux(decrease-14, can-13)
root(ROOT-0, decrease-14)
nn(concentrations-16, plasma-15)
dobj(decrease-14, concentrations-16)
prep_of(concentrations-16, oxcarbazepine-18)
conj_and(oxcarbazepine-18, MHD-20)

Sentence Id: DrugDDI.d20.s2
Oxcarbazepine/NN was/VBD evaluated/VBN in/IN human/JJ liver/NN microsomes/NNS to/TO determine/VB its/PRP$ capacity/NN to/TO inhibit/VB the/DT major/JJ cytochrome/NN P450/NN enzymes/NNS responsible/JJ for/IN the/DT metabolism/NN of/IN other/JJ drugs/NNS ./.

nsubjpass(evaluated-3, Oxcarbazepine-1)
xsubj(determine-9, Oxcarbazepine-1)
auxpass(evaluated-3, was-2)
root(ROOT-0, evaluated-3)
amod(microsomes-7, human-5)
nn(microsomes-7, liver-6)
prep_in(evaluated-3, microsomes-7)
aux(determine-9, to-8)
xcomp(evaluated-3, determine-9)
poss(capacity-11, its-10)
dobj(determine-9, capacity-11)
aux(inhibit-13, to-12)
infmod(capacity-11, inhibit-13)
det(enzymes-18, the-14)
amod(enzymes-18, major-15)
nn(enzymes-18, cytochrome-16)
nn(enzymes-18, P450-17)
dobj(inhibit-13, enzymes-18)
amod(enzymes-18, responsible-19)
det(metabolism-22, the-21)
prep_for(responsible-19, metabolism-22)
amod(drugs-25, other-24)
prep_of(metabolism-22, drugs-25)

Sentence Id: DrugDDI.d20.s3
Results/NNS demonstrate/VBP that/IN oxcarbazepine/NN and/CC its/PRP$ pharmacologically/RB active/JJ 10-monohydroxy/NN metabolite/NN (/-LRB- MHD/NN )/-RRB- have/VBP little/JJ or/CC no/DT capacity/NN to/TO function/VB as/IN inhibitors/NNS for/IN most/JJS of/IN the/DT human/JJ cytochrome/NN P450/NN enzymes/NNS evaluated/VBN (/-LRB- CYP1A2/NN ,/, CYP2A6/NN ,/, CYP2C9/NN ,/, CYP2D6/NN ,/, CYP2E1/NN ,/, CYP4A9/NN and/CC CYP4A11/NN )/-RRB- with/IN the/DT exception/NN of/IN CYP2C19/NN and/CC CYP3A4/NN /5/NN ./.

nsubj(demonstrate-2, Results-1)
root(ROOT-0, demonstrate-2)
complm(have-14, that-3)
nsubj(have-14, oxcarbazepine-4)
poss(metabolite-10, its-6)
advmod(active-8, pharmacologically-7)
amod(metabolite-10, active-8)
nn(metabolite-10, 10-monohydroxy-9)
conj_and(oxcarbazepine-4, metabolite-10)
abbrev(metabolite-10, MHD-12)
ccomp(demonstrate-2, have-14)
dobj(have-14, little-15)
det(capacity-18, no-17)
conj_or(little-15, capacity-18)
aux(function-20, to-19)
infmod(capacity-18, function-20)
prep_as(function-20, inhibitors-22)
prep_for(inhibitors-22, most-24)
det(enzymes-30, the-26)
amod(enzymes-30, human-27)
nn(enzymes-30, cytochrome-28)
nn(enzymes-30, P450-29)
prep_of(most-24, enzymes-30)
partmod(enzymes-30, evaluated-31)
dep(evaluated-31, CYP1A2-33)
conj_and(CYP1A2-33, CYP2A6-35)
conj_and(CYP1A2-33, CYP2C9-37)
conj_and(CYP1A2-33, CYP2D6-39)
conj_and(CYP1A2-33, CYP2E1-41)
conj_and(CYP1A2-33, CYP4A9-43)
conj_and(CYP1A2-33, CYP4A11-45)
det(exception-49, the-48)
prep_with(evaluated-31, exception-49)
prep_of(exception-49, CYP2C19-51)
nn(/5-54, CYP3A4-53)
conj_and(CYP2C19-51, /5-54)

Sentence Id: DrugDDI.d20.s4
Although/IN inhibition/NN of/IN CYP/NN 3A4/5/NN by/IN OXC/NN and/CC MHD/NN did/VBD occur/VB at/IN high/JJ concentrations/NNS ,/, it/PRP is/VBZ not/RB likely/JJ to/TO be/VB of/IN clinical/JJ significance/NN ./.

mark(occur-11, Although-1)
nsubj(occur-11, inhibition-2)
nn(3A4/5-5, CYP-4)
prep_of(inhibition-2, 3A4/5-5)
prep_by(inhibition-2, OXC-7)
conj_and(OXC-7, MHD-9)
aux(occur-11, did-10)
advcl(likely-19, occur-11)
amod(concentrations-14, high-13)
prep_at(occur-11, concentrations-14)
nsubj(likely-19, it-16)
cop(likely-19, is-17)
neg(likely-19, not-18)
root(ROOT-0, likely-19)
aux(be-21, to-20)
xcomp(likely-19, be-21)
amod(significance-24, clinical-23)
prep_of(be-21, significance-24)

Sentence Id: DrugDDI.d20.s5
The/DT inhibition/NN of/IN CYP-2C19/NN by/IN OXC/NN and/CC MHD/NN ,/, however/RB ,/, is/VBZ clinically/RB relevant/JJ ./.

det(inhibition-2, The-1)
nsubj(relevant-14, inhibition-2)
prep_of(inhibition-2, CYP-2C19-4)
prep_by(inhibition-2, OXC-6)
conj_and(OXC-6, MHD-8)
advmod(relevant-14, however-10)
cop(relevant-14, is-12)
advmod(relevant-14, clinically-13)
root(ROOT-0, relevant-14)

Sentence Id: DrugDDI.d20.s6
In/FW vitro/FW ,/, the/DT UDP-glucuronyl/JJ transferase/NN level/NN was/VBD increased/VBN ,/, indicating/VBG induction/NN of/IN this/DT enzyme/NN ./.

nn(vitro-2, In-1)
advmod(increased-9, vitro-2)
det(level-7, the-4)
amod(level-7, UDP-glucuronyl-5)
nn(level-7, transferase-6)
nsubjpass(increased-9, level-7)
auxpass(increased-9, was-8)
root(ROOT-0, increased-9)
xcomp(increased-9, indicating-11)
dobj(indicating-11, induction-12)
det(enzyme-15, this-14)
prep_of(induction-12, enzyme-15)

Sentence Id: DrugDDI.d20.s7
Increases/NNS of/IN 22/CD %/NN with/IN MHD/NN and/CC 47/CD %/NN with/IN oxcarbazepine/NN were/VBD observed/VBN ./.

nsubjpass(observed-13, Increases-1)
num(%-4, 22-3)
prep_of(Increases-1, %-4)
prep_with(%-4, MHD-6)
num(%-9, 47-8)
conj_and(%-4, %-9)
prep_with(%-9, oxcarbazepine-11)
auxpass(observed-13, were-12)
root(ROOT-0, observed-13)

Sentence Id: DrugDDI.d20.s8
As/IN MHD/NN ,/, the/DT predominant/JJ plasma/NN substrate/NN ,/, is/VBZ only/RB a/DT weak/JJ inducer/NN of/IN UDP-glucuronyl/NN transferase/NN ,/, it/PRP is/VBZ unlikely/JJ to/TO have/VB an/DT effect/NN on/IN drugs/NNS that/WDT are/VBP mainly/RB eliminated/VBN by/IN conjugation/NN through/IN UDP-glucuronyl/JJ transferase/NN (/-LRB- e.g./FW ,/, valproic/JJ acid/NN ,/, lamotrigine/NN )/-RRB- ./.

mark(inducer-13, As-1)
nsubj(inducer-13, MHD-2)
det(substrate-7, the-4)
amod(substrate-7, predominant-5)
nn(substrate-7, plasma-6)
appos(MHD-2, substrate-7)
cop(inducer-13, is-9)
advmod(inducer-13, only-10)
det(inducer-13, a-11)
amod(inducer-13, weak-12)
advcl(unlikely-20, inducer-13)
nn(transferase-16, UDP-glucuronyl-15)
prep_of(inducer-13, transferase-16)
nsubj(unlikely-20, it-18)
cop(unlikely-20, is-19)
root(ROOT-0, unlikely-20)
aux(have-22, to-21)
xcomp(unlikely-20, have-22)
det(effect-24, an-23)
dobj(have-22, effect-24)
prep_on(have-22, drugs-26)
nsubjpass(eliminated-30, drugs-26)
auxpass(eliminated-30, are-28)
advmod(eliminated-30, mainly-29)
rcmod(drugs-26, eliminated-30)
agent(eliminated-30, conjugation-32)
amod(transferase-35, UDP-glucuronyl-34)
prep_through(eliminated-30, transferase-35)
dep(lamotrigine-42, e.g.-37)
amod(acid-40, valproic-39)
pobj(e.g.-37, acid-40)
appos(transferase-35, lamotrigine-42)

Sentence Id: DrugDDI.d20.s9
In/IN addition/NN ,/, oxcarbazepine/NN and/CC MHD/NN induce/VBP a/DT subgroup/NN of/IN the/DT cytochrome/NN P450/NN 3A/NN family/NN (/-LRB- CYP3A4/NN and/CC CYP3A5/NN )/-RRB- responsible/JJ for/IN the/DT metabolism/NN of/IN dihydropyridine/NN calcium/NN antagonist/NN s/NN and/CC oral/JJ contraceptives/NNS ,/, resulting/VBG in/IN a/DT lower/JJR plasma/NN concentration/NN of/IN these/DT drugs/NNS ./.

prep_in(induce-7, addition-2)
nsubj(induce-7, oxcarbazepine-4)
conj_and(oxcarbazepine-4, MHD-6)
root(ROOT-0, induce-7)
det(subgroup-9, a-8)
dobj(induce-7, subgroup-9)
det(family-15, the-11)
nn(family-15, cytochrome-12)
nn(family-15, P450-13)
nn(family-15, 3A-14)
prep_of(subgroup-9, family-15)
dep(family-15, CYP3A4-17)
conj_and(CYP3A4-17, CYP3A5-19)
amod(family-15, responsible-21)
det(metabolism-24, the-23)
prep_for(responsible-21, metabolism-24)
nn(s-29, dihydropyridine-26)
nn(s-29, calcium-27)
nn(s-29, antagonist-28)
prep_of(metabolism-24, s-29)
amod(contraceptives-32, oral-31)
conj_and(s-29, contraceptives-32)
partmod(induce-7, resulting-34)
xcomp(induce-7, resulting-34)
det(concentration-39, a-36)
amod(concentration-39, lower-37)
nn(concentration-39, plasma-38)
prep_in(resulting-34, concentration-39)
det(drugs-42, these-41)
prep_of(concentration-39, drugs-42)

Sentence Id: DrugDDI.d20.s10
As/IN binding/NN of/IN MHD/NN to/TO plasma/NN proteins/NNS is/VBZ low/JJ (/-LRB- 40/CD %/NN )/-RRB- ,/, clinically/RB significant/JJ interactions/NNS with/IN other/JJ drugs/NNS through/IN competition/NN for/IN protein/NN binding/NN sites/NNS are/VBP unlikely/JJ ./.

mark(low-9, As-1)
nsubj(low-9, binding-2)
prep_of(binding-2, MHD-4)
nn(proteins-7, plasma-6)
prep_to(binding-2, proteins-7)
cop(low-9, is-8)
advcl(unlikely-28, low-9)
num(%-12, 40-11)
dep(low-9, %-12)
advmod(significant-16, clinically-15)
amod(interactions-17, significant-16)
nsubj(unlikely-28, interactions-17)
amod(drugs-20, other-19)
prep_with(interactions-17, drugs-20)
prep_through(interactions-17, competition-22)
nn(sites-26, protein-24)
nn(sites-26, binding-25)
prep_for(competition-22, sites-26)
cop(unlikely-28, are-27)
root(ROOT-0, unlikely-28)

Sentence Id: DrugDDI.d20.s11
Antiepileptic/JJ drugs/NNS Potential/JJ interactions/NNS between/IN Trileptal/NNP and/CC other/JJ AEDs/NNS were/VBD assessed/VBN in/IN clinical/JJ studies/NNS ./.

amod(drugs-2, Antiepileptic-1)
nsubjpass(assessed-11, drugs-2)
amod(interactions-4, Potential-3)
dep(drugs-2, interactions-4)
prep_between(interactions-4, Trileptal-6)
amod(AEDs-9, other-8)
conj_and(Trileptal-6, AEDs-9)
auxpass(assessed-11, were-10)
root(ROOT-0, assessed-11)
amod(studies-14, clinical-13)
prep_in(assessed-11, studies-14)

Sentence Id: DrugDDI.d20.s12
The/DT effect/NN of/IN these/DT interactions/NNS on/IN mean/JJ AUCs/NNS and/CC Cmin/NN are/VBP summarized/VBN in/IN Table/NN 2/CD :/: Table/NN 2/CD :/: Summary/NN of/IN AED/JJ interactions/NNS with/IN Trileptal/NN ./.

det(effect-2, The-1)
nsubjpass(summarized-12, effect-2)
det(interactions-5, these-4)
prep_of(effect-2, interactions-5)
amod(AUCs-8, mean-7)
prep_on(effect-2, AUCs-8)
conj_and(AUCs-8, Cmin-10)
auxpass(summarized-12, are-11)
root(ROOT-0, summarized-12)
prep_in(summarized-12, Table-14)
num(Table-14, 2-15)
dep(Table-14, Table-17)
num(Table-17, 2-18)
dep(Table-14, Summary-20)
amod(interactions-23, AED-22)
prep_of(Table-14, interactions-23)
prep_with(interactions-23, Trileptal-25)

Sentence Id: DrugDDI.d20.s15
Trileptal/JJ dose/NN (/-LRB- mg/day/NN )/-RRB- ./.

amod(dose-2, Trileptal-1)
root(ROOT-0, dose-2)
appos(dose-2, mg/day-4)

Sentence Id: DrugDDI.d20.s16
Influence/NN of/IN Trileptal/NN on/IN AED/JJ Concentration/NN (/-LRB- Mean/NN change/NN ,/, 90/CD %/NN Confidence/NN Interval/NN )/-RRB- ./.

root(ROOT-0, Influence-1)
prep_of(Influence-1, Trileptal-3)
amod(Concentration-6, AED-5)
prep_on(Influence-1, Concentration-6)
nn(change-9, Mean-8)
dep(Concentration-6, change-9)
number(%-12, 90-11)
amod(Interval-14, %-12)
nn(Interval-14, Confidence-13)
appos(change-9, Interval-14)

Sentence Id: DrugDDI.d20.s18
Carbamazepine/NN ./.

root(ROOT-0, Carbamazepine-1)

Sentence Id: DrugDDI.d20.s22
Phenobarbital/NN ./.

root(ROOT-0, Phenobarbital-1)

Sentence Id: DrugDDI.d20.s26
Phenytoin/NN ./.

root(ROOT-0, Phenytoin-1)

Sentence Id: DrugDDI.d20.s31
Valproic/JJ acid/NN ./.

amod(acid-2, Valproic-1)
root(ROOT-0, acid-2)

Sentence Id: DrugDDI.d20.s35
1-/CD nc/NN denotes/VBZ a/DT mean/JJ change/NN of/IN less/JJR than/IN 10/CD %/NN 2-/CD Pediatrics/NN 3-/CD Mean/NN increase/NN in/IN adults/NNS at/IN high/JJ Trileptal/NN doses/NNS In/FW vivo/FW ,/, the/DT plasma/NN levels/NNS of/IN phenytoin/NN increased/VBD by/IN up/RB to/TO 40/CD %/NN ,/, when/WRB Trileptal/NN was/VBD given/VBN at/IN doses/NNS above/IN 1200/CD mg/day/NN ./.

num(nc-2, 1--1)
nsubj(denotes-3, nc-2)
root(ROOT-0, denotes-3)
det(change-6, a-4)
amod(change-6, mean-5)
dobj(denotes-3, change-6)
mwe(than-9, less-8)
quantmod(10-10, than-9)
num(increase-16, 10-10)
nn(increase-16, %-11)
num(increase-16, 2--12)
nn(increase-16, Pediatrics-13)
num(increase-16, 3--14)
nn(increase-16, Mean-15)
prep_of(change-6, increase-16)
prep_in(increase-16, adults-18)
amod(doses-22, high-20)
nn(doses-22, Trileptal-21)
prep_at(increase-16, doses-22)
nn(vivo-24, In-23)
advmod(denotes-3, vivo-24)
det(levels-28, the-26)
nn(levels-28, plasma-27)
nsubj(increased-31, levels-28)
prep_of(levels-28, phenytoin-30)
ccomp(denotes-3, increased-31)
quantmod(40-35, up-33)
dep(40-35, to-34)
num(%-36, 40-35)
prep_by(increased-31, %-36)
advmod(given-41, when-38)
nsubjpass(given-41, Trileptal-39)
auxpass(given-41, was-40)
advcl(increased-31, given-41)
prep_at(given-41, doses-43)
num(mg/day-46, 1200-45)
prep_above(doses-43, mg/day-46)

Sentence Id: DrugDDI.d20.s36
Therefore/RB ,/, when/WRB using/VBG doses/NNS of/IN Trileptal/NN greater/JJR than/IN 1200/CD mg/day/NN during/IN adjunctive/JJ therapy/NN ,/, a/DT decrease/NN in/IN the/DT dose/NN of/IN phenytoin/NN may/MD be/VB required/VBN ./.

advmod(required-25, Therefore-1)
advmod(using-4, when-3)
advcl(required-25, using-4)
dobj(using-4, doses-5)
prep_of(doses-5, Trileptal-7)
mwe(than-9, greater-8)
quantmod(1200-10, than-9)
dep(mg/day-11, 1200-10)
dep(doses-5, mg/day-11)
amod(therapy-14, adjunctive-13)
prep_during(using-4, therapy-14)
det(decrease-17, a-16)
nsubjpass(required-25, decrease-17)
det(dose-20, the-19)
prep_in(decrease-17, dose-20)
prep_of(dose-20, phenytoin-22)
aux(required-25, may-23)
auxpass(required-25, be-24)
root(ROOT-0, required-25)

Sentence Id: DrugDDI.d20.s37
The/DT increase/NN of/IN phenobarbital/NN level/NN ,/, however/RB ,/, is/VBZ small/JJ (/-LRB- 15/CD %/NN )/-RRB- when/WRB given/VBN with/IN Trileptal/NN ./.

det(increase-2, The-1)
nsubj(small-10, increase-2)
nn(level-5, phenobarbital-4)
prep_of(increase-2, level-5)
advmod(small-10, however-7)
cop(small-10, is-9)
root(ROOT-0, small-10)
num(%-13, 15-12)
dep(small-10, %-13)
advmod(given-16, when-15)
advcl(small-10, given-16)
prep_with(given-16, Trileptal-18)

Sentence Id: DrugDDI.d20.s38
Strong/JJ inducers/NNS of/IN cytochrome/NN P450/NN enzymes/NNS (/-LRB- i.e./FW carbamazepine/NN ,/, phenytoin/NN and/CC phenobarbital/NN )/-RRB- have/VBP been/VBN shown/VBN to/TO decrease/VB the/DT plasma/NN levels/NNS of/IN MHD/NN (/-LRB- 29-40%)./NN

amod(inducers-2, Strong-1)
nsubjpass(shown-17, inducers-2)
xsubj(decrease-19, inducers-2)
nn(enzymes-6, cytochrome-4)
nn(enzymes-6, P450-5)
prep_of(inducers-2, enzymes-6)
dep(carbamazepine-9, i.e.-8)
dep(enzymes-6, carbamazepine-9)
conj_and(carbamazepine-9, phenytoin-11)
conj_and(carbamazepine-9, phenobarbital-13)
aux(shown-17, have-15)
auxpass(shown-17, been-16)
root(ROOT-0, shown-17)
aux(decrease-19, to-18)
xcomp(shown-17, decrease-19)
det(levels-22, the-20)
nn(levels-22, plasma-21)
dobj(decrease-19, levels-22)
prep_of(levels-22, MHD-24)
dep(decrease-19, 29-40%-RRB-.-26)

Sentence Id: DrugDDI.d20.s39
No/DT autoinduction/NN has/VBZ been/VBN observed/VBN with/IN Trileptal/NN ./.

det(autoinduction-2, No-1)
nsubjpass(observed-5, autoinduction-2)
aux(observed-5, has-3)
auxpass(observed-5, been-4)
root(ROOT-0, observed-5)
prep_with(observed-5, Trileptal-7)

Sentence Id: DrugDDI.d20.s40
Hormonal/JJ contraceptives/NNS Co-administration/NN of/IN Trileptal/NN with/IN an/DT oral/JJ contraceptive/NN has/VBZ been/VBN shown/VBN to/TO influence/VB the/DT plasma/NN concentrations/NNS of/IN the/DT two/CD hormonal/JJ components/NNS ,/, ethinylestradiol/NN (/-LRB- EE/NN )/-RRB- and/CC levonorgestrel/NN (/-LRB- LNG)./NN

amod(contraceptives-2, Hormonal-1)
root(ROOT-0, contraceptives-2)
nsubjpass(shown-12, Co-administration-3)
xsubj(influence-14, Co-administration-3)
prep_of(Co-administration-3, Trileptal-5)
det(contraceptive-9, an-7)
amod(contraceptive-9, oral-8)
prep_with(Co-administration-3, contraceptive-9)
aux(shown-12, has-10)
auxpass(shown-12, been-11)
dep(contraceptives-2, shown-12)
aux(influence-14, to-13)
xcomp(shown-12, influence-14)
det(concentrations-17, the-15)
nn(concentrations-17, plasma-16)
dobj(influence-14, concentrations-17)
det(components-22, the-19)
num(components-22, two-20)
amod(components-22, hormonal-21)
prep_of(concentrations-17, components-22)
appos(components-22, ethinylestradiol-24)
abbrev(ethinylestradiol-24, EE-26)
conj_and(ethinylestradiol-24, levonorgestrel-29)
dep(levonorgestrel-29, LNG-RRB-.-31)

Sentence Id: DrugDDI.d20.s43
Therefore/RB ,/, concurrent/JJ use/NN of/IN Trileptal/NN with/IN hormonal/JJ contraceptives/NNS may/MD render/VB these/DT contraceptives/NNS less/RBR effective/JJ ./.

advmod(render-11, Therefore-1)
amod(use-4, concurrent-3)
nsubj(render-11, use-4)
prep_of(use-4, Trileptal-6)
amod(contraceptives-9, hormonal-8)
prep_with(use-4, contraceptives-9)
aux(render-11, may-10)
root(ROOT-0, render-11)
det(contraceptives-13, these-12)
nsubj(effective-15, contraceptives-13)
advmod(effective-15, less-14)
xcomp(render-11, effective-15)

Sentence Id: DrugDDI.d20.s44
Studies/NNS with/IN other/JJ oral/JJ or/CC implant/JJ contraceptives/NNS have/VBP not/RB been/VBN conducted/VBN ./.

nsubjpass(conducted-11, Studies-1)
amod(contraceptives-7, other-3)
amod(contraceptives-7, oral-4)
conj_or(oral-4, implant-6)
prep_with(Studies-1, contraceptives-7)
aux(conducted-11, have-8)
neg(conducted-11, not-9)
auxpass(conducted-11, been-10)
root(ROOT-0, conducted-11)

Sentence Id: DrugDDI.d20.s45
Calcium/NN Antagonist/NN s/NN After/IN repeated/JJ co-administration/NN of/IN Trileptal/NN ,/, the/DT AUC/NN of/IN felodipine/NN was/VBD lowered/VBN by/IN 28/CD %/NN [90/CD %/NN CI/NN :/: 20-33/CD ]./NN

nn(s-3, Calcium-1)
nn(s-3, Antagonist-2)
npadvmod(lowered-15, s-3)
amod(co-administration-6, repeated-5)
prep_after(lowered-15, co-administration-6)
prep_of(co-administration-6, Trileptal-8)
det(AUC-11, the-10)
nsubjpass(lowered-15, AUC-11)
prep_of(AUC-11, felodipine-13)
auxpass(lowered-15, was-14)
root(ROOT-0, lowered-15)
num(%-18, 28-17)
agent(lowered-15, %-18)
number(%-20, -LSB-90-19)
amod(CI-21, %-20)
dep(%-18, CI-21)
num(-RSB-.-24, 20-33-23)
nsubjpass(lowered-15, -RSB-.-24)

Sentence Id: DrugDDI.d20.s46
Verapamil/NN produced/VBD a/DT decrease/NN of/IN 20/CD %/NN [90/CD %/NN CI/CD :/: 18-27/CD ]/-RRB- of/IN the/DT plasma/NN levels/NNS of/IN MHD/NN ./.

nsubj(produced-2, Verapamil-1)
root(ROOT-0, produced-2)
det(decrease-4, a-3)
dobj(produced-2, decrease-4)
num(%-9, 20-6)
nn(%-9, %-7)
num(%-9, -LSB-90-8)
prep_of(decrease-4, %-9)
num(%-9, CI-10)
num(%-9, 18-27-12)
punct(%-9, -RSB--13)
det(levels-17, the-15)
nn(levels-17, plasma-16)
prep_of(%-9, levels-17)
prep_of(levels-17, MHD-19)

Sentence Id: DrugDDI.d20.s47
Other/JJ drug/NN interactions/NNS Cimetidine/NN ,/, erythromycin/NN and/CC dextropropoxyphene/NN had/VBD no/DT effect/NN on/IN the/DT pharmacokinetics/NNS of/IN MHD/NN ./.

amod(interactions-3, Other-1)
nn(interactions-3, drug-2)
nsubj(had-9, interactions-3)
dep(interactions-3, Cimetidine-4)
conj_and(Cimetidine-4, erythromycin-6)
conj_and(Cimetidine-4, dextropropoxyphene-8)
root(ROOT-0, had-9)
det(effect-11, no-10)
dobj(had-9, effect-11)
det(pharmacokinetics-14, the-13)
prep_on(had-9, pharmacokinetics-14)
prep_of(pharmacokinetics-14, MHD-16)

Sentence Id: DrugDDI.d20.s48
Results/NNS with/IN warfarin/NN wshow/VBP no/DT evidence/NN of/IN interaction/NN with/IN either/CC single/JJ or/CC repeated/JJ doses/NNS of/IN Trileptal/NN ./.

nsubj(wshow-4, Results-1)
prep_with(Results-1, warfarin-3)
root(ROOT-0, wshow-4)
det(evidence-6, no-5)
dobj(wshow-4, evidence-6)
prep_of(evidence-6, interaction-8)
preconj(single-11, either-10)
amod(doses-14, single-11)
conj_or(single-11, repeated-13)
prep_with(interaction-8, doses-14)
prep_of(doses-14, Trileptal-16)

Sentence Id: DrugDDI.d480.s0
In/IN a/DT Phase/NN :/: I/NN trial/NN using/VBG escalating/JJ doses/NNS of/IN TAXOL/NN (/-LRB- 110-200/CD mg/m2/NN )/-RRB- and/CC cisplatin/NN (/-LRB- 50/CD or/CC 75/CD mg/m2/NN )/-RRB- given/VBN as/IN sequential/JJ infusions/NNS ,/, myelosuppression/NN was/VBD more/RBR profound/JJ when/WRB TAXOL/NN was/VBD given/VBN after/IN cisplatin/NN than/IN with/IN the/DT alternate/JJ sequence/NN (/-LRB- ie/FW ,/, TAXOL/NN before/IN cisplatin/NN )/-RRB- ./.

det(trial-6, a-2)
nn(trial-6, Phase-3)
nn(trial-6, I-5)
prep_in(profound-32, trial-6)
partmod(trial-6, using-7)
amod(doses-9, escalating-8)
dobj(using-7, doses-9)
prep_of(doses-9, TAXOL-11)
num(mg/m2-14, 110-200-13)
appos(TAXOL-11, mg/m2-14)
conj_and(TAXOL-11, cisplatin-17)
num(mg/m2-22, 50-19)
conj_or(50-19, 75-21)
appos(cisplatin-17, mg/m2-22)
partmod(doses-9, given-24)
amod(infusions-27, sequential-26)
prep_as(given-24, infusions-27)
nsubj(profound-32, myelosuppression-29)
cop(profound-32, was-30)
advmod(profound-32, more-31)
root(ROOT-0, profound-32)
advmod(given-36, when-33)
nsubjpass(given-36, TAXOL-34)
auxpass(given-36, was-35)
advcl(profound-32, given-36)
prep_after(given-36, cisplatin-38)
prep(given-36, than-39)
pcomp(than-39, with-40)
det(sequence-43, the-41)
amod(sequence-43, alternate-42)
prep_with(than-39, sequence-43)
dep(TAXOL-47, ie-45)
dep(sequence-43, TAXOL-47)
prep_before(TAXOL-47, cisplatin-49)

Sentence Id: DrugDDI.d480.s1
Pharmacokinetic/JJ data/NNS from/IN these/DT patients/NNS demonstrated/VBD a/DT decrease/NN in/IN paclitaxel/NN clearance/NN of/IN approximately/RB 33/CD %/NN when/WRB TAXOL/NN was/VBD administered/VBN following/VBG cisplatin/NN ./.

amod(data-2, Pharmacokinetic-1)
nsubj(demonstrated-6, data-2)
det(patients-5, these-4)
prep_from(data-2, patients-5)
root(ROOT-0, demonstrated-6)
det(decrease-8, a-7)
dobj(demonstrated-6, decrease-8)
nn(clearance-11, paclitaxel-10)
prep_in(decrease-8, clearance-11)
quantmod(33-14, approximately-13)
num(%-15, 33-14)
prep_of(clearance-11, %-15)
advmod(administered-19, when-16)
nsubjpass(administered-19, TAXOL-17)
auxpass(administered-19, was-18)
advcl(demonstrated-6, administered-19)
prep_following(administered-19, cisplatin-21)

Sentence Id: DrugDDI.d480.s2
The/DT metabolism/NN of/IN TAXOL/NN is/VBZ catalyzed/VBN by/IN cytochrome/NN P450/NN isoen-zymes/NNS CYP2C8/NN and/CC CYP3A4/NN ./.

det(metabolism-2, The-1)
nsubjpass(catalyzed-6, metabolism-2)
prep_of(metabolism-2, TAXOL-4)
auxpass(catalyzed-6, is-5)
root(ROOT-0, catalyzed-6)
nn(isoen-zymes-10, cytochrome-8)
nn(isoen-zymes-10, P450-9)
agent(catalyzed-6, isoen-zymes-10)
dep(isoen-zymes-10, CYP2C8-11)
conj_and(CYP2C8-11, CYP3A4-13)

Sentence Id: DrugDDI.d480.s3
In/IN the/DT absence/NN of/IN formal/JJ clinical/JJ drug/NN interaction/NN studies/NNS ,/, caution/NN should/MD be/VB exercised/VBN when/WRB administering/VBG TAXOL/NN concomitantly/RB with/IN known/JJ substrates/NNS or/CC inhibitors/NNS of/IN the/DT cytochrome/NN P450/NN isoenzymes/NNS CYP2C8/NN and/CC CYP3A4/NN ./.

dep(exercised-14, In-1)
dep(exercised-14, the-2)
dep(exercised-14, absence-3)
amod(studies-9, formal-5)
amod(studies-9, clinical-6)
nn(studies-9, drug-7)
nn(studies-9, interaction-8)
prep_of(exercised-14, studies-9)
nsubjpass(exercised-14, caution-11)
aux(exercised-14, should-12)
auxpass(exercised-14, be-13)
root(ROOT-0, exercised-14)
advmod(administering-16, when-15)
advcl(exercised-14, administering-16)
dobj(administering-16, TAXOL-17)
advmod(TAXOL-17, concomitantly-18)
amod(substrates-21, known-20)
prep_with(administering-16, substrates-21)
conj_or(substrates-21, inhibitors-23)
det(isoenzymes-28, the-25)
nn(isoenzymes-28, cytochrome-26)
nn(isoenzymes-28, P450-27)
prep_of(inhibitors-23, isoenzymes-28)
dep(isoenzymes-28, CYP2C8-29)
conj_and(CYP2C8-29, CYP3A4-31)

Sentence Id: DrugDDI.d480.s4
Potential/JJ interactions/NNS between/IN TAXOL/NN ,/, a/DT substrate/NN of/IN CYP3A4/NN ,/, and/CC protease/NN inhibitors/NNS (/-LRB- ritonavir/NN ,/, saquinavir/NN ,/, indinavir/NN ,/, and/CC nelfinavir/NN )/-RRB- ,/, which/WDT are/VBP substrates/NNS and/or/CC inhibitors/NNS of/IN CYP3A4/NN ,/, have/VBP not/RB been/VBN evaluated/VBN in/IN clinical/JJ trials/NNS ./.

amod(interactions-2, Potential-1)
nsubj(substrates-27, interactions-2)
nsubjpass(evaluated-36, interactions-2)
prep_between(interactions-2, TAXOL-4)
det(substrate-7, a-6)
appos(TAXOL-4, substrate-7)
prep_of(substrate-7, CYP3A4-9)
nn(inhibitors-13, protease-12)
conj_and(TAXOL-4, inhibitors-13)
dep(inhibitors-13, ritonavir-15)
conj_and(ritonavir-15, saquinavir-17)
conj_and(ritonavir-15, indinavir-19)
conj_and(ritonavir-15, nelfinavir-22)
cop(substrates-27, are-26)
rcmod(interactions-2, substrates-27)
conj_and/or(substrates-27, inhibitors-29)
prep_of(substrates-27, CYP3A4-31)
aux(evaluated-36, have-33)
neg(evaluated-36, not-34)
auxpass(evaluated-36, been-35)
root(ROOT-0, evaluated-36)
amod(trials-39, clinical-38)
prep_in(evaluated-36, trials-39)

Sentence Id: DrugDDI.d480.s5
Reports/NNS in/IN the/DT literature/NN suggest/VBP that/IN plasma/NN levels/NNS of/IN doxorubicin/NN (/-LRB- and/CC its/PRP$ active/JJ metabolite/NN doxorubicinol/NN )/-RRB- may/MD be/VB increased/VBN when/WRB paclitaxel/NN and/CC doxorubicin/NN are/VBP used/VBN in/IN combination/NN ./.

nsubj(suggest-5, Reports-1)
det(literature-4, the-3)
prep_in(Reports-1, literature-4)
root(ROOT-0, suggest-5)
complm(increased-20, that-6)
nn(levels-8, plasma-7)
nsubjpass(increased-20, levels-8)
prep_of(levels-8, doxorubicin-10)
poss(doxorubicinol-16, its-13)
amod(doxorubicinol-16, active-14)
nn(doxorubicinol-16, metabolite-15)
conj_and(levels-8, doxorubicinol-16)
aux(increased-20, may-18)
auxpass(increased-20, be-19)
ccomp(suggest-5, increased-20)
advmod(used-26, when-21)
nsubjpass(used-26, paclitaxel-22)
conj_and(paclitaxel-22, doxorubicin-24)
auxpass(used-26, are-25)
advcl(increased-20, used-26)
prep_in(used-26, combination-28)

Sentence Id: DrugDDI.d480.s6
Hematology/NNP :/: TAXOL/NN therapy/NN should/MD not/RB be/VB administered/VBN to/TO patients/NNS with/IN baseline/NN neutrophil/NN counts/NNS of/IN less/JJR than/IN 1,500/CD cells/mm3/NN ./.

root(ROOT-0, Hematology-1)
nn(therapy-4, TAXOL-3)
nsubjpass(administered-8, therapy-4)
aux(administered-8, should-5)
neg(administered-8, not-6)
auxpass(administered-8, be-7)
dep(Hematology-1, administered-8)
prep_to(administered-8, patients-10)
nn(counts-14, baseline-12)
nn(counts-14, neutrophil-13)
prep_with(patients-10, counts-14)
mwe(than-17, less-16)
quantmod(1,500-18, than-17)
num(cells/mm3-19, 1,500-18)
prep_of(counts-14, cells/mm3-19)

Sentence Id: DrugDDI.d480.s7
In/IN order/NN to/TO monitor/VB the/DT occurrence/NN of/IN myelotoxicity/NN ,/, it/PRP is/VBZ recommended/VBN that/IN frequent/JJ peripheral/JJ blood/NN cell/NN counts/NNS be/VB performed/VBN on/IN all/DT patients/NNS receiving/VBG TAXOL/NN ./.

mark(monitor-4, In-1)
dep(monitor-4, order-2)
aux(monitor-4, to-3)
dep(recommended-12, monitor-4)
det(occurrence-6, the-5)
dobj(monitor-4, occurrence-6)
prep_of(occurrence-6, myelotoxicity-8)
nsubjpass(recommended-12, it-10)
auxpass(recommended-12, is-11)
root(ROOT-0, recommended-12)
complm(performed-20, that-13)
amod(counts-18, frequent-14)
amod(counts-18, peripheral-15)
nn(counts-18, blood-16)
nn(counts-18, cell-17)
nsubjpass(performed-20, counts-18)
auxpass(performed-20, be-19)
ccomp(recommended-12, performed-20)
det(patients-23, all-22)
prep_on(performed-20, patients-23)
partmod(patients-23, receiving-24)
dobj(receiving-24, TAXOL-25)

Sentence Id: DrugDDI.d480.s8
Patients/NNS should/MD not/RB be/VB re-treated/VBN with/IN subsequent/JJ cycles/NNS of/IN TAXOL/NN until/IN neutrophils/NNS recover/VBP to/TO a/DT level/NN 1500/CD cells/mm3/NN and/CC platelets/NNS recover/VBP to/TO a/DT level/NN 100,000/CD cells/mm3/NN ./.

nsubjpass(re-treated-5, Patients-1)
aux(re-treated-5, should-2)
neg(re-treated-5, not-3)
auxpass(re-treated-5, be-4)
root(ROOT-0, re-treated-5)
amod(cycles-8, subsequent-7)
prep_with(re-treated-5, cycles-8)
prep_of(cycles-8, TAXOL-10)
mark(recover-13, until-11)
nsubj(recover-13, neutrophils-12)
advcl(re-treated-5, recover-13)
det(level-16, a-15)
prep_to(recover-13, level-16)
number(cells/mm3-18, 1500-17)
amod(level-16, cells/mm3-18)
nsubj(recover-21, platelets-20)
conj_and(recover-13, recover-21)
det(level-24, a-23)
prep_to(recover-21, level-24)
number(cells/mm3-26, 100,000-25)
amod(level-24, cells/mm3-26)

Sentence Id: DrugDDI.d480.s9
In/IN the/DT case/NN of/IN severe/JJ neutropenia/NN (/-LRB- 500/CD cells/mm3/NN for/IN seven/CD days/NNS or/CC more/JJR )/-RRB- during/IN a/DT course/NN of/IN TAXOL/NN therapy/NN ,/, a/DT 20/CD %/NN reduction/NN in/IN dose/NN for/IN subsequent/JJ courses/NNS of/IN therapy/NN is/VBZ recommended/VBN ./.

det(case-3, the-2)
prep_in(recommended-35, case-3)
amod(neutropenia-6, severe-5)
prep_of(case-3, neutropenia-6)
num(cells/mm3-9, 500-8)
dep(neutropenia-6, cells/mm3-9)
dep(cells/mm3-9, for-10)
num(days-12, seven-11)
pobj(for-10, days-12)
conj_or(days-12, more-14)
det(course-18, a-17)
prep_during(case-3, course-18)
nn(therapy-21, TAXOL-20)
prep_of(course-18, therapy-21)
det(reduction-26, a-23)
num(reduction-26, 20-24)
nn(reduction-26, %-25)
nsubjpass(recommended-35, reduction-26)
prep_in(reduction-26, dose-28)
amod(courses-31, subsequent-30)
prep_for(reduction-26, courses-31)
prep_of(courses-31, therapy-33)
auxpass(recommended-35, is-34)
root(ROOT-0, recommended-35)

Sentence Id: DrugDDI.d480.s10
For/IN patients/NNS with/IN advanced/JJ HIV/NN disease/NN and/CC poor-risk/JJ AIDS-related/JJ Kaposi/NN @/NN s/NN sarcoma/NN ,/, TAXOL/NN ,/, at/IN the/DT recommended/VBN dose/NN for/IN this/DT disease/NN ,/, can/MD be/VB initiated/VBN and/CC repeated/VBN if/IN the/DT neutrophil/NN count/NN is/VBZ at/IN least/JJS 1000/CD cells/mm3/NN ./.

prep_for(initiated-27, patients-2)
amod(disease-6, advanced-4)
nn(disease-6, HIV-5)
prep_with(patients-2, disease-6)
amod(sarcoma-13, poor-risk-8)
amod(sarcoma-13, AIDS-related-9)
nn(sarcoma-13, Kaposi-10)
nn(sarcoma-13, @-11)
nn(sarcoma-13, s-12)
conj_and(disease-6, sarcoma-13)
nsubjpass(initiated-27, TAXOL-15)
det(dose-20, the-18)
amod(dose-20, recommended-19)
prep_at(TAXOL-15, dose-20)
det(disease-23, this-22)
prep_for(dose-20, disease-23)
aux(initiated-27, can-25)
auxpass(initiated-27, be-26)
root(ROOT-0, initiated-27)
conj_and(initiated-27, repeated-29)
mark(cells/mm3-38, if-30)
det(count-33, the-31)
nn(count-33, neutrophil-32)
nsubj(cells/mm3-38, count-33)
cop(cells/mm3-38, is-34)
quantmod(1000-37, at-35)
mwe(at-35, least-36)
pobj(at-35, least-36)
num(cells/mm3-38, 1000-37)
advcl(repeated-29, cells/mm3-38)

Sentence Id: DrugDDI.d480.s11
Hypersensitivity/NN Reactions/NNS :/: Patients/NNS with/IN a/DT history/NN of/IN severe/JJ hypersensitivity/NN reactions/NNS to/TO products/NNS containing/VBG Cremophor/NN @/NN EL/NN (/-LRB- eg/NN ,/, cyclosporin/NN for/IN injection/NN concentrate/NN and/CC teniposide/NN for/IN injection/NN concentrate/NN )/-RRB- should/MD not/RB be/VB treated/VBN with/IN TAXOL/NN ./.

nn(Reactions-2, Hypersensitivity-1)
root(ROOT-0, Reactions-2)
nsubjpass(treated-34, Patients-4)
det(history-7, a-6)
prep_with(Patients-4, history-7)
amod(reactions-11, severe-9)
nn(reactions-11, hypersensitivity-10)
prep_of(history-7, reactions-11)
prep_to(reactions-11, products-13)
partmod(products-13, containing-14)
nn(EL-17, Cremophor-15)
nn(EL-17, @-16)
dobj(containing-14, EL-17)
dep(EL-17, eg-19)
appos(eg-19, cyclosporin-21)
prep_for(cyclosporin-21, injection-23)
dep(injection-23, concentrate-24)
conj_and(injection-23, teniposide-26)
nn(concentrate-29, injection-28)
prep_for(cyclosporin-21, concentrate-29)
aux(treated-34, should-31)
neg(treated-34, not-32)
auxpass(treated-34, be-33)
dep(Reactions-2, treated-34)
prep_with(treated-34, TAXOL-36)

Sentence Id: DrugDDI.d480.s12
In/IN order/NN to/TO avoid/VB the/DT occurrence/NN of/IN severe/JJ hypersensitivity/NN reactions/NNS ,/, all/DT patients/NNS treated/VBN with/IN TAXOL/NN should/MD be/VB premedicated/VBN with/IN corticosteroids/NNS (/-LRB- such/JJ as/IN dexamethasone/NN )/-RRB- ,/, diphen/NN -hydramine/NN and/CC H2/NN antagonists/NNS (/-LRB- such/JJ as/IN cimetidine/NN or/CC ranitidine/NN )/-RRB- ./.

mark(avoid-4, In-1)
dep(avoid-4, order-2)
aux(avoid-4, to-3)
dep(premedicated-19, avoid-4)
det(occurrence-6, the-5)
dobj(avoid-4, occurrence-6)
amod(reactions-10, severe-8)
nn(reactions-10, hypersensitivity-9)
prep_of(occurrence-6, reactions-10)
det(patients-13, all-12)
nsubjpass(premedicated-19, patients-13)
partmod(patients-13, treated-14)
prep_with(treated-14, TAXOL-16)
aux(premedicated-19, should-17)
auxpass(premedicated-19, be-18)
root(ROOT-0, premedicated-19)
prep_with(premedicated-19, corticosteroids-21)
dep(corticosteroids-21, such-23)
prep_as(such-23, dexamethasone-25)
nn(-hydramine-29, diphen-28)
conj_and(corticosteroids-21, -hydramine-29)
nn(antagonists-32, H2-31)
conj_and(corticosteroids-21, antagonists-32)
prep_such_as(antagonists-32, cimetidine-36)
conj_or(cimetidine-36, ranitidine-38)

Sentence Id: DrugDDI.d480.s14
However/RB ,/, severe/JJ reactions/NNS ,/, such/JJ as/IN hypotension/NN requiring/VBG treatment/NN ,/, dyspnea/NN requiring/VBG bronchodilators/NNS ,/, angioedema/NN ,/, or/CC generalized/JJ urticaria/NN require/VBP immediate/JJ discontinuation/NN of/IN TAXOL/NN and/CC aggressive/JJ symptomatic/JJ therapy/NN ./.

advmod(require-21, However-1)
amod(reactions-4, severe-3)
nsubj(require-21, reactions-4)
prep_such_as(reactions-4, hypotension-8)
partmod(hypotension-8, requiring-9)
dobj(requiring-9, treatment-10)
conj_or(treatment-10, dyspnea-12)
partmod(dyspnea-12, requiring-13)
dobj(requiring-13, bronchodilators-14)
conj_or(treatment-10, angioedema-16)
amod(urticaria-20, generalized-19)
conj_or(treatment-10, urticaria-20)
root(ROOT-0, require-21)
amod(discontinuation-23, immediate-22)
dobj(require-21, discontinuation-23)
prep_of(discontinuation-23, TAXOL-25)
amod(therapy-29, aggressive-27)
amod(therapy-29, symptomatic-28)
conj_and(TAXOL-25, therapy-29)

Sentence Id: DrugDDI.d480.s15
Patients/NNS who/WP have/VBP developed/VBN severe/JJ hypersensitivity/NN reactions/NNS should/MD not/RB be/VB rechallenged/VBN with/IN TAXOL/NN ./.

nsubj(developed-4, Patients-1)
nsubjpass(rechallenged-11, Patients-1)
aux(developed-4, have-3)
rcmod(Patients-1, developed-4)
amod(reactions-7, severe-5)
nn(reactions-7, hypersensitivity-6)
dobj(developed-4, reactions-7)
aux(rechallenged-11, should-8)
neg(rechallenged-11, not-9)
auxpass(rechallenged-11, be-10)
root(ROOT-0, rechallenged-11)
prep_with(rechallenged-11, TAXOL-13)

Sentence Id: DrugDDI.d480.s16
Cardiovascular/NN :/: Hypotension/NN ,/, bradycardia/NN ,/, and/CC hypertension/NN have/VBP been/VBN observed/VBN during/IN administration/NN of/IN TAXOL/NN ,/, but/CC generally/RB do/VBP not/RB require/VB treatment/NN ./.

root(ROOT-0, Cardiovascular-1)
nsubjpass(observed-11, Hypotension-3)
conj_and(Hypotension-3, bradycardia-5)
conj_and(Hypotension-3, hypertension-8)
aux(observed-11, have-9)
auxpass(observed-11, been-10)
dep(Cardiovascular-1, observed-11)
prep_during(observed-11, administration-13)
prep_of(administration-13, TAXOL-15)
advmod(require-21, generally-18)
aux(require-21, do-19)
neg(require-21, not-20)
conj_but(observed-11, require-21)
dobj(require-21, treatment-22)

Sentence Id: DrugDDI.d480.s17
Occasionally/RB TAXOL/NN infusions/NNS must/MD be/VB interrupted/VBN or/CC discontinued/VBD because/IN of/IN initial/JJ or/CC recurrent/JJ hypertension/NN ./.

advmod(interrupted-6, Occasionally-1)
nn(infusions-3, TAXOL-2)
nsubjpass(interrupted-6, infusions-3)
aux(interrupted-6, must-4)
auxpass(interrupted-6, be-5)
root(ROOT-0, interrupted-6)
conj_or(interrupted-6, discontinued-8)
amod(hypertension-14, initial-11)
conj_or(initial-11, recurrent-13)
prep_because_of(discontinued-8, hypertension-14)

Sentence Id: DrugDDI.d480.s18
Frequent/JJ vital/JJ sign/NN monitoring/NN ,/, particularly/RB during/IN the/DT first/JJ hour/NN of/IN TAXOL/NN infusion/NN ,/, is/VBZ recommended/VBN ./.

amod(monitoring-4, Frequent-1)
amod(monitoring-4, vital-2)
nn(monitoring-4, sign-3)
nsubjpass(recommended-16, monitoring-4)
advmod(monitoring-4, particularly-6)
det(hour-10, the-8)
amod(hour-10, first-9)
prep_during(monitoring-4, hour-10)
nn(infusion-13, TAXOL-12)
prep_of(hour-10, infusion-13)
auxpass(recommended-16, is-15)
root(ROOT-0, recommended-16)

Sentence Id: DrugDDI.d480.s20
Nervous/JJ System/NN :/: Although/IN the/DT occurrence/NN of/IN peripheral/JJ neuropathy/NN is/VBZ frequent/JJ ,/, the/DT development/NN of/IN severe/JJ symptomatology/NN is/VBZ unusual/JJ and/CC requires/VBZ a/DT dose/NN reduction/NN of/IN 20/CD %/NN for/IN all/DT subsequentcourses/NNS of/IN TAXOL/NN ./.

amod(System-2, Nervous-1)
root(ROOT-0, System-2)
mark(frequent-11, Although-4)
det(occurrence-6, the-5)
nsubj(frequent-11, occurrence-6)
amod(neuropathy-9, peripheral-8)
prep_of(occurrence-6, neuropathy-9)
cop(frequent-11, is-10)
advcl(unusual-19, frequent-11)
det(development-14, the-13)
nsubj(unusual-19, development-14)
amod(symptomatology-17, severe-16)
prep_of(development-14, symptomatology-17)
cop(unusual-19, is-18)
dep(System-2, unusual-19)
conj_and(unusual-19, requires-21)
det(reduction-24, a-22)
nn(reduction-24, dose-23)
dobj(requires-21, reduction-24)
num(%-27, 20-26)
prep_of(reduction-24, %-27)
det(subsequentcourses-30, all-29)
prep_for(reduction-24, subsequentcourses-30)
prep_of(subsequentcourses-30, TAXOL-32)

Sentence Id: DrugDDI.d480.s21
TAXOL/NN contains/VBZ dehydrated/JJ alcohol/NN USP/NN ,/, 396/CD mg/mL/NN ;/: ./.

nsubj(contains-2, TAXOL-1)
root(ROOT-0, contains-2)
amod(USP-5, dehydrated-3)
nn(USP-5, alcohol-4)
dobj(contains-2, USP-5)
num(mg/mL-8, 396-7)
appos(USP-5, mg/mL-8)

Sentence Id: DrugDDI.d480.s22
consideration/NN should/MD be/VB given/VBN to/TO possible/JJ CNS/NNS and/CC other/JJ effects/NNS of/IN alcohol/NN ./.

nsubjpass(given-4, consideration-1)
aux(given-4, should-2)
auxpass(given-4, be-3)
root(ROOT-0, given-4)
amod(CNS-7, possible-6)
prep_to(given-4, CNS-7)
amod(effects-10, other-9)
conj_and(CNS-7, effects-10)
prep_of(CNS-7, alcohol-12)

Sentence Id: DrugDDI.d480.s23
Hepatic/JJ :/: There/EX is/VBZ limited/JJ evidence/NN that/IN the/DT myelotoxicity/NN of/IN TAXOL/NN may/MD be/VB exacerbated/JJ in/IN patients/NNS with/IN serum/NN total/JJ bilirubin/NN 2/CD times/NNS ULN/NN ./.

root(ROOT-0, Hepatic-1)
expl(is-4, There-3)
dep(Hepatic-1, is-4)
amod(evidence-6, limited-5)
nsubj(is-4, evidence-6)
complm(exacerbated-14, that-7)
det(myelotoxicity-9, the-8)
nsubj(exacerbated-14, myelotoxicity-9)
prep_of(myelotoxicity-9, TAXOL-11)
aux(exacerbated-14, may-12)
cop(exacerbated-14, be-13)
ccomp(evidence-6, exacerbated-14)
prep_in(exacerbated-14, patients-16)
nn(ULN-23, serum-18)
amod(ULN-23, total-19)
nn(ULN-23, bilirubin-20)
num(ULN-23, 2-21)
nn(ULN-23, times-22)
prep_with(patients-16, ULN-23)

Sentence Id: DrugDDI.d480.s24
Extreme/JJ caution/NN should/MD be/VB exercised/VBN when/WRB administering/VBG TAXOL/NN to/TO such/JJ patients/NNS ,/, with/IN dose/NN reduction/NN as/IN recommended/VBN in/IN DOSAGE/NN AND/CC ADMINISTRATION/NN ,/, Table/NN 17/CD ./.

amod(caution-2, Extreme-1)
nsubjpass(exercised-5, caution-2)
aux(exercised-5, should-3)
auxpass(exercised-5, be-4)
root(ROOT-0, exercised-5)
advmod(administering-7, when-6)
advcl(exercised-5, administering-7)
dobj(administering-7, TAXOL-8)
amod(patients-11, such-10)
prep_to(TAXOL-8, patients-11)
nn(reduction-15, dose-14)
prep_with(exercised-5, reduction-15)
mark(recommended-17, as-16)
advcl(exercised-5, recommended-17)
prep_in(recommended-17, DOSAGE-19)
conj_and(DOSAGE-19, ADMINISTRATION-21)
appos(ADMINISTRATION-21, Table-23)
num(Table-23, 17-24)

Sentence Id: DrugDDI.d480.s27
Recurrence/NN of/IN skin/NN reactions/NNS at/IN a/DT site/NN of/IN previous/JJ extravasation/NN following/VBG administration/NN of/IN TAXOL/NN at/IN a/DT different/JJ site/NN ,/, ie/FW ,/, recall/NN ,/, has/VBZ been/VBN reported/VBN rarely/RB ./.

nsubjpass(reported-26, Recurrence-1)
nn(reactions-4, skin-3)
prep_of(Recurrence-1, reactions-4)
det(site-7, a-6)
prep_at(Recurrence-1, site-7)
amod(extravasation-10, previous-9)
prep_of(site-7, extravasation-10)
prep_following(site-7, administration-12)
prep_of(administration-12, TAXOL-14)
det(site-18, a-16)
amod(site-18, different-17)
prep_at(administration-12, site-18)
prep(Recurrence-1, ie-20)
pobj(ie-20, recall-22)
aux(reported-26, has-24)
auxpass(reported-26, been-25)
root(ROOT-0, reported-26)
advmod(reported-26, rarely-27)

Sentence Id: DrugDDI.d480.s28
Rare/JJ reports/NNS of/IN more/RBR severe/JJ events/NNS such/JJ as/IN phlebitis/NN ,/, cellulitis/NN ,/, induration/NN ,/, skin/NN exfoliation/NN ,/, necrosis/NN ,/, and/CC fibrosis/NN have/VBP been/VBN received/VBN as/IN part/NN of/IN the/DT continuing/VBG surveillance/NN of/IN TAXOL/NN safety/NN ./.

amod(reports-2, Rare-1)
nsubjpass(received-24, reports-2)
advmod(severe-5, more-4)
amod(events-6, severe-5)
prep_of(reports-2, events-6)
prep_such_as(events-6, phlebitis-9)
conj_and(phlebitis-9, cellulitis-11)
conj_and(phlebitis-9, induration-13)
nn(exfoliation-16, skin-15)
conj_and(phlebitis-9, exfoliation-16)
conj_and(phlebitis-9, necrosis-18)
conj_and(phlebitis-9, fibrosis-21)
aux(received-24, have-22)
auxpass(received-24, been-23)
root(ROOT-0, received-24)
prep_as(received-24, part-26)
det(surveillance-30, the-28)
amod(surveillance-30, continuing-29)
prep_of(part-26, surveillance-30)
nn(safety-33, TAXOL-32)
prep_of(surveillance-30, safety-33)

Sentence Id: DrugDDI.d235.s0
Aminoglycosides/NNS :/: The/DT mixing/NN of/IN piperacillin/NN with/IN an/DT aminoglycoside/NN in/IN vitro/FW can/MD result/VB in/IN substantial/JJ inactivation/NN of/IN the/DT aminoglycoside/NN ./.

root(ROOT-0, Aminoglycosides-1)
det(mixing-4, The-3)
nsubj(result-13, mixing-4)
prep_of(mixing-4, piperacillin-6)
det(aminoglycoside-9, an-8)
prep_with(mixing-4, aminoglycoside-9)
prep_in(aminoglycoside-9, vitro-11)
aux(result-13, can-12)
dep(Aminoglycosides-1, result-13)
amod(inactivation-16, substantial-15)
prep_in(result-13, inactivation-16)
det(aminoglycoside-19, the-18)
prep_of(inactivation-16, aminoglycoside-19)

Sentence Id: DrugDDI.d235.s1
Vecuronium/NN :/: When/WRB used/VBN in/IN the/DT perioperative/JJ period/NN ,/, piperacillin/NN has/VBZ been/VBN implicated/VBN in/IN the/DT prolongation/NN of/IN the/DT neuromuscular/JJ blockade/NN of/IN vecuronium/NN ./.

root(ROOT-0, Vecuronium-1)
advmod(used-4, When-3)
advcl(implicated-13, used-4)
det(period-8, the-6)
amod(period-8, perioperative-7)
prep_in(used-4, period-8)
nsubjpass(implicated-13, piperacillin-10)
aux(implicated-13, has-11)
auxpass(implicated-13, been-12)
dep(Vecuronium-1, implicated-13)
det(prolongation-16, the-15)
prep_in(implicated-13, prolongation-16)
det(blockade-20, the-18)
amod(blockade-20, neuromuscular-19)
prep_of(prolongation-16, blockade-20)
prep_of(blockade-20, vecuronium-22)

Sentence Id: DrugDDI.d235.s2
Caution/NN is/VBZ indicated/VBN when/WRB piperacillin/NN is/VBZ used/VBN perioperatively/NN ./.

nsubjpass(indicated-3, Caution-1)
auxpass(indicated-3, is-2)
root(ROOT-0, indicated-3)
advmod(used-7, when-4)
nsubjpass(used-7, piperacillin-5)
auxpass(used-7, is-6)
advcl(indicated-3, used-7)
dobj(used-7, perioperatively-8)

Sentence Id: DrugDDI.d235.s3
In/IN one/CD controlled/JJ clinical/JJ study/NN ,/, the/DT ureidopenicillins/NNS ,/, including/VBG piperacillin/NN ,/, were/VBD reported/VBN to/TO prolong/VB the/DT action/NN of/IN vecuronium/NN ./.

num(study-5, one-2)
amod(study-5, controlled-3)
amod(study-5, clinical-4)
prep_in(reported-14, study-5)
det(ureidopenicillins-8, the-7)
nsubjpass(reported-14, ureidopenicillins-8)
xsubj(prolong-16, ureidopenicillins-8)
prep_including(ureidopenicillins-8, piperacillin-11)
auxpass(reported-14, were-13)
root(ROOT-0, reported-14)
aux(prolong-16, to-15)
xcomp(reported-14, prolong-16)
det(action-18, the-17)
dobj(prolong-16, action-18)
prep_of(action-18, vecuronium-20)

Sentence Id: DrugDDI.d235.s4
Due/JJ to/TO their/PRP$ similar/JJ mechanism/NN of/IN action/NN ,/, it/PRP is/VBZ expected/VBN that/IN the/DT neuromuscular/JJ blockade/NN produced/VBN by/IN any/DT of/IN the/DT non-depolarizing/JJ muscle/NN relaxants/NNS could/MD be/VB prolonged/VBD in/IN the/DT presence/NN of/IN piperacillin/NN ./.

poss(mechanism-5, their-3)
amod(mechanism-5, similar-4)
prep_due_to(expected-11, mechanism-5)
prep_of(mechanism-5, action-7)
nsubjpass(expected-11, it-9)
auxpass(expected-11, is-10)
root(ROOT-0, expected-11)
complm(prolonged-26, that-12)
det(blockade-15, the-13)
amod(blockade-15, neuromuscular-14)
nsubjpass(prolonged-26, blockade-15)
partmod(blockade-15, produced-16)
agent(produced-16, any-18)
det(relaxants-23, the-20)
amod(relaxants-23, non-depolarizing-21)
nn(relaxants-23, muscle-22)
prep_of(any-18, relaxants-23)
aux(prolonged-26, could-24)
auxpass(prolonged-26, be-25)
ccomp(expected-11, prolonged-26)
det(presence-29, the-28)
prep_in(prolonged-26, presence-29)
prep_of(presence-29, piperacillin-31)

Sentence Id: DrugDDI.d235.s5
Probenecid/NN :/: The/DT oral/JJ combination/NN of/IN probenecid/NN before/IN intramuscular/JJ injection/NN of/IN PIPRACIL/NN produces/VBZ an/DT increase/NN in/IN piperacillin/JJ peak/JJ serum/NN level/NN of/IN about/RB 30/CD %./NN

root(ROOT-0, Probenecid-1)
det(combination-5, The-3)
amod(combination-5, oral-4)
nsubj(produces-13, combination-5)
prep_of(combination-5, probenecid-7)
amod(injection-10, intramuscular-9)
prep_before(combination-5, injection-10)
prep_of(injection-10, PIPRACIL-12)
dep(Probenecid-1, produces-13)
det(increase-15, an-14)
dobj(produces-13, increase-15)
amod(level-20, piperacillin-17)
amod(level-20, peak-18)
nn(level-20, serum-19)
prep_in(increase-15, level-20)
quantmod(30-23, about-22)
num(%.-24, 30-23)
prep_of(level-20, %.-24)

Sentence Id: DrugDDI.d235.s6
Anticoagulants/NNS Coagulation/NN parameters/NNS should/MD be/VB tested/VBN more/RBR frequently/RB and/CC monitored/VBN regularly/RB during/IN simultaneous/JJ administration/NN of/IN high/JJ doses/NNS of/IN heparin/NN ,/, oral/JJ anticoagulants/NNS ,/, or/CC other/JJ drugs/NNS that/WDT may/MD affect/VB the/DT blood/NN coagulation/NN system/NN or/CC the/DT thrombocyte/JJ function/NN ./.

nn(parameters-3, Anticoagulants-1)
nn(parameters-3, Coagulation-2)
nsubjpass(tested-6, parameters-3)
aux(tested-6, should-4)
auxpass(tested-6, be-5)
root(ROOT-0, tested-6)
advmod(frequently-8, more-7)
advmod(tested-6, frequently-8)
conj_and(tested-6, monitored-10)
advmod(monitored-10, regularly-11)
amod(administration-14, simultaneous-13)
prep_during(monitored-10, administration-14)
amod(doses-17, high-16)
prep_of(administration-14, doses-17)
prep_of(doses-17, heparin-19)
amod(anticoagulants-22, oral-21)
conj_or(administration-14, anticoagulants-22)
amod(drugs-26, other-25)
conj_or(administration-14, drugs-26)
nsubj(affect-29, drugs-26)
aux(affect-29, may-28)
rcmod(drugs-26, affect-29)
det(system-33, the-30)
nn(system-33, blood-31)
nn(system-33, coagulation-32)
dobj(affect-29, system-33)
det(function-37, the-35)
amod(function-37, thrombocyte-36)
conj_or(administration-14, function-37)

Sentence Id: DrugDDI.d235.s7
Methotrexate/NN Piperacillin/NN sodium/NN may/MD reduce/VB the/DT excretion/NN of/IN methotrexate/NN ./.

nn(sodium-3, Methotrexate-1)
nn(sodium-3, Piperacillin-2)
nsubj(reduce-5, sodium-3)
aux(reduce-5, may-4)
root(ROOT-0, reduce-5)
det(excretion-7, the-6)
dobj(reduce-5, excretion-7)
prep_of(excretion-7, methotrexate-9)

Sentence Id: DrugDDI.d235.s8
Therefore/RB ,/, serum/NN levels/NNS of/IN methotrexate/NN should/MD be/VB monitored/VBN in/IN patients/NNS to/TO avoid/VB drug/NN toxicity/NN ./.

advmod(monitored-9, Therefore-1)
nn(levels-4, serum-3)
nsubjpass(monitored-9, levels-4)
xsubj(avoid-13, levels-4)
prep_of(levels-4, methotrexate-6)
aux(monitored-9, should-7)
auxpass(monitored-9, be-8)
root(ROOT-0, monitored-9)
prep_in(monitored-9, patients-11)
aux(avoid-13, to-12)
xcomp(monitored-9, avoid-13)
nn(toxicity-15, drug-14)
dobj(avoid-13, toxicity-15)

Sentence Id: DrugDDI.d235.s9
Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: As/IN with/IN other/JJ penicillins/NNS ,/, the/DT administration/NN of/IN PIPRACIL/NN may/MD result/VB in/IN a/DT false-positive/JJ reaction/NN for/IN glucose/NN in/IN the/DT urine/NN using/VBG a/DT copper/NN -reduction/NN method/NN ./.

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
prep(result-16, As-6)
pcomp(As-6, with-7)
amod(penicillins-9, other-8)
prep_with(As-6, penicillins-9)
det(administration-12, the-11)
nsubj(result-16, administration-12)
prep_of(administration-12, PIPRACIL-14)
aux(result-16, may-15)
dep(Interactions-4, result-16)
det(reaction-20, a-18)
amod(reaction-20, false-positive-19)
prep_in(result-16, reaction-20)
prep_for(reaction-20, glucose-22)
det(urine-25, the-24)
prep_in(reaction-20, urine-25)
partmod(urine-25, using-26)
det(method-30, a-27)
nn(method-30, copper-28)
nn(method-30, -reduction-29)
dobj(using-26, method-30)

Sentence Id: DrugDDI.d235.s10
It/PRP is/VBZ recommended/VBN that/IN glucose/NN tests/NNS based/VBN on/IN enzymatic/JJ glucose/NN oxidase/NN reactions/NNS be/VB used/VBN ./.

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(used-14, that-4)
nn(tests-6, glucose-5)
nsubjpass(used-14, tests-6)
partmod(tests-6, based-7)
amod(reactions-12, enzymatic-9)
nn(reactions-12, glucose-10)
nn(reactions-12, oxidase-11)
prep_on(based-7, reactions-12)
auxpass(used-14, be-13)
ccomp(recommended-3, used-14)

Sentence Id: DrugDDI.d235.s11
There/EX have/VBP been/VBN reports/NNS of/IN positive/JJ test/NN results/NNS using/VBG the/DT Bio-Rad/JJ Laboratories/NNS Platelia/NN Aspergillus/NN EIA/NN test/NN in/IN patients/NNS receiving/VBG piperacillin/NN //: tazobactam/NN injection/NN who/WP were/VBD subsequently/RB found/VBN to/TO be/VB free/JJ of/IN Aspergillus/JJ infection/NN ./.

expl(reports-4, There-1)
aux(reports-4, have-2)
cop(reports-4, been-3)
root(ROOT-0, reports-4)
amod(results-8, positive-6)
nn(results-8, test-7)
prep_of(reports-4, results-8)
xcomp(reports-4, using-9)
det(test-16, the-10)
amod(Laboratories-12, Bio-Rad-11)
nn(test-16, Laboratories-12)
nn(test-16, Platelia-13)
nn(test-16, Aspergillus-14)
nn(test-16, EIA-15)
dobj(using-9, test-16)
prep_in(test-16, patients-18)
nsubjpass(found-27, patients-18)
partmod(patients-18, receiving-19)
nn(injection-23, piperacillin-20)
punct(injection-23, /-21)
nn(injection-23, tazobactam-22)
dobj(receiving-19, injection-23)
auxpass(found-27, were-25)
advmod(found-27, subsequently-26)
rcmod(patients-18, found-27)
aux(free-30, to-28)
cop(free-30, be-29)
xcomp(found-27, free-30)
amod(infection-33, Aspergillus-32)
prep_of(free-30, infection-33)

Sentence Id: DrugDDI.d235.s12
Cross-reactions/NNS with/IN non-Aspergillus/JJ polysaccharides/NNS and/CC polyfuranoses/NNS with/IN the/DT Bio-Rad/JJ Laboratories/NNS Platelia/FW Aspergillus/FW EIA/NN test/NN have/VBP been/VBN reported/VBN ./.

nsubjpass(reported-17, Cross-reactions-1)
amod(polysaccharides-4, non-Aspergillus-3)
prep_with(Cross-reactions-1, polysaccharides-4)
conj_and(Cross-reactions-1, polyfuranoses-6)
det(Laboratories-10, the-8)
amod(Laboratories-10, Bio-Rad-9)
prep_with(polyfuranoses-6, Laboratories-10)
nn(Aspergillus-12, Platelia-11)
amod(test-14, Aspergillus-12)
nn(test-14, EIA-13)
dep(Cross-reactions-1, test-14)
aux(reported-17, have-15)
auxpass(reported-17, been-16)
root(ROOT-0, reported-17)

Sentence Id: DrugDDI.d235.s13
Therefore/RB ,/, positive/JJ test/NN results/NNS in/IN patients/NNS receiving/VBG piperacillin/NN should/MD be/VB interpreted/VBN cautiously/RB and/CC confirmed/VBN by/IN other/JJ diagnostic/JJ methods/NNS ./.

advmod(interpreted-12, Therefore-1)
amod(results-5, positive-3)
nn(results-5, test-4)
nsubjpass(interpreted-12, results-5)
prep_in(results-5, patients-7)
partmod(patients-7, receiving-8)
dobj(receiving-8, piperacillin-9)
aux(interpreted-12, should-10)
auxpass(interpreted-12, be-11)
root(ROOT-0, interpreted-12)
advmod(interpreted-12, cautiously-13)
conj_and(interpreted-12, confirmed-15)
amod(methods-19, other-17)
amod(methods-19, diagnostic-18)
prep_by(confirmed-15, methods-19)

Sentence Id: DrugDDI.d253.s0
Effect/NN of/IN other/JJ drugs/NNS on/IN Vardenafil/NN ./.

root(ROOT-0, Effect-1)
amod(drugs-4, other-3)
prep_of(Effect-1, drugs-4)
prep_on(Effect-1, Vardenafil-6)

Sentence Id: DrugDDI.d253.s1
In/FW vitro/FW studies/NNS :/: Studies/NNS in/IN human/JJ liver/NN microsomes/NNS showed/VBD that/IN vardenafil/NN is/VBZ metabolized/VBN primarily/RB by/IN cytochrome/NN P450/NN (/-LRB- CYP/NN )/-RRB- isoforms/NNS 3A4/5/NN ,/, and/CC to/TO a/DT lesser/JJR degree/NN by/IN CYP2C9/NN ./.

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
root(ROOT-0, studies-3)
nsubj(showed-10, Studies-5)
amod(microsomes-9, human-7)
nn(microsomes-9, liver-8)
prep_in(Studies-5, microsomes-9)
dep(studies-3, showed-10)
complm(metabolized-14, that-11)
nsubjpass(metabolized-14, vardenafil-12)
auxpass(metabolized-14, is-13)
ccomp(showed-10, metabolized-14)
advmod(metabolized-14, primarily-15)
nn(P450-18, cytochrome-17)
nn(3A4/5-23, P450-18)
abbrev(P450-18, CYP-20)
nn(3A4/5-23, isoforms-22)
agent(metabolized-14, 3A4/5-23)
conj_and(metabolized-14, to-26)
det(degree-29, a-27)
amod(degree-29, lesser-28)
prep_to(metabolized-14, degree-29)
agent(metabolized-14, CYP2C9-31)

Sentence Id: DrugDDI.d253.s2
Therefore/RB ,/, inhibitors/NNS of/IN these/DT enzymes/NNS are/VBP expected/VBN to/TO reduce/VB vardenafil/NN clearance/NN ./.

advmod(expected-8, Therefore-1)
nsubjpass(expected-8, inhibitors-3)
xsubj(reduce-10, inhibitors-3)
det(enzymes-6, these-5)
prep_of(inhibitors-3, enzymes-6)
auxpass(expected-8, are-7)
root(ROOT-0, expected-8)
aux(reduce-10, to-9)
xcomp(expected-8, reduce-10)
nn(clearance-12, vardenafil-11)
dobj(reduce-10, clearance-12)

Sentence Id: DrugDDI.d253.s3
In/FW vivo/FW studies/NNS :/: Cytochrome/NN P450/NN Inhibitors/NNS ./.

nn(vivo-2, In-1)
amod(studies-3, vivo-2)
dep(Inhibitors-7, studies-3)
nn(Inhibitors-7, Cytochrome-5)
nn(Inhibitors-7, P450-6)
root(ROOT-0, Inhibitors-7)

Sentence Id: DrugDDI.d253.s4
Cimetidine/NN (/-LRB- 400/CD mg/NN b.i.d./NN )/-RRB- had/VBD no/DT effect/NN on/IN vardenafil/NN bioavailability/NN (/-LRB- AUC/NN )/-RRB- and/CC maximum/NN concentration/NN (/-LRB- Cmax/NN )/-RRB- of/IN vardenafil/NN when/WRB co-administered/VBN with/IN 20/CD mg/NN Vardenafil/NN in/IN healthy/JJ volunteers/NNS ./.

nsubj(had-7, Cimetidine-1)
number(mg-4, 400-3)
amod(b.i.d.-5, mg-4)
appos(Cimetidine-1, b.i.d.-5)
root(ROOT-0, had-7)
det(effect-9, no-8)
dobj(had-7, effect-9)
nn(bioavailability-12, vardenafil-11)
prep_on(effect-9, bioavailability-12)
abbrev(bioavailability-12, AUC-14)
nn(concentration-18, maximum-17)
conj_and(bioavailability-12, concentration-18)
appos(concentration-18, Cmax-20)
prep_of(effect-9, vardenafil-23)
advmod(co-administered-25, when-24)
advcl(had-7, co-administered-25)
num(Vardenafil-29, 20-27)
nn(Vardenafil-29, mg-28)
prep_with(co-administered-25, Vardenafil-29)
amod(volunteers-32, healthy-31)
prep_in(co-administered-25, volunteers-32)

Sentence Id: DrugDDI.d253.s5
Erythromycin/NN (/-LRB- 500/CD mg/NN t.i.d/CD )/-RRB- produced/VBD a/DT 4-fold/JJ increase/NN in/IN vardenafil/NN AUC/NN and/CC a/DT 3-fold/JJ increase/NN in/IN Cmax/NN when/WRB co-administered/VBN with/IN Vardenafil/NN 5/CD mg/NN in/IN healthy/JJ volunteers/NNS ./.

nsubj(produced-7, Erythromycin-1)
num(mg-4, 500-3)
appos(Erythromycin-1, mg-4)
num(mg-4, t.i.d-5)
root(ROOT-0, produced-7)
det(increase-10, a-8)
amod(increase-10, 4-fold-9)
dobj(produced-7, increase-10)
nn(AUC-13, vardenafil-12)
prep_in(increase-10, AUC-13)
det(increase-17, a-15)
amod(increase-17, 3-fold-16)
conj_and(increase-10, increase-17)
prep_in(increase-17, Cmax-19)
advmod(co-administered-21, when-20)
advcl(produced-7, co-administered-21)
nn(mg-25, Vardenafil-23)
num(mg-25, 5-24)
prep_with(co-administered-21, mg-25)
amod(volunteers-28, healthy-27)
prep_in(mg-25, volunteers-28)

Sentence Id: DrugDDI.d253.s6
It/PRP is/VBZ recommended/VBN not/RB to/TO exceed/VB a/DT single/JJ 5/CD mg/NN dose/NN of/IN Vardenafil/NN in/IN a/DT 24-hour/JJ period/NN when/WRB used/VBN in/IN combination/NN with/IN erythromycin/NN ./.

nsubjpass(recommended-3, It-1)
xsubj(exceed-6, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
neg(exceed-6, not-4)
aux(exceed-6, to-5)
ccomp(recommended-3, exceed-6)
xcomp(recommended-3, exceed-6)
det(dose-11, a-7)
amod(dose-11, single-8)
number(mg-10, 5-9)
amod(dose-11, mg-10)
dobj(exceed-6, dose-11)
prep_of(dose-11, Vardenafil-13)
det(period-17, a-15)
amod(period-17, 24-hour-16)
prep_in(exceed-6, period-17)
advmod(used-19, when-18)
dep(period-17, used-19)
prep_in(used-19, combination-21)
prep_with(combination-21, erythromycin-23)

Sentence Id: DrugDDI.d253.s7
Ketoconazole/NN (/-LRB- 200/CD mg/NN once/RB daily/JJ )/-RRB- produced/VBD a/DT 10-fold/JJ increase/NN in/IN vardenafil/NN AUC/NN and/CC a/DT 4-fold/JJ increase/NN in/IN Cmax/NN when/WRB co-administered/VBN with/IN Vardenafil/NN (/-LRB- 5/CD mg/NN )/-RRB- in/IN healthy/JJ volunteers/NNS ./.

nsubj(produced-8, Ketoconazole-1)
num(mg-4, 200-3)
dep(Ketoconazole-1, mg-4)
advmod(daily-6, once-5)
amod(mg-4, daily-6)
root(ROOT-0, produced-8)
det(increase-11, a-9)
amod(increase-11, 10-fold-10)
dobj(produced-8, increase-11)
nn(AUC-14, vardenafil-13)
prep_in(increase-11, AUC-14)
det(increase-18, a-16)
amod(increase-18, 4-fold-17)
conj_and(increase-11, increase-18)
prep_in(increase-18, Cmax-20)
advmod(co-administered-22, when-21)
advcl(produced-8, co-administered-22)
prep_with(co-administered-22, Vardenafil-24)
num(mg-27, 5-26)
appos(Vardenafil-24, mg-27)
amod(volunteers-31, healthy-30)
prep_in(Vardenafil-24, volunteers-31)

Sentence Id: DrugDDI.d253.s8
A/DT 5-mg/JJ Vardenafil/NN dose/NN should/MD not/RB be/VB exceeded/VBD when/WRB used/VBN in/IN combination/NN with/IN 200/CD mg/NN once/IN daily/JJ ketoconazole/NN ./.

det(dose-4, A-1)
amod(dose-4, 5-mg-2)
nn(dose-4, Vardenafil-3)
nsubjpass(exceeded-8, dose-4)
aux(exceeded-8, should-5)
neg(exceeded-8, not-6)
auxpass(exceeded-8, be-7)
root(ROOT-0, exceeded-8)
advmod(used-10, when-9)
advcl(exceeded-8, used-10)
prep_in(used-10, combination-12)
num(mg-15, 200-14)
prep_with(combination-12, mg-15)
amod(ketoconazole-18, daily-17)
prep_once(mg-15, ketoconazole-18)

Sentence Id: DrugDDI.d253.s9
Since/IN higher/JJR doses/NNS of/IN ketoconazole/NN (/-LRB- 400/CD mg/NN daily/RB )/-RRB- may/MD result/VB in/IN higher/JJR increases/NNS in/IN Cmax/NN and/CC AUC/NN ,/, a/DT single/JJ 2.5/CD mg/NN dose/NN of/IN Vardenafil/NN should/MD not/RB be/VB exceeded/VBD in/IN a/DT 24-hour/JJ period/NN when/WRB used/VBN in/IN combination/NN with/IN ketoconazole/NN 400/CD mg/NN daily/RB ./.

mark(result-12, Since-1)
amod(doses-3, higher-2)
nsubj(result-12, doses-3)
prep_of(doses-3, ketoconazole-5)
num(mg-8, 400-7)
dep(doses-3, mg-8)
advmod(mg-8, daily-9)
aux(result-12, may-11)
advcl(exceeded-31, result-12)
amod(increases-15, higher-14)
prep_in(result-12, increases-15)
prep_in(increases-15, Cmax-17)
conj_and(Cmax-17, AUC-19)
det(dose-25, a-21)
amod(dose-25, single-22)
number(mg-24, 2.5-23)
amod(dose-25, mg-24)
nsubjpass(exceeded-31, dose-25)
prep_of(dose-25, Vardenafil-27)
aux(exceeded-31, should-28)
neg(exceeded-31, not-29)
auxpass(exceeded-31, be-30)
root(ROOT-0, exceeded-31)
det(period-35, a-33)
amod(period-35, 24-hour-34)
prep_in(exceeded-31, period-35)
advmod(used-37, when-36)
advcl(exceeded-31, used-37)
prep_in(used-37, combination-39)
nn(mg-43, ketoconazole-41)
num(mg-43, 400-42)
prep_with(combination-39, mg-43)
advmod(mg-43, daily-44)

Sentence Id: DrugDDI.d253.s10
HIV/NN Protease/NN Inhibitors/NNS :/: Indinavir/NN (/-LRB- 800/CD mg/NN t.i.d./NN )/-RRB- co-administered/VBN with/IN Vardenafil/NN 10/CD mg/NN resulted/VBD in/IN a/DT 16-fold/JJ increase/NN in/IN vardenafil/NN AUC/NN ,/, a/DT 7-fold/JJ increase/NN in/IN vardenafil/NN Cmax/NN and/CC a/DT 2-fold/JJ increase/NN in/IN vardenafil/NN half-life/NN ./.

nn(Inhibitors-3, HIV-1)
nn(Inhibitors-3, Protease-2)
nsubj(resulted-16, Inhibitors-3)
dep(Inhibitors-3, Indinavir-5)
number(mg-8, 800-7)
amod(t.i.d.-9, mg-8)
appos(Indinavir-5, t.i.d.-9)
partmod(Inhibitors-3, co-administered-11)
prep_with(co-administered-11, Vardenafil-13)
number(mg-15, 10-14)
amod(Vardenafil-13, mg-15)
root(ROOT-0, resulted-16)
det(increase-20, a-18)
amod(increase-20, 16-fold-19)
prep_in(resulted-16, increase-20)
nn(AUC-23, vardenafil-22)
prep_in(increase-20, AUC-23)
det(increase-27, a-25)
amod(increase-27, 7-fold-26)
conj_and(increase-20, increase-27)
nn(Cmax-30, vardenafil-29)
prep_in(increase-27, Cmax-30)
det(increase-34, a-32)
amod(increase-34, 2-fold-33)
conj_and(increase-20, increase-34)
nn(half-life-37, vardenafil-36)
prep_in(increase-34, half-life-37)

Sentence Id: DrugDDI.d253.s11
It/PRP is/VBZ recommended/VBN not/RB to/TO exceed/VB a/DT single/JJ 2.5/CD mg/NN Vardenafil/NN dose/NN in/IN a/DT 24-hour/JJ period/NN when/WRB used/VBN in/IN combination/NN with/IN indinavir/NN ./.

nsubjpass(recommended-3, It-1)
xsubj(exceed-6, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
neg(exceed-6, not-4)
aux(exceed-6, to-5)
ccomp(recommended-3, exceed-6)
xcomp(recommended-3, exceed-6)
det(dose-12, a-7)
amod(dose-12, single-8)
number(mg-10, 2.5-9)
amod(dose-12, mg-10)
nn(dose-12, Vardenafil-11)
dobj(exceed-6, dose-12)
det(period-16, a-14)
amod(period-16, 24-hour-15)
prep_in(exceed-6, period-16)
advmod(used-18, when-17)
dep(period-16, used-18)
prep_in(used-18, combination-20)
prep_with(combination-20, indinavir-22)

Sentence Id: DrugDDI.d253.s12
Ritonavir/NN (/-LRB- 600/CD mg/NN b.i.d./NN )/-RRB- co-administered/VBN with/IN Vardenafil/NN 5/CD mg/NN resulted/VBD in/IN a/DT 49-fold/JJ increase/NN in/IN vardenafil/NN AUC/NN and/CC a/DT 13-fold/RB increase/NN in/IN vardenafil/NN Cmax/NN ./.

nsubj(resulted-12, Ritonavir-1)
number(mg-4, 600-3)
amod(b.i.d.-5, mg-4)
appos(Ritonavir-1, b.i.d.-5)
partmod(Ritonavir-1, co-administered-7)
nn(mg-11, Vardenafil-9)
num(mg-11, 5-10)
prep_with(co-administered-7, mg-11)
root(ROOT-0, resulted-12)
det(increase-16, a-14)
amod(increase-16, 49-fold-15)
prep_in(resulted-12, increase-16)
nn(AUC-19, vardenafil-18)
prep_in(increase-16, AUC-19)
det(increase-23, a-21)
amod(increase-23, 13-fold-22)
conj_and(increase-16, increase-23)
nn(Cmax-26, vardenafil-25)
prep_in(increase-23, Cmax-26)

Sentence Id: DrugDDI.d253.s13
The/DT interaction/NN is/VBZ a/DT consequence/NN of/IN blocking/VBG hepatic/JJ metabolism/NN of/IN vardenafil/NN by/IN ritonavir/NN ,/, a/DT highly/RB potent/JJ CYP3A4/NN inhibitor/NN ,/, which/WDT also/RB inhibits/VBZ CYP2C9/NN ./.

det(interaction-2, The-1)
nsubj(consequence-5, interaction-2)
cop(consequence-5, is-3)
det(consequence-5, a-4)
root(ROOT-0, consequence-5)
prepc_of(consequence-5, blocking-7)
amod(metabolism-9, hepatic-8)
dobj(blocking-7, metabolism-9)
prep_of(metabolism-9, vardenafil-11)
prep_by(blocking-7, ritonavir-13)
det(inhibitor-19, a-15)
advmod(potent-17, highly-16)
amod(inhibitor-19, potent-17)
nn(inhibitor-19, CYP3A4-18)
appos(ritonavir-13, inhibitor-19)
nsubj(inhibits-23, inhibitor-19)
advmod(inhibits-23, also-22)
rcmod(inhibitor-19, inhibits-23)
dobj(inhibits-23, CYP2C9-24)

Sentence Id: DrugDDI.d253.s14
Ritonavir/NN significantly/RB prolonged/VBD the/DT half-life/NN of/IN vardenafil/NN to/TO 26/CD hours/NNS ./.

nsubj(prolonged-3, Ritonavir-1)
advmod(prolonged-3, significantly-2)
root(ROOT-0, prolonged-3)
det(half-life-5, the-4)
dobj(prolonged-3, half-life-5)
prep_of(half-life-5, vardenafil-7)
num(hours-10, 26-9)
prep_to(half-life-5, hours-10)

Sentence Id: DrugDDI.d253.s15
Consequently/RB ,/, it/PRP is/VBZ recommended/VBN not/RB to/TO exceed/VB a/DT single/JJ 2.5/CD mg/NN Vardenafil/NN dose/NN in/IN a/DT 72-hour/JJ period/NN when/WRB used/VBN in/IN combination/NN with/IN ritonavir/NN ./.

advmod(recommended-5, Consequently-1)
nsubjpass(recommended-5, it-3)
xsubj(exceed-8, it-3)
auxpass(recommended-5, is-4)
root(ROOT-0, recommended-5)
neg(exceed-8, not-6)
aux(exceed-8, to-7)
ccomp(recommended-5, exceed-8)
xcomp(recommended-5, exceed-8)
det(dose-14, a-9)
amod(dose-14, single-10)
number(mg-12, 2.5-11)
amod(dose-14, mg-12)
nn(dose-14, Vardenafil-13)
dobj(exceed-8, dose-14)
det(period-18, a-16)
amod(period-18, 72-hour-17)
prep_in(exceed-8, period-18)
advmod(used-20, when-19)
dep(period-18, used-20)
prep_in(used-20, combination-22)
prep_with(combination-22, ritonavir-24)

Sentence Id: DrugDDI.d253.s16
Other/JJ Drug/NN Interactions/NNS :/: No/DT pharmacokinetic/JJ interactions/NNS were/VBD observed/VBN between/IN vardenafil/NN and/CC the/DT following/JJ drugs/NNS :/: glyburide/NN ,/, warfarin/NN ,/, digoxin/NN ,/, Maalox/NN ,/, and/CC ranitidine/NN ./.

amod(Interactions-3, Other-1)
nn(Interactions-3, Drug-2)
root(ROOT-0, Interactions-3)
det(interactions-7, No-5)
amod(interactions-7, pharmacokinetic-6)
nsubjpass(observed-9, interactions-7)
auxpass(observed-9, were-8)
dep(Interactions-3, observed-9)
prep_between(observed-9, vardenafil-11)
det(drugs-15, the-13)
amod(drugs-15, following-14)
conj_and(vardenafil-11, drugs-15)
dep(Interactions-3, glyburide-17)
conj_and(glyburide-17, warfarin-19)
conj_and(glyburide-17, digoxin-21)
conj_and(glyburide-17, Maalox-23)
conj_and(glyburide-17, ranitidine-26)

Sentence Id: DrugDDI.d253.s17
In/IN the/DT warfarin/JJ study/NN ,/, vardenafil/NN had/VBD no/DT effect/NN on/IN the/DT prothrombin/NN time/NN or/CC other/JJ pharmacodynamic/JJ parameters/NNS ./.

det(study-4, the-2)
amod(study-4, warfarin-3)
prep_in(had-7, study-4)
nsubj(had-7, vardenafil-6)
root(ROOT-0, had-7)
det(effect-9, no-8)
dobj(had-7, effect-9)
det(time-13, the-11)
nn(time-13, prothrombin-12)
prep_on(had-7, time-13)
amod(parameters-17, other-15)
amod(parameters-17, pharmacodynamic-16)
conj_or(time-13, parameters-17)

Sentence Id: DrugDDI.d253.s18
Effects/NNS of/IN Vardenafil/NN on/IN other/JJ drugs/NNS ./.

root(ROOT-0, Effects-1)
prep_of(Effects-1, Vardenafil-3)
amod(drugs-6, other-5)
prep_on(Effects-1, drugs-6)

Sentence Id: DrugDDI.d253.s19
In/FW vitro/FW studies/NNS :/: Vardenafil/NN and/CC its/PRP$ metabolites/NNS had/VBD no/DT effect/NN on/IN CYP1A2/NN ,/, 2A6/NN ,/, and/CC 2E1/NN (/-LRB- Ki/NN 100uM/NN )/-RRB- ./.

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
root(ROOT-0, studies-3)
nsubj(had-9, Vardenafil-5)
poss(metabolites-8, its-7)
conj_and(Vardenafil-5, metabolites-8)
dep(studies-3, had-9)
det(effect-11, no-10)
dobj(had-9, effect-11)
prep_on(had-9, CYP1A2-13)
conj_and(CYP1A2-13, 2A6-15)
conj_and(CYP1A2-13, 2E1-18)
nn(100uM-21, Ki-20)
appos(2E1-18, 100uM-21)

Sentence Id: DrugDDI.d253.s20
Weak/JJ inhibitory/JJ effects/NNS toward/IN other/JJ isoforms/NNS (/-LRB- CYP2C8/NN ,/, 2C9/NN ,/, 2C19/NN ,/, 2D6/NN ,/, 3A4/NN )/-RRB- were/VBD found/VBN ,/, but/CC Ki/NN values/NNS were/VBD in/IN excess/NN of/IN plasma/NN concentrations/NNS achieved/VBN following/VBG dosing/NN ./.

amod(effects-3, Weak-1)
amod(effects-3, inhibitory-2)
nsubjpass(found-19, effects-3)
amod(isoforms-6, other-5)
prep_toward(effects-3, isoforms-6)
dep(isoforms-6, CYP2C8-8)
appos(CYP2C8-8, 2C9-10)
appos(CYP2C8-8, 2C19-12)
appos(CYP2C8-8, 2D6-14)
appos(CYP2C8-8, 3A4-16)
auxpass(found-19, were-18)
root(ROOT-0, found-19)
nn(values-23, Ki-22)
nsubj(were-24, values-23)
conj_but(found-19, were-24)
prep_in(were-24, excess-26)
nn(concentrations-29, plasma-28)
prep_of(excess-26, concentrations-29)
partmod(concentrations-29, achieved-30)
prep_following(achieved-30, dosing-32)

Sentence Id: DrugDDI.d253.s21
The/DT most/RBS potent/JJ inhibitory/JJ activity/NN was/VBD observed/VBN for/IN vardenafil/NN metabolite/NN M1/NN ,/, which/WDT had/VBD a/DT Ki/NN of/IN 1.4/CD uM/NN toward/IN CYP3A4/NN ,/, which/WDT is/VBZ about/RB 20/CD times/NNS higher/JJR than/IN the/DT M1/NN Cmax/NN values/NNS after/IN an/DT 80/CD mg/NN Vardenafil/NN dose/NN ./.

det(activity-5, The-1)
advmod(potent-3, most-2)
amod(activity-5, potent-3)
amod(activity-5, inhibitory-4)
nsubjpass(observed-7, activity-5)
auxpass(observed-7, was-6)
root(ROOT-0, observed-7)
nn(M1-11, vardenafil-9)
nn(M1-11, metabolite-10)
prep_for(observed-7, M1-11)
nsubj(had-14, M1-11)
rcmod(M1-11, had-14)
det(Ki-16, a-15)
dobj(had-14, Ki-16)
nsubj(times-27, Ki-16)
num(uM-19, 1.4-18)
prep_of(Ki-16, uM-19)
prep_toward(uM-19, CYP3A4-21)
cop(times-27, is-24)
quantmod(times-27, about-25)
number(times-27, 20-26)
rcmod(Ki-16, times-27)
dep(times-27, higher-28)
det(values-33, the-30)
nn(values-33, M1-31)
nn(values-33, Cmax-32)
prep_than(times-27, values-33)
det(dose-39, an-35)
number(mg-37, 80-36)
amod(dose-39, mg-37)
nn(dose-39, Vardenafil-38)
prep_after(values-33, dose-39)

Sentence Id: DrugDDI.d253.s22
In/FW vivo/FW studies/NNS :/: Nitrates/NNS :/: The/DT blood/NN pressure/NN lowering/JJ effects/NNS of/IN sublingual/JJ nitrates/NNS (/-LRB- 0.4/CD mg/NN )/-RRB- taken/VBN 1/CD and/CC 4/CD hours/NNS after/IN vardenafil/NN and/CC increases/NNS in/IN heart/NN rate/NN when/WRB taken/VBN at/IN 1/CD ,/, 4/CD and/CC 8/CD hours/NNS were/VBD potentiated/VBN by/IN a/DT 20/CD mg/NN dose/NN of/IN Vardenafil/NN in/IN healthy/JJ middle-aged/JJ subjects/NNS ./.

nn(vivo-2, In-1)
amod(studies-3, vivo-2)
nsubjpass(potentiated-41, studies-3)
conj_and(studies-3, Nitrates-5)
det(effects-11, The-7)
nn(effects-11, blood-8)
nn(effects-11, pressure-9)
amod(effects-11, lowering-10)
conj_and(studies-3, effects-11)
amod(nitrates-14, sublingual-13)
prep_of(effects-11, nitrates-14)
num(mg-17, 0.4-16)
appos(nitrates-14, mg-17)
partmod(nitrates-14, taken-19)
num(hours-23, 1-20)
conj_and(1-20, 4-22)
npadvmod(taken-19, hours-23)
prep_after(taken-19, vardenafil-25)
conj_and(studies-3, increases-27)
nn(rate-30, heart-29)
prep_in(increases-27, rate-30)
advmod(taken-32, when-31)
dep(rate-30, taken-32)
num(hours-39, 1-34)
number(1-34, 4-36)
conj_and(1-34, 8-38)
prep_at(taken-32, hours-39)
auxpass(potentiated-41, were-40)
root(ROOT-0, potentiated-41)
det(dose-46, a-43)
number(mg-45, 20-44)
amod(dose-46, mg-45)
agent(potentiated-41, dose-46)
prep_of(dose-46, Vardenafil-48)
amod(subjects-52, healthy-50)
amod(subjects-52, middle-aged-51)
prep_in(Vardenafil-48, subjects-52)

Sentence Id: DrugDDI.d253.s23
These/DT effects/NNS were/VBD not/RB observed/VBN when/WRB Vardenafil/NN 20/CD mg/NN was/VBD taken/VBN 24/CD hours/NNS before/IN the/DT NTG/NN ./.

det(effects-2, These-1)
nsubjpass(observed-5, effects-2)
auxpass(observed-5, were-3)
neg(observed-5, not-4)
root(ROOT-0, observed-5)
advmod(taken-11, when-6)
nn(mg-9, Vardenafil-7)
num(mg-9, 20-8)
nsubjpass(taken-11, mg-9)
auxpass(taken-11, was-10)
advcl(observed-5, taken-11)
num(hours-13, 24-12)
npadvmod(taken-11, hours-13)
det(NTG-16, the-15)
prep_before(taken-11, NTG-16)

Sentence Id: DrugDDI.d253.s24
Potentiation/NN of/IN the/DT hypotensive/JJ effects/NNS of/IN nitrates/NNS for/IN patients/NNS with/IN ischemic/JJ heart/NN disease/NN has/VBZ not/RB been/VBN evaluated/VBN ,/, and/CC concomitant/JJ use/NN of/IN Vardenafil/NN and/CC nitrates/NNS is/VBZ contraindicated/VBN ./.

nsubjpass(evaluated-17, Potentiation-1)
det(effects-5, the-3)
amod(effects-5, hypotensive-4)
prep_of(Potentiation-1, effects-5)
prep_of(effects-5, nitrates-7)
prep_for(effects-5, patients-9)
amod(disease-13, ischemic-11)
nn(disease-13, heart-12)
prep_with(patients-9, disease-13)
aux(evaluated-17, has-14)
neg(evaluated-17, not-15)
auxpass(evaluated-17, been-16)
root(ROOT-0, evaluated-17)
amod(use-21, concomitant-20)
nsubjpass(contraindicated-27, use-21)
prep_of(use-21, Vardenafil-23)
conj_and(Vardenafil-23, nitrates-25)
auxpass(contraindicated-27, is-26)
conj_and(evaluated-17, contraindicated-27)

Sentence Id: DrugDDI.d253.s25
Nifedipine/NN :/: Vardenafil/NN 20/CD mg/NN ,/, when/WRB co-administered/VBN with/IN slow-release/JJ nifedipine/NN 30/CD mg/NN or/CC 60/CD mg/NN once/RB daily/RB ,/, did/VBD not/RB affect/VB the/DT relative/JJ bioavailability/NN (/-LRB- AUC/NN )/-RRB- or/CC maximum/JJ concentration/NN (/-LRB- Cmax/NN )/-RRB- of/IN nifedipine/NN ,/, a/DT drug/NN that/WDT is/VBZ metabolized/VBN via/IN CYP3A4/NN ./.

nsubj(affect-22, Nifedipine-1)
dep(Nifedipine-1, Vardenafil-3)
number(mg-5, 20-4)
amod(Vardenafil-3, mg-5)
advmod(co-administered-8, when-7)
dep(Nifedipine-1, co-administered-8)
amod(mg-13, slow-release-10)
nn(mg-13, nifedipine-11)
num(mg-13, 30-12)
prep_with(co-administered-8, mg-13)
num(mg-16, 60-15)
conj_or(mg-13, mg-16)
advmod(daily-18, once-17)
advmod(mg-16, daily-18)
aux(affect-22, did-20)
neg(affect-22, not-21)
root(ROOT-0, affect-22)
det(bioavailability-25, the-23)
amod(bioavailability-25, relative-24)
dobj(affect-22, bioavailability-25)
abbrev(bioavailability-25, AUC-27)
amod(concentration-31, maximum-30)
conj_or(bioavailability-25, concentration-31)
appos(concentration-31, Cmax-33)
prep_of(concentration-31, nifedipine-36)
det(drug-39, a-38)
appos(nifedipine-36, drug-39)
nsubjpass(metabolized-42, drug-39)
auxpass(metabolized-42, is-41)
rcmod(drug-39, metabolized-42)
prep_via(metabolized-42, CYP3A4-44)

Sentence Id: DrugDDI.d253.s26
Nifedipine/NN did/VBD not/RB alter/VB the/DT plasma/NN levels/NNS of/IN Vardenafil/NN when/WRB taken/VBN in/IN combination/NN ./.

nsubj(alter-4, Nifedipine-1)
aux(alter-4, did-2)
neg(alter-4, not-3)
root(ROOT-0, alter-4)
det(levels-7, the-5)
nn(levels-7, plasma-6)
dobj(alter-4, levels-7)
prep_of(levels-7, Vardenafil-9)
advmod(taken-11, when-10)
advcl(alter-4, taken-11)
prep_in(taken-11, combination-13)

Sentence Id: DrugDDI.d253.s27
In/IN these/DT patients/NNS whose/WP$ hypertension/NN was/VBD controlled/VBN with/IN nifedipine/NN ,/, Vardenafil/NN 20/CD mg/NN produced/VBD mean/JJ additional/JJ supine/NN systolic/diastolic/JJ blood/NN pressure/NN reductions/NNS of/IN 6/5/CD mm/NN Hg/NN compared/VBN to/TO placebo/NN ./.

det(patients-3, these-2)
poss(hypertension-5, patients-3)
prep_in(produced-14, patients-3)
nsubjpass(controlled-7, hypertension-5)
auxpass(controlled-7, was-6)
rcmod(patients-3, controlled-7)
prep_with(controlled-7, nifedipine-9)
nsubj(produced-14, Vardenafil-11)
number(mg-13, 20-12)
amod(Vardenafil-11, mg-13)
root(ROOT-0, produced-14)
amod(pressure-20, mean-15)
amod(pressure-20, additional-16)
nn(pressure-20, supine-17)
amod(pressure-20, systolic/diastolic-18)
nn(pressure-20, blood-19)
nn(reductions-21, pressure-20)
dobj(produced-14, reductions-21)
number(mm-24, 6/5-23)
amod(Hg-25, mm-24)
prep_of(reductions-21, Hg-25)
prepc_compared_to(produced-14, to-27)
pobj(produced-14, placebo-28)

Sentence Id: DrugDDI.d253.s28
Alpha-blockers/NNS :/: When/WRB Vardenafil/NN 10/CD or/CC 20/CD mg/NN was/VBD given/VBN to/TO healthy/JJ volunteers/NNS either/CC simultaneously/RB or/CC 6/CD hours/NNS after/IN a/DT 10/CD mg/NN dose/NN of/IN terazosin/NN ,/, significant/JJ hypotension/NN developed/VBD in/IN a/DT substantial/JJ number/NN of/IN subjects/NNS ./.

root(ROOT-0, Alpha-blockers-1)
advmod(was-9, When-3)
nsubj(was-9, Vardenafil-4)
num(Vardenafil-4, 10-5)
num(mg-8, 20-7)
conj_or(Vardenafil-4, mg-8)
advcl(developed-29, was-9)
dep(was-9, given-10)
amod(volunteers-13, healthy-12)
prep_to(given-10, volunteers-13)
preconj(given-10, either-14)
conj_or(given-10, simultaneously-15)
conj_or(given-10, or-16)
num(hours-18, 6-17)
npadvmod(after-19, hours-18)
conj_or(given-10, after-19)
det(dose-23, a-20)
number(mg-22, 10-21)
amod(dose-23, mg-22)
pobj(after-19, dose-23)
prep_of(dose-23, terazosin-25)
amod(hypotension-28, significant-27)
nsubj(developed-29, hypotension-28)
dep(Alpha-blockers-1, developed-29)
det(number-33, a-31)
amod(number-33, substantial-32)
prep_in(developed-29, number-33)
prep_of(number-33, subjects-35)

Sentence Id: DrugDDI.d253.s29
With/IN simultaneous/JJ dosing/NN of/IN Vardenafil/NN 10/CD mg/NN and/CC terazosin/NN 10/CD mg/NN ,/, 6/CD of/IN 8/CD subjects/NNS experienced/VBN a/DT standing/JJ systolic/JJ blood/NN pressure/NN of/IN less/JJR than/IN 85/CD mm/NN Hg/NN ./.

amod(dosing-3, simultaneous-2)
prep_with(experienced-17, dosing-3)
nn(mg-7, Vardenafil-5)
num(mg-7, 10-6)
prep_of(dosing-3, mg-7)
nn(mg-11, terazosin-9)
num(mg-11, 10-10)
conj_and(mg-7, mg-11)
number(8-15, 6-13)
quantmod(8-15, of-14)
num(subjects-16, 8-15)
nsubj(experienced-17, subjects-16)
root(ROOT-0, experienced-17)
det(pressure-22, a-18)
amod(pressure-22, standing-19)
amod(pressure-22, systolic-20)
nn(pressure-22, blood-21)
dobj(experienced-17, pressure-22)
mwe(than-25, less-24)
quantmod(85-26, than-25)
num(Hg-28, 85-26)
nn(Hg-28, mm-27)
prep_of(pressure-22, Hg-28)

Sentence Id: DrugDDI.d253.s30
With/IN simultaneous/JJ dosing/NN of/IN Vardenafil/NN 20/CD mg/NN and/CC terazosin/NN 10/CD mg/NN ,/, 2/CD of/IN 9/CD subjects/NNS experienced/VBN a/DT standing/JJ systolic/JJ blood/NN pressure/NN of/IN less/JJR than/IN 85/CD mm/NN Hg/NN ./.

amod(dosing-3, simultaneous-2)
prep_with(experienced-17, dosing-3)
nn(mg-7, Vardenafil-5)
num(mg-7, 20-6)
prep_of(dosing-3, mg-7)
nn(mg-11, terazosin-9)
num(mg-11, 10-10)
conj_and(mg-7, mg-11)
number(9-15, 2-13)
quantmod(9-15, of-14)
num(subjects-16, 9-15)
nsubj(experienced-17, subjects-16)
root(ROOT-0, experienced-17)
det(pressure-22, a-18)
amod(pressure-22, standing-19)
amod(pressure-22, systolic-20)
nn(pressure-22, blood-21)
dobj(experienced-17, pressure-22)
mwe(than-25, less-24)
quantmod(85-26, than-25)
num(Hg-28, 85-26)
nn(Hg-28, mm-27)
prep_of(pressure-22, Hg-28)

Sentence Id: DrugDDI.d253.s31
When/WRB Vardenafil/NN dosing/NN was/VBD separated/VBN from/IN terazosin/NN 10/CD mg/NN by/IN 6/CD hours/NNS ,/, 7/CD of/IN 28/CD subjects/NNS who/WP received/VBD 20/CD mg/NN of/IN Vardenafil/NN experienced/VBN a/DT decrease/NN in/IN standing/JJ systolic/JJ blood/NN pressure/NN below/IN 85/CD mm/NN Hg/NN ./.

advmod(separated-5, When-1)
nn(dosing-3, Vardenafil-2)
nsubjpass(separated-5, dosing-3)
auxpass(separated-5, was-4)
advcl(experienced-24, separated-5)
nn(mg-9, terazosin-7)
num(mg-9, 10-8)
prep_from(separated-5, mg-9)
num(hours-12, 6-11)
agent(separated-5, hours-12)
number(28-16, 7-14)
quantmod(28-16, of-15)
num(subjects-17, 28-16)
nsubj(received-19, subjects-17)
nsubj(experienced-24, subjects-17)
rcmod(subjects-17, received-19)
num(mg-21, 20-20)
dobj(received-19, mg-21)
prep_of(mg-21, Vardenafil-23)
root(ROOT-0, experienced-24)
det(decrease-26, a-25)
dobj(experienced-24, decrease-26)
amod(pressure-31, standing-28)
amod(pressure-31, systolic-29)
nn(pressure-31, blood-30)
prep_in(decrease-26, pressure-31)
number(mm-34, 85-33)
amod(Hg-35, mm-34)
prep_below(pressure-31, Hg-35)

Sentence Id: DrugDDI.d253.s32
In/IN a/DT similar/JJ study/NN with/IN tamsulosin/NN in/IN healthy/JJ volunteers/NNS ,/, 1/CD of/IN 24/CD subjects/NNS dosed/VBN with/IN Vardenafil/NN 20/CD mg/NN and/CC tamsulosin/NN 0.4/CD mg/NN separated/VBN by/IN 6/CD hours/NNS experienced/VBN a/DT standing/JJ systolic/JJ blood/NN pressure/NN below/IN 85/CD mm/NN Hg/NN ./.

det(study-4, a-2)
amod(study-4, similar-3)
prep_in(experienced-28, study-4)
prep_with(study-4, tamsulosin-6)
amod(volunteers-9, healthy-8)
prep_in(study-4, volunteers-9)
number(24-13, 1-11)
quantmod(24-13, of-12)
num(subjects-14, 24-13)
nsubj(experienced-28, subjects-14)
partmod(subjects-14, dosed-15)
nn(mg-19, Vardenafil-17)
num(mg-19, 20-18)
prep_with(dosed-15, mg-19)
nn(mg-23, tamsulosin-21)
num(mg-23, 0.4-22)
conj_and(mg-19, mg-23)
partmod(mg-19, separated-24)
num(hours-27, 6-26)
agent(separated-24, hours-27)
root(ROOT-0, experienced-28)
det(pressure-33, a-29)
amod(pressure-33, standing-30)
amod(pressure-33, systolic-31)
nn(pressure-33, blood-32)
dobj(experienced-28, pressure-33)
number(mm-36, 85-35)
amod(Hg-37, mm-36)
prep_below(pressure-33, Hg-37)

Sentence Id: DrugDDI.d253.s33
Two/CD of/IN 16/CD subjects/NNS dosed/VBN simultaneously/RB with/IN Vardenafil/NN 10/CD mg/NN and/CC tamsulosin/NN 0.4/CD mg/NN experienced/VBN a/DT standing/JJ systolic/JJ blood/NN pressure/NN below/IN 85/CD mm/NN Hg/NN ./.

nsubj(experienced-15, Two-1)
num(subjects-4, 16-3)
prep_of(Two-1, subjects-4)
partmod(subjects-4, dosed-5)
advmod(dosed-5, simultaneously-6)
nn(mg-10, Vardenafil-8)
num(mg-10, 10-9)
prep_with(dosed-5, mg-10)
nn(mg-14, tamsulosin-12)
num(mg-14, 0.4-13)
conj_and(mg-10, mg-14)
root(ROOT-0, experienced-15)
det(pressure-20, a-16)
amod(pressure-20, standing-17)
amod(pressure-20, systolic-18)
nn(pressure-20, blood-19)
dobj(experienced-15, pressure-20)
number(mm-23, 85-22)
amod(Hg-24, mm-23)
prep_below(pressure-20, Hg-24)

Sentence Id: DrugDDI.d253.s34
The/DT administration/NN of/IN lower/JJR doses/NNS of/IN Vardenafil/NN with/IN alpha-blockers/NNS has/VBZ not/RB been/VBN completely/RB evaluated/VBN to/TO determine/VB if/IN they/PRP can/MD be/VB safely/RB administered/VBN together/RB ./.

det(administration-2, The-1)
nsubjpass(evaluated-14, administration-2)
xsubj(determine-16, administration-2)
amod(doses-5, lower-4)
prep_of(administration-2, doses-5)
prep_of(doses-5, Vardenafil-7)
prep_with(Vardenafil-7, alpha-blockers-9)
aux(evaluated-14, has-10)
neg(evaluated-14, not-11)
auxpass(evaluated-14, been-12)
advmod(evaluated-14, completely-13)
root(ROOT-0, evaluated-14)
aux(determine-16, to-15)
xcomp(evaluated-14, determine-16)
mark(administered-22, if-17)
nsubjpass(administered-22, they-18)
aux(administered-22, can-19)
auxpass(administered-22, be-20)
advmod(administered-22, safely-21)
advcl(determine-16, administered-22)
advmod(administered-22, together-23)

Sentence Id: DrugDDI.d253.s35
Based/VBN on/IN these/DT data/NNS ,/, Vardenafil/NN should/MD not/RB be/VB used/VBN in/IN patients/NNS on/IN alpha-blocker/NN therapy/NN ./.

prepc_based_on(used-10, on-2)
det(data-4, these-3)
pobj(used-10, data-4)
nsubjpass(used-10, Vardenafil-6)
aux(used-10, should-7)
neg(used-10, not-8)
auxpass(used-10, be-9)
root(ROOT-0, used-10)
prep_in(used-10, patients-12)
nn(therapy-15, alpha-blocker-14)
prep_on(patients-12, therapy-15)

Sentence Id: DrugDDI.d253.s36
Ritonavir/NN and/CC indinavir/NN :/: Upon/IN concomitant/JJ administration/NN of/IN 5/CD mg/NN of/IN Vardenafil/NN with/IN 600/CD mg/NN BID/NN ritonavir/NN ,/, the/DT Cmax/NN and/CC AUC/NN of/IN ritonavir/NN were/VBD reduced/VBN by/IN approximately/RB 20/CD %./NN

root(ROOT-0, Ritonavir-1)
conj_and(Ritonavir-1, indinavir-3)
amod(administration-7, concomitant-6)
prep_upon(reduced-26, administration-7)
num(mg-10, 5-9)
prep_of(administration-7, mg-10)
prep_of(mg-10, Vardenafil-12)
number(mg-15, 600-14)
amod(ritonavir-17, mg-15)
nn(ritonavir-17, BID-16)
prep_with(mg-10, ritonavir-17)
dep(Cmax-20, the-19)
nsubjpass(reduced-26, Cmax-20)
conj_and(Cmax-20, AUC-22)
prep_of(Cmax-20, ritonavir-24)
auxpass(reduced-26, were-25)
dep(Ritonavir-1, reduced-26)
quantmod(20-29, approximately-28)
num(%.-30, 20-29)
agent(reduced-26, %.-30)

Sentence Id: DrugDDI.d253.s37
Upon/IN administration/NN of/IN 10/CD mg/NN of/IN Vardenafil/NN with/IN 800/CD mg/NN TID/NN indinavir/NN ,/, the/DT Cmax/NN and/CC AUC/NN of/IN indinavir/NN were/VBD reduced/VBN by/IN 40/CD %/NN and/CC 30/CD %/NN ,/, respectively/RB ./.

prep_upon(reduced-21, administration-2)
num(mg-5, 10-4)
prep_of(administration-2, mg-5)
prep_of(mg-5, Vardenafil-7)
number(mg-10, 800-9)
amod(indinavir-12, mg-10)
nn(indinavir-12, TID-11)
prep_with(mg-5, indinavir-12)
dep(Cmax-15, the-14)
nsubjpass(reduced-21, Cmax-15)
conj_and(Cmax-15, AUC-17)
prep_of(Cmax-15, indinavir-19)
auxpass(reduced-21, were-20)
root(ROOT-0, reduced-21)
num(%-24, 40-23)
agent(reduced-21, %-24)
num(%-27, 30-26)
conj_and(%-24, %-27)
advmod(%-24, respectively-29)
conj_and(%-24, respectively-29)

Sentence Id: DrugDDI.d253.s38
Alcohol/NN :/: Alcohol/NN (/-LRB- 0.5/CD g/kg/NN body/NN weight/NN :/: approximately/RB 40/CD mL/NN of/IN absolute/JJ alcohol/NN in/IN a/DT 70/CD kg/NN person/NN )/-RRB- and/CC vardenafil/NN plasma/NN levels/NNS were/VBD not/RB altered/VBN when/WRB dosed/VBN simultaneously/RB ./.

nsubjpass(altered-28, Alcohol-1)
conj_and(Alcohol-1, Alcohol-3)
num(weight-8, 0.5-5)
nn(weight-8, g/kg-6)
nn(weight-8, body-7)
dep(Alcohol-3, weight-8)
quantmod(40-11, approximately-10)
num(mL-12, 40-11)
dep(weight-8, mL-12)
amod(alcohol-15, absolute-14)
prep_of(mL-12, alcohol-15)
det(person-20, a-17)
num(person-20, 70-18)
nn(person-20, kg-19)
prep_in(alcohol-15, person-20)
nn(levels-25, vardenafil-23)
nn(levels-25, plasma-24)
conj_and(Alcohol-1, levels-25)
auxpass(altered-28, were-26)
neg(altered-28, not-27)
root(ROOT-0, altered-28)
advmod(dosed-30, when-29)
advcl(altered-28, dosed-30)
advmod(dosed-30, simultaneously-31)

Sentence Id: DrugDDI.d253.s39
Vardenafil/NN (/-LRB- 20/CD mg/NN )/-RRB- did/VBD not/RB potentiate/VB the/DT hypotensive/JJ effects/NNS of/IN alcohol/NN during/IN the/DT 4-hour/JJ observation/NN period/NN in/IN healthy/JJ volunteers/NNS when/WRB administered/VBN with/IN alcohol/NN (/-LRB- 0.5/CD g/kg/NN body/NN weight/NN )./CD

root(ROOT-0, Vardenafil-1)
num(mg-4, 20-3)
appos(Vardenafil-1, mg-4)
aux(potentiate-8, did-6)
neg(potentiate-8, not-7)
partmod(Vardenafil-1, potentiate-8)
det(effects-11, the-9)
amod(effects-11, hypotensive-10)
dobj(potentiate-8, effects-11)
prep_of(effects-11, alcohol-13)
det(period-18, the-15)
amod(period-18, 4-hour-16)
nn(period-18, observation-17)
prep_during(effects-11, period-18)
amod(volunteers-21, healthy-20)
prep_in(period-18, volunteers-21)
advmod(administered-23, when-22)
advcl(potentiate-8, administered-23)
prep_with(administered-23, alcohol-25)
num(weight-30, 0.5-27)
nn(weight-30, g/kg-28)
nn(weight-30, body-29)
dep(administered-23, weight-30)
num(weight-30, -RRB-.-31)

Sentence Id: DrugDDI.d253.s40
Aspirin/NN :/: Vardenafil/NN (/-LRB- 10/CD mg/NN and/CC 20/CD mg/NN )/-RRB- did/VBD not/RB potentiate/VB the/DT increase/NN in/IN bleeding/JJ time/NN caused/VBN by/IN aspirin/NN (/-LRB- two/CD 81/CD mg/NN tablets/NNS )./CD

root(ROOT-0, Aspirin-1)
nsubj(potentiate-13, Vardenafil-3)
num(mg-6, 10-5)
dep(Vardenafil-3, mg-6)
num(mg-9, 20-8)
conj_and(mg-6, mg-9)
aux(potentiate-13, did-11)
neg(potentiate-13, not-12)
dep(Aspirin-1, potentiate-13)
det(increase-15, the-14)
dobj(potentiate-13, increase-15)
amod(time-18, bleeding-17)
prep_in(increase-15, time-18)
partmod(time-18, caused-19)
nn(tablets-26, aspirin-21)
num(tablets-26, two-23)
num(tablets-26, 81-24)
nn(tablets-26, mg-25)
agent(caused-19, tablets-26)
num(tablets-26, -RRB-.-27)

Sentence Id: DrugDDI.d253.s41
Other/JJ interactions/NNS :/: Vardenafil/NN had/VBD no/DT effect/NN on/IN the/DT pharmacodynamics/NNS of/IN glyburide/NN (/-LRB- glucose/NN and/CC insulin/NN concentrations/NNS )/-RRB- and/CC warfarin/NN (/-LRB- prothrombin/NN time/NN or/CC other/JJ pharmacodynamic/JJ parameters/NNS )./NN

amod(interactions-2, Other-1)
root(ROOT-0, interactions-2)
nsubj(had-5, Vardenafil-4)
dep(interactions-2, had-5)
det(effect-7, no-6)
dobj(had-5, effect-7)
det(pharmacodynamics-10, the-9)
prep_on(had-5, pharmacodynamics-10)
prep_of(pharmacodynamics-10, glyburide-12)
nn(concentrations-17, glucose-14)
conj_and(glucose-14, insulin-16)
appos(glyburide-12, concentrations-17)
conj_and(glyburide-12, warfarin-20)
nn(time-23, prothrombin-22)
conj_and(glyburide-12, time-23)
amod(parameters-27, other-25)
amod(parameters-27, pharmacodynamic-26)
conj_or(glyburide-12, parameters-27)
dep(glyburide-12, -RRB-.-28)

Sentence Id: DrugDDI.d528.s0
Zidovudine/NN :/: There/EX is/VBZ no/DT significant/JJ pharmacokinetic/JJ interaction/NN between/IN ZDV/NN and/CC zalcitabine/NN which/WDT has/VBZ been/VBN confirmed/VBN clinically/RB ./.

dep(is-4, Zidovudine-1)
expl(is-4, There-3)
root(ROOT-0, is-4)
det(interaction-8, no-5)
amod(interaction-8, significant-6)
amod(interaction-8, pharmacokinetic-7)
nsubj(is-4, interaction-8)
nsubjpass(confirmed-16, interaction-8)
prep_between(interaction-8, ZDV-10)
conj_and(ZDV-10, zalcitabine-12)
aux(confirmed-16, has-14)
auxpass(confirmed-16, been-15)
rcmod(interaction-8, confirmed-16)
advmod(confirmed-16, clinically-17)

Sentence Id: DrugDDI.d528.s1
Zalcitabine/NN also/RB has/VBZ no/DT significant/JJ effect/NN on/IN the/DT intracellular/JJ phosphorylation/NN of/IN ZDV/NN ,/, as/IN shown/VBN in/FW vitro/FW in/IN peripheral/JJ blood/NN mononuclear/JJ cells/NNS or/CC in/IN two/CD other/JJ cell/NN lines/NNS (/-LRB- U937/NN and/CC Molt-4/NN )./NN

nsubj(has-3, Zalcitabine-1)
advmod(has-3, also-2)
root(ROOT-0, has-3)
det(effect-6, no-4)
amod(effect-6, significant-5)
dobj(has-3, effect-6)
det(phosphorylation-10, the-8)
amod(phosphorylation-10, intracellular-9)
prep_on(has-3, phosphorylation-10)
prep_of(phosphorylation-10, ZDV-12)
mark(shown-15, as-14)
advcl(has-3, shown-15)
nn(vitro-17, in-16)
advmod(shown-15, vitro-17)
amod(cells-22, peripheral-19)
nn(cells-22, blood-20)
amod(cells-22, mononuclear-21)
prep_in(shown-15, cells-22)
num(lines-28, two-25)
amod(lines-28, other-26)
nn(lines-28, cell-27)
conj_or(cells-22, lines-28)
dep(lines-28, U937-30)
conj_and(U937-30, Molt-4-32)
dep(U937-30, -RRB-.-33)

Sentence Id: DrugDDI.d528.s2
In/IN the/DT same/JJ study/NN it/PRP was/VBD shown/VBN that/IN didanosine/NN and/CC stavudine/NN had/VBD no/DT significant/JJ effect/NN on/IN the/DT intracellular/JJ phosphorylation/NN of/IN zalcitabine/NN in/IN peripheral/JJ blood/NN mononuclear/JJ cells/NNS ./.

det(study-4, the-2)
amod(study-4, same-3)
prep_in(shown-7, study-4)
nsubjpass(shown-7, it-5)
auxpass(shown-7, was-6)
root(ROOT-0, shown-7)
complm(had-12, that-8)
nsubj(had-12, didanosine-9)
conj_and(didanosine-9, stavudine-11)
ccomp(shown-7, had-12)
det(effect-15, no-13)
amod(effect-15, significant-14)
dobj(had-12, effect-15)
det(phosphorylation-19, the-17)
amod(phosphorylation-19, intracellular-18)
prep_on(had-12, phosphorylation-19)
prep_of(phosphorylation-19, zalcitabine-21)
amod(cells-26, peripheral-23)
nn(cells-26, blood-24)
amod(cells-26, mononuclear-25)
prep_in(phosphorylation-19, cells-26)

Sentence Id: DrugDDI.d528.s3
Lamivudine/NN :/: In/FW vitro/FW studies/NNS in/IN peripheral/JJ blood/NN mononuclear/JJ cells/NNS ,/, U937/NN and/CC Molt-4/NN cells/NNS revealed/VBD that/IN lamivudine/NN significantly/RB inhibited/VBD zalcitabine/NN phosphorylation/NN in/IN a/DT dose/NN dependent/JJ manner/NN ./.

root(ROOT-0, Lamivudine-1)
nn(vitro-4, In-3)
amod(studies-5, vitro-4)
nsubj(revealed-16, studies-5)
amod(cells-10, peripheral-7)
nn(cells-10, blood-8)
amod(cells-10, mononuclear-9)
prep_in(studies-5, cells-10)
conj_and(cells-10, U937-12)
nn(cells-15, Molt-4-14)
conj_and(cells-10, cells-15)
dep(Lamivudine-1, revealed-16)
complm(inhibited-20, that-17)
nsubj(inhibited-20, lamivudine-18)
advmod(inhibited-20, significantly-19)
ccomp(revealed-16, inhibited-20)
nn(phosphorylation-22, zalcitabine-21)
dobj(inhibited-20, phosphorylation-22)
det(manner-27, a-24)
dep(dependent-26, dose-25)
amod(manner-27, dependent-26)
prep_in(inhibited-20, manner-27)

Sentence Id: DrugDDI.d528.s4
Effects/NNS were/VBD already/RB seen/VBN with/IN doses/NNS corresponding/VBG to/TO relevant/JJ plasma/NN levels/NNS in/IN humans/NNS ,/, and/CC the/DT intracellular/JJ phosphorylation/NN of/IN zalcitabine/NN to/TO its/PRP$ three/CD metabolites/NNS (/-LRB- including/VBG the/DT active/JJ zalcitabine/NN triphosphate/NN metabolite/NN )/-RRB- was/VBD significantly/RB inhibited/VBN ./.

nsubjpass(seen-4, Effects-1)
auxpass(seen-4, were-2)
advmod(seen-4, already-3)
root(ROOT-0, seen-4)
prep_with(seen-4, doses-6)
partmod(doses-6, corresponding-7)
amod(levels-11, relevant-9)
nn(levels-11, plasma-10)
prep_to(corresponding-7, levels-11)
prep_in(levels-11, humans-13)
det(phosphorylation-18, the-16)
amod(phosphorylation-18, intracellular-17)
nsubjpass(inhibited-35, phosphorylation-18)
prep_of(phosphorylation-18, zalcitabine-20)
poss(metabolites-24, its-22)
num(metabolites-24, three-23)
prep_to(phosphorylation-18, metabolites-24)
dep(metabolites-24, including-26)
det(metabolite-31, the-27)
amod(metabolite-31, active-28)
nn(metabolite-31, zalcitabine-29)
nn(metabolite-31, triphosphate-30)
dobj(including-26, metabolite-31)
auxpass(inhibited-35, was-33)
advmod(inhibited-35, significantly-34)
conj_and(seen-4, inhibited-35)

Sentence Id: DrugDDI.d528.s5
Zalcitabine/NN inhibited/VBD lamivudine/NN phosphorylation/NN at/IN high/JJ concentration/NN ratios/NNS (/-LRB- 10/CD and/CC 100/CD )/-RRB- ;/: ./.

nsubj(inhibited-2, Zalcitabine-1)
root(ROOT-0, inhibited-2)
nn(phosphorylation-4, lamivudine-3)
dobj(inhibited-2, phosphorylation-4)
amod(ratios-8, high-6)
nn(ratios-8, concentration-7)
prep_at(inhibited-2, ratios-8)
dep(inhibited-2, 10-10)
conj_and(10-10, 100-12)

Sentence Id: DrugDDI.d528.s6
however/RB ,/, it/PRP is/VBZ considered/VBN to/TO be/VB unlikely/JJ that/IN this/DT decrease/NN of/IN phosphorylated/VBN lamivudine/NN concentration/NN is/VBZ of/IN clinical/JJ significance/NN ,/, as/IN lamivudine/NN is/VBZ a/DT more/RBR efficient/JJ substrate/NN for/IN deoxycytidine/NN kinase/NN than/IN zalcitabine/NN ./.

advmod(considered-5, however-1)
nsubjpass(considered-5, it-3)
xsubj(unlikely-8, it-3)
auxpass(considered-5, is-4)
root(ROOT-0, considered-5)
aux(unlikely-8, to-6)
cop(unlikely-8, be-7)
xcomp(considered-5, unlikely-8)
complm(is-16, that-9)
det(decrease-11, this-10)
nsubj(is-16, decrease-11)
amod(concentration-15, phosphorylated-13)
nn(concentration-15, lamivudine-14)
prep_of(decrease-11, concentration-15)
ccomp(unlikely-8, is-16)
amod(significance-19, clinical-18)
prep_of(is-16, significance-19)
mark(substrate-27, as-21)
nsubj(substrate-27, lamivudine-22)
cop(substrate-27, is-23)
det(substrate-27, a-24)
advmod(efficient-26, more-25)
amod(substrate-27, efficient-26)
advcl(is-16, substrate-27)
nn(kinase-30, deoxycytidine-29)
prep_for(substrate-27, kinase-30)
prep_than(substrate-27, zalcitabine-32)

Sentence Id: DrugDDI.d528.s7
These/DT in/FW vitro/FW studies/NNS suggest/VBP that/IN concomitant/JJ administration/NN of/IN zalcitabine/NN and/CC lamivudine/NN in/IN humans/NNS may/MD result/VB in/IN sub-therapeutic/JJ concentrations/NNS of/IN active/JJ phosphorylated/JJ zalcitabine/NN ,/, which/WDT may/MD lead/VB to/TO a/DT decreased/VBN antiretroviral/JJ effect/NN of/IN zalcitabine/NN ./.

det(studies-4, These-1)
nn(vitro-3, in-2)
amod(studies-4, vitro-3)
nsubj(suggest-5, studies-4)
root(ROOT-0, suggest-5)
complm(result-16, that-6)
amod(administration-8, concomitant-7)
nsubj(result-16, administration-8)
prep_of(administration-8, zalcitabine-10)
conj_and(zalcitabine-10, lamivudine-12)
prep_in(administration-8, humans-14)
aux(result-16, may-15)
ccomp(suggest-5, result-16)
amod(concentrations-19, sub-therapeutic-18)
prep_in(result-16, concentrations-19)
amod(zalcitabine-23, active-21)
amod(zalcitabine-23, phosphorylated-22)
prep_of(concentrations-19, zalcitabine-23)
nsubj(lead-27, zalcitabine-23)
aux(lead-27, may-26)
rcmod(zalcitabine-23, lead-27)
det(effect-32, a-29)
amod(effect-32, decreased-30)
amod(effect-32, antiretroviral-31)
prep_to(lead-27, effect-32)
prep_of(effect-32, zalcitabine-34)

Sentence Id: DrugDDI.d528.s9
Concomitant/JJ use/NN of/IN zalcitabine/NN and/CC lamivudine/NN is/VBZ not/RB recommended/VBN ./.

amod(use-2, Concomitant-1)
nsubjpass(recommended-9, use-2)
prep_of(use-2, zalcitabine-4)
conj_and(zalcitabine-4, lamivudine-6)
auxpass(recommended-9, is-7)
neg(recommended-9, not-8)
root(ROOT-0, recommended-9)

Sentence Id: DrugDDI.d528.s10
Saquinavir/NN :/: The/DT combination/NN of/IN HIVID/NN ,/, saquinavir/NN ,/, and/CC ZDV/NN has/VBZ been/VBN studied/VBN (/-LRB- as/IN triple/JJ combination/NN )/-RRB- in/IN adults/NNS ./.

root(ROOT-0, Saquinavir-1)
det(combination-4, The-3)
nsubjpass(studied-14, combination-4)
prep_of(combination-4, HIVID-6)
conj_and(HIVID-6, saquinavir-8)
conj_and(HIVID-6, ZDV-11)
aux(studied-14, has-12)
auxpass(studied-14, been-13)
dep(Saquinavir-1, studied-14)
dep(studied-14, as-16)
amod(combination-18, triple-17)
pobj(as-16, combination-18)
prep_in(studied-14, adults-21)

Sentence Id: DrugDDI.d528.s11
Pharmacokinetic/JJ data/NNS suggest/VBP that/IN absorption/NN ,/, metabolism/NN ,/, and/CC elimination/NN of/IN each/DT of/IN these/DT drugs/NNS are/VBP unchanged/JJ when/WRB they/PRP are/VBP used/VBN together/RB ./.

amod(data-2, Pharmacokinetic-1)
nsubj(suggest-3, data-2)
root(ROOT-0, suggest-3)
complm(unchanged-17, that-4)
nsubj(unchanged-17, absorption-5)
conj_and(absorption-5, metabolism-7)
conj_and(absorption-5, elimination-10)
prep_of(absorption-5, each-12)
det(drugs-15, these-14)
prep_of(each-12, drugs-15)
cop(unchanged-17, are-16)
ccomp(suggest-3, unchanged-17)
advmod(used-21, when-18)
nsubjpass(used-21, they-19)
auxpass(used-21, are-20)
advcl(unchanged-17, used-21)
advmod(used-21, together-22)

Sentence Id: DrugDDI.d528.s12
Drugs/NNS Associated/VBN With/IN Peripheral/JJ Neuropathy/NN :/: The/DT concomitant/JJ use/NN of/IN HIVID/NN with/IN drugs/NNS that/WDT have/VBP the/DT potential/NN to/TO cause/VB peripheral/JJ neuropathy/NN should/MD be/VB avoided/VBN where/WRB possible/JJ ./.

root(ROOT-0, Drugs-1)
partmod(Drugs-1, Associated-2)
amod(Neuropathy-5, Peripheral-4)
prep_with(Associated-2, Neuropathy-5)
det(use-9, The-7)
amod(use-9, concomitant-8)
nsubjpass(avoided-24, use-9)
prep_of(use-9, HIVID-11)
prep_with(use-9, drugs-13)
nsubj(have-15, drugs-13)
rcmod(drugs-13, have-15)
det(potential-17, the-16)
dobj(have-15, potential-17)
aux(cause-19, to-18)
infmod(potential-17, cause-19)
amod(neuropathy-21, peripheral-20)
dobj(cause-19, neuropathy-21)
aux(avoided-24, should-22)
auxpass(avoided-24, be-23)
dep(Drugs-1, avoided-24)
advmod(possible-26, where-25)
advcl(avoided-24, possible-26)

Sentence Id: DrugDDI.d528.s13
Drugs/NNS that/WDT have/VBP been/VBN associated/VBN with/IN peripheral/JJ neuropathy/NN include/VBP antiretroviral/JJ nucleoside/NN analogues/NNS ,/, chloramphenicol/NN ,/, cisplatin/NN ,/, dapsone/NN ,/, disulfiram/NN ,/, ethionamide/NN ,/, glutethimide/NN ,/, gold/NN ,/, hydralazine/NN ,/, iodoquinol/NN ,/, isoniazid/NN ,/, metronidazole/NN ,/, nitrofurantoin/NN ,/, phenytoin/NN ,/, ribavirin/NN ,/, and/CC vincristine/NN ./.

root(ROOT-0, Drugs-1)
nsubjpass(associated-5, Drugs-1)
aux(associated-5, have-3)
auxpass(associated-5, been-4)
rcmod(Drugs-1, associated-5)
amod(neuropathy-8, peripheral-7)
prep_with(associated-5, neuropathy-8)
ccomp(associated-5, include-9)
amod(analogues-12, antiretroviral-10)
nn(analogues-12, nucleoside-11)
dobj(include-9, analogues-12)
appos(analogues-12, chloramphenicol-14)
appos(analogues-12, cisplatin-16)
appos(analogues-12, dapsone-18)
conj_and(dapsone-18, disulfiram-20)
conj_and(dapsone-18, ethionamide-22)
conj_and(dapsone-18, glutethimide-24)
conj_and(dapsone-18, gold-26)
conj_and(dapsone-18, hydralazine-28)
conj_and(dapsone-18, iodoquinol-30)
conj_and(dapsone-18, isoniazid-32)
conj_and(dapsone-18, metronidazole-34)
conj_and(dapsone-18, nitrofurantoin-36)
conj_and(dapsone-18, phenytoin-38)
conj_and(dapsone-18, ribavirin-40)
conj_and(dapsone-18, vincristine-43)

Sentence Id: DrugDDI.d528.s14
Concomitant/JJ use/NN of/IN HIVID/NN with/IN didanosine/NN is/VBZ not/RB recommended/VBN ./.

amod(use-2, Concomitant-1)
nsubjpass(recommended-9, use-2)
prep_of(use-2, HIVID-4)
prep_with(use-2, didanosine-6)
auxpass(recommended-9, is-7)
neg(recommended-9, not-8)
root(ROOT-0, recommended-9)

Sentence Id: DrugDDI.d528.s15
Intravenous/JJ Pentamidin/NN e/NN :/: Treatment/NN with/IN HIVID/NN should/MD be/VB interrupted/VBN when/WRB the/DT use/NN of/IN a/DT drug/NN that/WDT has/VBZ the/DT potential/NN to/TO cause/VB pancreatitis/NN is/VBZ required/VBN ./.

amod(e-3, Intravenous-1)
nn(e-3, Pentamidin-2)
root(ROOT-0, e-3)
nsubjpass(interrupted-10, Treatment-5)
prep_with(Treatment-5, HIVID-7)
aux(interrupted-10, should-8)
auxpass(interrupted-10, be-9)
dep(e-3, interrupted-10)
advmod(required-25, when-11)
det(use-13, the-12)
nsubjpass(required-25, use-13)
det(drug-16, a-15)
prep_of(use-13, drug-16)
nsubj(has-18, drug-16)
rcmod(drug-16, has-18)
det(potential-20, the-19)
dobj(has-18, potential-20)
aux(cause-22, to-21)
infmod(potential-20, cause-22)
dobj(cause-22, pancreatitis-23)
auxpass(required-25, is-24)
advcl(interrupted-10, required-25)

Sentence Id: DrugDDI.d528.s16
Death/NN due/IN to/TO fulminant/JJ pancreatitis/NN possibly/RB related/JJ to/TO intravenous/JJ pentamidin/NN e/NN and/CC HIVID/NN has/VBZ been/VBN reported/VBN ./.

nsubjpass(reported-16, Death-1)
amod(pancreatitis-5, fulminant-4)
prep_due_to(Death-1, pancreatitis-5)
advmod(related-7, possibly-6)
amod(Death-1, related-7)
amod(e-11, intravenous-9)
nn(e-11, pentamidin-10)
prep_to(related-7, e-11)
conj_and(e-11, HIVID-13)
aux(reported-16, has-14)
auxpass(reported-16, been-15)
root(ROOT-0, reported-16)

Sentence Id: DrugDDI.d528.s17
If/IN intravenous/JJ pentamidin/NN e/NN is/VBZ required/VBN to/TO treat/VB Pneumocystis/NN carinii/NN pneumonia/NNS ,/, treatment/NN with/IN HIVID/NN should/MD be/VB interrupted/VBN ./.

mark(required-6, If-1)
amod(e-4, intravenous-2)
nn(e-4, pentamidin-3)
nsubjpass(required-6, e-4)
xsubj(treat-8, e-4)
auxpass(required-6, is-5)
advcl(interrupted-18, required-6)
aux(treat-8, to-7)
xcomp(required-6, treat-8)
nn(pneumonia-11, Pneumocystis-9)
nn(pneumonia-11, carinii-10)
dobj(treat-8, pneumonia-11)
nsubjpass(interrupted-18, treatment-13)
prep_with(treatment-13, HIVID-15)
aux(interrupted-18, should-16)
auxpass(interrupted-18, be-17)
root(ROOT-0, interrupted-18)

Sentence Id: DrugDDI.d528.s18
Amphotericin/NN ,/, Foscarnet/NN ,/, and/CC Aminoglycosides/NN :/: Drugs/NNS such/JJ as/IN amphotericin/NN ,/, foscarnet/NN ,/, and/CC aminoglycosides/NNS may/MD increase/VB the/DT risk/NN of/IN developing/VBG peripheral/JJ neuropathy/NN or/CC other/JJ HIVID/NN -associated/JJ adverse/JJ events/NNS by/IN interfering/VBG with/IN the/DT renal/JJ clearance/NN of/IN zalcitabine/NN (/-LRB- thereby/RB raising/VBG systemic/JJ exposure/NN )./NN

root(ROOT-0, Amphotericin-1)
conj_and(Amphotericin-1, Foscarnet-3)
conj_and(Amphotericin-1, Aminoglycosides-6)
nsubj(increase-18, Drugs-8)
prep_such_as(Drugs-8, amphotericin-11)
conj_and(amphotericin-11, foscarnet-13)
conj_and(amphotericin-11, aminoglycosides-16)
aux(increase-18, may-17)
dep(Amphotericin-1, increase-18)
det(risk-20, the-19)
dobj(increase-18, risk-20)
amod(events-30, developing-22)
amod(neuropathy-24, peripheral-23)
npadvmod(-associated-28, neuropathy-24)
amod(HIVID-27, other-26)
conj_or(neuropathy-24, HIVID-27)
amod(events-30, -associated-28)
amod(events-30, adverse-29)
prep_of(risk-20, events-30)
prepc_by(increase-18, interfering-32)
det(clearance-36, the-34)
amod(clearance-36, renal-35)
prep_with(interfering-32, clearance-36)
prep_of(clearance-36, zalcitabine-38)
advmod(raising-41, thereby-40)
xcomp(increase-18, raising-41)
amod(-RRB-.-44, systemic-42)
nn(-RRB-.-44, exposure-43)
dobj(raising-41, -RRB-.-44)

Sentence Id: DrugDDI.d528.s19
Patients/NNS who/WP require/VBP the/DT use/NN of/IN one/CD of/IN these/DT drugs/NNS with/IN HIVID/NN should/MD have/VBP frequent/JJ clinical/JJ and/CC laboratory/JJ monitoring/NN with/IN dosage/JJ adjustment/NN for/IN any/DT significant/JJ change/NN in/IN renal/JJ function/NN ./.

nsubj(require-3, Patients-1)
nsubj(have-14, Patients-1)
rcmod(Patients-1, require-3)
det(use-5, the-4)
dobj(require-3, use-5)
prep_of(use-5, one-7)
det(drugs-10, these-9)
prep_of(one-7, drugs-10)
prep_with(use-5, HIVID-12)
aux(have-14, should-13)
root(ROOT-0, have-14)
amod(monitoring-19, frequent-15)
amod(monitoring-19, clinical-16)
conj_and(clinical-16, laboratory-18)
dobj(have-14, monitoring-19)
amod(adjustment-22, dosage-21)
prep_with(have-14, adjustment-22)
det(change-26, any-24)
amod(change-26, significant-25)
prep_for(adjustment-22, change-26)
amod(function-29, renal-28)
prep_in(change-26, function-29)

Sentence Id: DrugDDI.d528.s20
Probenecid/NN or/CC Cimetidine/NN :/: Concomitant/JJ administration/NN of/IN probenecid/NN or/CC cimetidine/NN decreases/VBZ the/DT elimination/NN of/IN zalcitabine/NN ,/, most/RBS likely/RB by/IN inhibition/NN of/IN renal/JJ tubular/JJ secretion/NN of/IN zalcitabine/NN ./.

root(ROOT-0, Probenecid-1)
conj_or(Probenecid-1, Cimetidine-3)
amod(administration-6, Concomitant-5)
nsubj(decreases-11, administration-6)
prep_of(administration-6, probenecid-8)
conj_or(probenecid-8, cimetidine-10)
dep(Probenecid-1, decreases-11)
det(elimination-13, the-12)
dobj(decreases-11, elimination-13)
prep_of(elimination-13, zalcitabine-15)
advmod(likely-18, most-17)
advmod(decreases-11, likely-18)
prep_by(decreases-11, inhibition-20)
amod(secretion-24, renal-22)
amod(secretion-24, tubular-23)
prep_of(inhibition-20, secretion-24)
prep_of(secretion-24, zalcitabine-26)

Sentence Id: DrugDDI.d528.s21
Patients/NNS receiving/VBG these/DT drugs/NNS in/IN combination/NN with/IN zalcitabine/NN should/MD be/VB monitored/VBN for/IN signs/NNS of/IN toxicity/NN and/CC the/DT dose/NN of/IN zalcitabine/NN reduced/VBD if/IN warranted/VBN ./.

nsubjpass(monitored-11, Patients-1)
partmod(Patients-1, receiving-2)
det(drugs-4, these-3)
dobj(receiving-2, drugs-4)
prep_in(receiving-2, combination-6)
prep_with(combination-6, zalcitabine-8)
aux(monitored-11, should-9)
auxpass(monitored-11, be-10)
root(ROOT-0, monitored-11)
prep_for(monitored-11, signs-13)
prep_of(signs-13, toxicity-15)
det(dose-18, the-17)
nsubj(reduced-21, dose-18)
prep_of(dose-18, zalcitabine-20)
conj_and(monitored-11, reduced-21)
mark(warranted-23, if-22)
advcl(reduced-21, warranted-23)

Sentence Id: DrugDDI.d528.s22
Magnesium/NN /Aluminum-containing/JJ Antacid/JJ Products/NNS :/: Absorption/NN of/IN zalcitabine/NN is/VBZ moderately/RB reduced/VBN (/-LRB- approximately/RB 25/CD %/NN )/-RRB- when/WRB coadministered/VBN with/IN magnesium/NN /aluminum-containing/NN antacid/JJ products/NNS ./.

nn(Products-4, Magnesium-1)
amod(Products-4, /Aluminum-containing-2)
amod(Products-4, Antacid-3)
root(ROOT-0, Products-4)
nsubjpass(reduced-11, Absorption-6)
prep_of(Absorption-6, zalcitabine-8)
auxpass(reduced-11, is-9)
advmod(reduced-11, moderately-10)
dep(Products-4, reduced-11)
quantmod(25-14, approximately-13)
num(%-15, 25-14)
dep(reduced-11, %-15)
advmod(coadministered-18, when-17)
advcl(reduced-11, coadministered-18)
nn(products-23, magnesium-20)
nn(products-23, /aluminum-containing-21)
amod(products-23, antacid-22)
prep_with(coadministered-18, products-23)

Sentence Id: DrugDDI.d528.s23
The/DT clinical/JJ significance/NN of/IN this/DT reduction/NN is/VBZ not/RB known/VBN ,/, hence/RB zalcitabine/NN is/VBZ not/RB recommended/VBN to/TO be/VB ingested/VBN simultaneously/RB with/IN magnesium/NN //: aluminum-containing/JJ antacids/NNS ./.

det(significance-3, The-1)
amod(significance-3, clinical-2)
nsubjpass(known-9, significance-3)
det(reduction-6, this-5)
prep_of(significance-3, reduction-6)
auxpass(known-9, is-7)
neg(known-9, not-8)
root(ROOT-0, known-9)
advmod(known-9, hence-11)
nsubjpass(recommended-15, zalcitabine-12)
xsubj(ingested-18, zalcitabine-12)
auxpass(recommended-15, is-13)
neg(recommended-15, not-14)
dep(known-9, recommended-15)
aux(ingested-18, to-16)
auxpass(ingested-18, be-17)
xcomp(recommended-15, ingested-18)
advmod(ingested-18, simultaneously-19)
prep_with(ingested-18, magnesium-21)
punct(magnesium-21, /-22)
amod(antacids-24, aluminum-containing-23)
dep(magnesium-21, antacids-24)

Sentence Id: DrugDDI.d528.s24
Metoclopramide/NN :/: Bioavailability/NN is/VBZ mildly/RB reduced/VBN (/-LRB- approximately/RB 10/CD %/NN )/-RRB- when/WRB zalcitabine/NN and/CC metoclopramide/NN are/VBP coadministered/VBN ./.

nn(Bioavailability-3, Metoclopramide-1)
nsubjpass(reduced-6, Bioavailability-3)
auxpass(reduced-6, is-4)
advmod(reduced-6, mildly-5)
root(ROOT-0, reduced-6)
quantmod(10-9, approximately-8)
num(%-10, 10-9)
dep(reduced-6, %-10)
advmod(coadministered-17, when-12)
nsubjpass(coadministered-17, zalcitabine-13)
conj_and(zalcitabine-13, metoclopramide-15)
auxpass(coadministered-17, are-16)
advcl(reduced-6, coadministered-17)

Sentence Id: DrugDDI.d528.s25
Doxorubicin/NN :/: Doxorubicin/NN caused/VBD a/DT decrease/NN in/IN zalcitabine/NN phosphorylation/NN (/-LRB- 50/CD %/NN inhibition/NN of/IN total/JJ phosphate/NN formation/NN )/-RRB- in/IN U937/Molt/NN 4/CD cells/NNS ./.

root(ROOT-0, Doxorubicin-1)
nsubj(caused-4, Doxorubicin-3)
dep(Doxorubicin-1, caused-4)
det(decrease-6, a-5)
dobj(caused-4, decrease-6)
iobj(caused-4, decrease-6)
nn(phosphorylation-9, zalcitabine-8)
prep_in(decrease-6, phosphorylation-9)
number(%-12, 50-11)
amod(inhibition-13, %-12)
dep(decrease-6, inhibition-13)
amod(formation-17, total-15)
nn(formation-17, phosphate-16)
prep_of(inhibition-13, formation-17)
nn(cells-22, U937/Molt-20)
num(cells-22, 4-21)
prep_in(caused-4, cells-22)

Sentence Id: DrugDDI.d528.s26
Although/IN there/EX may/MD be/VB decreased/VBN zalcitabine/NN activity/NN because/IN of/IN lessened/JJ active/JJ metabolite/NN formation/NN ,/, the/DT clinical/JJ relevance/NN of/IN these/DT in/FW vitro/FW results/NNS are/VBP not/RB known/VBN ./.

mark(activity-7, Although-1)
expl(activity-7, there-2)
aux(activity-7, may-3)
dep(activity-7, be-4)
amod(activity-7, decreased-5)
nn(activity-7, zalcitabine-6)
advcl(known-25, activity-7)
amod(formation-13, lessened-10)
amod(formation-13, active-11)
nn(formation-13, metabolite-12)
prep_because_of(activity-7, formation-13)
det(relevance-17, the-15)
amod(relevance-17, clinical-16)
nsubjpass(known-25, relevance-17)
det(results-22, these-19)
nn(vitro-21, in-20)
amod(results-22, vitro-21)
prep_of(relevance-17, results-22)
auxpass(known-25, are-23)
neg(known-25, not-24)
root(ROOT-0, known-25)

